Sentence,class,file
https://www.imf.org/external/pubs/ft/weo/2015/02/ weodata/index.aspx (accessed 16 Jan 2016).,OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
"Geneva: World Health Organization, 2003. http://www.who.int/choice/publications/p_2003_generalised_cea.pdf (accessed 10 Nov2014).",Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
"Copenhagen, Denmark and Lausanne, Switzerland: Copenhagen Consensus Center and Rush Foundation, 2011. http://www.copenhagenconsensus.com/sites/default/files/behrman_kohler.pdf (accessed 10 Nov 2014).",Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
"Washington DC: World Bank, 2012. http://reliefweb.int/sites/reliefweb.int/files/resources/Full_Report_2938.pdf (accessed 20 Apr 2015).",Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
http://www.healthdata.org/policy-report/financing-global-health-2013-transition-age-austerity(accessed 2 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
http://www.unitaid.eu/en/resources/ publications/annual-reports (accessed 1 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
http://www.iffim.org/about/overview/(accessed 1 Nov 2014).44.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2015-009656.PMC4785296.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010184).,Non-OADS,/arxiv_data1/oa_pdf/32/eb/bmjopen-2015-010184.PMC4785298.pdf
http://www.ungdata.no (October2015).,Non-OADS,/arxiv_data1/oa_pdf/32/eb/bmjopen-2015-010184.PMC4785298.pdf
"Børn og unge i Danmark, velfærd og trivsel 2014, Det nationale forskningscenter for velfærd.http://www.sfi.dk (October 2015).",Non-OADS,/arxiv_data1/oa_pdf/32/eb/bmjopen-2015-010184.PMC4785298.pdf
http://www.mucf.se/publikationer/ung-i-dag-2013-sammanfattning (October 2015).,Non-OADS,/arxiv_data1/oa_pdf/32/eb/bmjopen-2015-010184.PMC4785298.pdf
doi:10.1136/bmjopen-2015- 009212 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009212).,Non-OADS,/arxiv_data1/oa_pdf/91/77/bmjopen-2015-009212.PMC4785299.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/77/bmjopen-2015-009212.PMC4785299.pdf
"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, 2004. http://www.wma.net/en/30publications/10policies/b3/ 22.",Non-OADS,/arxiv_data1/oa_pdf/91/77/bmjopen-2015-009212.PMC4785299.pdf
A bespoke modulareducation package was developed in collaboration with an NHS provider of web-based interactive educational materials (LearnPro NHS: http://www.learnpro.co.uk).This includes in-built assessment to ensure acquisition of core knowledge across a range of relevant domains.,Non-OADS,/arxiv_data1/oa_pdf/b9/76/bmjopen-2015-010148.PMC4785300.pdf
"DATA COLLECTION Demographic and sedation-related dataFor all participating patients age, sex, APACHE II score and admission diagnosis were recorded via the Scottish Intensive Care Society Audit database (http://www.sicsag.scot.nhs.uk).",Non-OADS,/arxiv_data1/oa_pdf/b9/76/bmjopen-2015-010148.PMC4785300.pdf
"The planned analyses will be performed using STATA (StataCorp; http://www.stata.com), MLwiN (University of Bristol; http://www.bristol.ac.uk/cmm/software/mlwin) and SAS (http://www.sas.com) statis- tical software.",OADS,/arxiv_data1/oa_pdf/b9/76/bmjopen-2015-010148.PMC4785300.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010802).,Non-OADS,/arxiv_data1/oa_pdf/80/a3/bmjopen-2015-010802.PMC4785302.pdf
http://www.help.senate.gov/imo/media/doc/Yeh1.pdf (assessed 15 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/80/a3/bmjopen-2015-010802.PMC4785302.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010662).,Non-OADS,/arxiv_data1/oa_pdf/59/a7/bmjopen-2015-010662.PMC4785303.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/59/a7/bmjopen-2015-010662.PMC4785303.pdf
Competing interests All the authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activitiesthat could appear to have influenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. International Diabetes Federation.,Non-OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
2010. http://www.idf.org/china-spends-rmb-1734-billion-us25-billion-year-diabetes-treatment 7.,Non-OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
"Secondary Current demography of Fengtai oldresidents, 2012. http://www.ft.bjstats.gov.cn/html/20130617/807522.html 17.",OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
"Canberra, 2012. http://www.abs.",Non-OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
"Secondary 2011 National Demonstration CommunityHealth Service Center List, 2011. http://www.moh.gov.cn/zwgkzt/wsbysj/201112/53666.shtml 34.",Non-OADS,/arxiv_data1/oa_pdf/6b/f4/bmjopen-2015-009319.PMC4785304.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010818).,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
2012. http://apps.who.int/iris/bitstream/10665/85313/1/9789241504935_eng.pdf?ua=1 (accessed Nov 2015).,OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
2008. http://www.nice.org.uk/guidance/PH11 (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
https://clinicaltrials.gov/ (accessed Nov 2015).43.,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
http://www.cap.org (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
http://www.deqas.org (accessed Nov 2015).45.,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
http://www.stat.ubc.ca/~rollin/stats/ ssize/ (accessed Nov 2015).,OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
http://www.safety.duke.edu/Radsafety/ consents/default.asp (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b3/a9/bmjopen-2015-010818.PMC4785305.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009723).,Non-OADS,/arxiv_data1/oa_pdf/aa/10/bmjopen-2015-009723.PMC4785307.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/10/bmjopen-2015-009723.PMC4785307.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009396).,Non-OADS,/arxiv_data1/oa_pdf/24/a1/bmjopen-2015-009396.PMC4785308.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/24/a1/bmjopen-2015-009396.PMC4785308.pdf
Edinburgh: SIGN; 2012. http://www.sign.ac.uk 16.,Non-OADS,/arxiv_data1/oa_pdf/24/a1/bmjopen-2015-009396.PMC4785308.pdf
http://www.education.vic.,Non-OADS,/arxiv_data1/oa_pdf/24/a1/bmjopen-2015-009396.PMC4785308.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008330).,Non-OADS,/arxiv_data1/oa_pdf/7d/8c/bmjopen-2015-008330.PMC4785309.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/1f/bmjopen-2015-010042.PMC4785310.pdf
http://www.ons.gov.uk/ons/data/dataset-finder/-/q/datasetView/Census/DC2804EWr?p_auth=qwA7IMRn&p_p_auth=V0gcqSls&p_p_lifecycle=1&_FOFlow1_WAR_FOFlow1portlet_geoTypeId=2011STATH&_FOFlow1_WAR_FOFlow1portlet_UUID=0# 12.,OADS,/arxiv_data1/oa_pdf/01/1f/bmjopen-2015-010042.PMC4785310.pdf
http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=1757978&tool=pmcentrez&rendertype=abstract http://dx.doi.org/10.1136/qhc.10.2.90 26.,OADS,/arxiv_data1/oa_pdf/01/1f/bmjopen-2015-010042.PMC4785310.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010442).,Non-OADS,/arxiv_data1/oa_pdf/bf/f1/bmjopen-2015-010442.PMC4785311.pdf
"Competing interests All the authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on requestfrom the corresponding author) and declare that they have received no support from any organisation for the submitted work, that they have no financial or non-financial interests that may be relevant to the submitted work, nor do their spouses, partners, or children.",Non-OADS,/arxiv_data1/oa_pdf/bf/f1/bmjopen-2015-010442.PMC4785311.pdf
http://publicationethics.org/files/u7141/COPE2000pdfcomplete.pdf(accessed 26 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/bf/f1/bmjopen-2015-010442.PMC4785311.pdf
http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000033.pub2/abstract (accessed 26 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/bf/f1/bmjopen-2015-010442.PMC4785311.pdf
http://community.cochrane.org/news/tags/authors/mecir-reporting-standards-now-finalized (accessed 26 Oct 2015).,OADS,/arxiv_data1/oa_pdf/bf/f1/bmjopen-2015-010442.PMC4785311.pdf
2015. https://in.news.yahoo.com/why-are-we-pretending-that-there-isn-t-a-growing-mountain-of-menstrual-waste-we-need-to-deal-with-111659074.html(accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/bmjopen-2015-010290.PMC4785312.pdf
2015. http://www.hindustantimes.com/wellness/ladies-be-careful-when-you-throw-away-the-sanitary-napkin/article1-1366417.aspx (accessed 24 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/bmjopen-2015-010290.PMC4785312.pdf
2000. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/283599/sex_and_relationship_education_guidance.pdf (accessed 24 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/bmjopen-2015-010290.PMC4785312.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009738).,Non-OADS,/arxiv_data1/oa_pdf/a7/ad/bmjopen-2015-009738.PMC4785317.pdf
"Secondary American Cancer Societyguidelines for the early detection of cancer March 5, 2008 2008.http://www.cancer.org/docroot/PED/content/PED_2_3X_ACS_Cancer_Detection_Guidelines_36.asp 29.",Non-OADS,/arxiv_data1/oa_pdf/a7/ad/bmjopen-2015-009738.PMC4785317.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010509).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
13 Participants Participants included in this study were published full text Cochrane Schizophrenia Group systematic reviews in TheCochrane Library with PLS which are available for free at http://www.summaries.cochrane.org.,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
Table 1 Example of the three tweets relating to the same review Tweet 1 #Clozapine combined with different #antipsychotic #drugs for#treatment resistant #schizophrenia http://ow.ly/yaKAU Tweet 2 How effective is #clozapine in addition to another #antipsychotics at treating ‘hard to treat ’ #schizophrenia?,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
"http://ow.ly/yaKAU Tweet 3 Not clear if combining #clozapine with other #antipsychotics is effective for #treatmentresistant #schizophrenia http://ow.ly/yaKAU 2 Adams CE, et al.BMJ Open 2016; 6:e010509.",Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
This free package allows formulation and scheduling of Tweets and is now available in China and integrates with Weibo (http://blog.hootsuite.com/chinese-localization-weibo/).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
Standards for the reporting of Plain Language Summaries in new Cochrane Intervention Reviews(PLEACS) 2014. http://consumers.cochrane.org/PLEACS (accessed 1 May 2015).,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2014. http://www.cochrane.org/search/site (accessed 1 May 2015).,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2014. https://about.twitter.com/ company (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2011. http://releases.jhu.edu/2011/07/06/tracking-public-health-trends-from-twitter-messages/ (accessed1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2013. http://www.go-globe.com/blog/social-media-china/ (accessed1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2011. http://www.orei.unimelb.,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2013. http://www.hra-decisiontools.org.uk/ethics/ (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2010. http://webanalysis.blogspot.co.uk/2010/07/best-time-to-tweet.html#axzz2qdk2Y69r (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2013 http://mashable.com/2013/09/18/hootsuite-beginners-guide/(accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2014. http://www.google.com/ analytics/ (accessed 1 May 2015).,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2014. http://yourbusiness.azcentral.com/purpose-google-analytics-6390.html (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2012. http://blog.bitly.com/post/ 22663850994/time-is-on-your-side (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2013. http://www.orbitmedia.com/blog/ inaccurate-google-analytics-traffic-sources/ (accessed 1 May 2015).,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
2013. http://www.352inc.com/blog/google-analytics-terms-defined/?utm_source=www.352media.com (accessed 1 May 2015).,OADS,/arxiv_data1/oa_pdf/ae/46/bmjopen-2015-010509.PMC4785321.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010956).,Non-OADS,/arxiv_data1/oa_pdf/b3/f2/bmjopen-2015-010956.PMC4785322.pdf
The trial is registered at http://www.clinicaltrials.gov (NCT01962571) and http://www.,Non-OADS,/arxiv_data1/oa_pdf/b3/f2/bmjopen-2015-010956.PMC4785322.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/f2/bmjopen-2015-010956.PMC4785322.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009594).,Non-OADS,/arxiv_data1/oa_pdf/89/d9/bmjopen-2015-009594.PMC4785323.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010343).,Non-OADS,/arxiv_data1/oa_pdf/fd/9b/bmjopen-2015-010343.PMC4785324.pdf
http://www.iasp-pain.org/Taxonomy#Centralsensitization (accessed 12 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/9b/bmjopen-2015-010343.PMC4785324.pdf
33. http://www.fk.cvz.nl/Preparaatteksten/D/duloxetine.asp (accessed 2 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/fd/9b/bmjopen-2015-010343.PMC4785324.pdf
http://pi.lilly.com/us/cymbalta-pi.pdf (accessed 18Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/fd/9b/bmjopen-2015-010343.PMC4785324.pdf
http://www.nfu.nl/img/pdf/NFU12.6053_Kwaliteitsborging_mensgebonden_onderzoek_2.0.pdf (accessed 18 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/9b/bmjopen-2015-010343.PMC4785324.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010471).,Non-OADS,/arxiv_data1/oa_pdf/9f/44/bmjopen-2015-010471.PMC4785325.pdf
"http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf(available in December 2015, in Japanese).",OADS,/arxiv_data1/oa_pdf/9f/44/bmjopen-2015-010471.PMC4785325.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010801).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
http://www.zm.undp.org/content/dam/zambia/docs/mdgs/MDG%20Report%202013.pdf (accessed 29 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
Published Online First: 2003. http://cdrwww.who.int/entity/healthinfo/survey/ageing_mds_report_en_pretoria.pdf (accessed 8 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
2014. http://hdr.undp.org/sites/default/files/ hdr14-report-en-1.pdf (accessed 18 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
"Lusaka, Zambia: Central Statistical Office, 2012. http://www.zamstats.gov.zm/report/Census/2010/National/2010%20Census%20of%20Population%20National%20Analytical%20Report.pdf 10.",Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
http://unstats.un.org/unsd/demographic/sources/census/2010_phc/Zambia/PreliminaryReport.pdf (accessed 24 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
"Lusaka, Zambia, 2014. http://www.unaids.org/sites/ default/files/country/documents/ZMB_narrative_report_2014.pdf(accessed 21 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
http://www.iasociety.org/Default.aspx?pageId=11&abstractId=2177493 31.,OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
2013. http://esa.un.org/wpp/documentation/pdf/WPP2012_Volume-II-Demographic-Profiles.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/bmjopen-2015-010801.PMC4785326.pdf
"The trial is registered at the EU Clinical Trials Register (EudraCT: 2012-000452-34), as well as at http://www.clinicaltrial.gov (NCT02040441).",Non-OADS,/arxiv_data1/oa_pdf/90/c0/bmjopen-2015-010310.PMC4785328.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009937).,Non-OADS,/arxiv_data1/oa_pdf/8d/34/bmjopen-2015-009937.PMC4785329.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/34/bmjopen-2015-009937.PMC4785329.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
2008. http://www.guardian.co.uk/world/2008/aug/07/china.olympics2008(accessed 25 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
2010. http://www.chinadaily.com.cn/china/2010-09/08/content_11275815.htm (accessed 25 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
2013. http://www.who.int/tobacco/global_report/2013/ report.pdf (accessed 25 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
2004. http://en.wikipedia.org/wiki/List_of_People ’s_Republic_of_China_administrative_divisions_by_ population_density (accessed 25 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
http://whb.ncpublichealth.com/Manuals/counseling/ Secondhand-Smoke.pdf (accessed 25 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
"Hobart, Australia, 2007. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.508.4336&rep=rep1&type=pdf(accessed 28 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2015-010058.PMC4785330.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008571).,Non-OADS,/arxiv_data1/oa_pdf/fb/99/bmjopen-2015-008571.PMC4785340.pdf
"Ithaca, New York, USA: Palisade Corporation, 2011.http://www.palisade.com/risk; SAS Institute Inc. SAS user ’s guide: statistics Version 9.4 ed.",Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
"Ithaca, New York, USA: Palisade Corporation, 2011. http://www.palisade.com/risk) and NeuroShell2(Ward Systems Group.",Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://health.state.tn.us/ceds/WebAim/WEBAim_criteria.aspx 16.,Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://new.dhh.louisiana.gov/index.cfm/newsroom/archives/64 17.,Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://www.dphhs.mt.gov/publichealth/cdepi/surveillance/index.shtml 18.,Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://www.michigan.,Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
"gov/documents/mdch/2005_CD_Epi_Profile_177917_7.pdf, http://www.michigan.gov/documents/mdch/2009_CDEpiProfile_337815_7.pdf, http://www.michigan.gov/documents/mdch/2011_CDEpiProfile_400563_7.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://www.Census.gov.20.,OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
"http://msdh.ms.gov/ msdhsite/_static/31,0,211.html 21.",OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
http://www.who.int/ foodsafety/en/ (accessed 25 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/47/9f/bmjopen-2015-009255.PMC4785344.pdf
"However, steroid therapy for IgG4-RD-associated HT has been Open AccessH Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.",Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
( doi:10.5009/ gnl14107 ) H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
(doi:10.1210/en.2008-0345 ) Received in ﬁnal form 7 January 2016 Accepted 19 February 2016 H Minamino and others Association of IgG4-RD and vasculitis with HTID: 16-0004; March 2016 DOI: 10.1530/EDM-16-0004 http://www.edmcasereports.com 7,Non-OADS,/arxiv_data1/oa_pdf/63/a1/edmcr-2016-160004.PMC4785346.pdf
"Retrieved April 12, 2012, from http://statline.cbs.nl/StatWeb/ Steverink, N., & Lindenberg, S. (2006).",Non-OADS,/arxiv_data1/oa_pdf/cc/04/gnt169.PMC4785393.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/6a/rjw027.PMC4785395.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/76/ofw011.PMC4785405.pdf
The World Health Organization (WHO) de ﬁnes diarrhea as the passage of 3 or more loose or liquid stools (mostly in larger amounts)within 24 hours ( http://www.who.int/topics/diarrhoea/en/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/76/ofw011.PMC4785405.pdf
J Cardiovasc Magn Reson 2014;16:16. http://jcmr-online.com/content/16/1/16 19.,Non-OADS,/arxiv_data1/oa_pdf/db/35/openhrt-2015-000330.PMC4785435.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/bb/b5/hgv20147.PMC4785511.pdf
"The sequencing reads were aligned to the human reference genome (hg19) using Burrows –Wheeler aligner (BWA, version 0.7.8; http://bio-bwa.sourceforge.net/).9The alignments were converted from a sequence alignment map (SAM) format to a sorted and indexed binary alignment map ﬁles (SAMtools version 0.1.19; http://samtools.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
Duplicate reads were removed using Picard (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"Local rea- lignment around the indels, base quality score recalibration andUniﬁedGenotyper calls were performed using Genome Analysis Toolkit software (GATK, version 3.1-1; http://www.broadinstitute.",OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"org/gatk/).10All sequence variants were annotated using Annovar.11To identify single-nucleotide variations, we excluded sequence variants with minor allele frequency 40.05 from the 1000 Genomes Project databases (http://www.1000genomes.org/), NHLBI GO Exome Sequencing Project (ESP6500, http://evs.gs.",OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"washington.edu/EVS/) and the Human Genetic Variation Database(HGVD, http://www.genome.med.kyoto-u.ac.jp/SnpDB/).",OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"To com- plement the single-nucleotide variations and indel analyses, a CNA detection algorithm was applied to the alignment map ﬁles to identify large CNAs as follows: (1) binary alignment map ﬁles were converted into ﬁles covering target regions using GATK, (2) log coverage ratios and Zscores were calculated between the case and other samples and (3) regions with an abnormal copy number were detected using circular binary segmentation with DNAcopy(R/Bioconductor; http://bioconductor.org).",OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"The affected transcript and protein were labeled NM_000264.3 (PTCH1_v001):c.426dup and NM_000264.3 (PTCH1_i001):p.(Thr143Tyrfs*12), respectively, using the Human Genome Variation Society (HGVS) nomenclature version 2.0 (Mutalyzer 2.0.beta-32, https://mutalyzer.nl/).",Non-OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"This mutation has not been previously reported in any patients with Gorlin syndrome (Human Gene Mutation Database professional 2014.2, http://www.hgmd.org/ and ClinVar, http://www.ncbi.nlm.nih.gov/clinvar/) andis not present in the 1000 Genomes, ESP6500 or HGVD databases.",Non-OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/ m9.ﬁgshare.hgv.513.ACKNOWLEDGEMENTS We thank the patient and his family for their participation in this study.,Non-OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Novel PTCH1 mutation in Gorlin syndrome N Okamoto et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14022",Non-OADS,/arxiv_data1/oa_pdf/0d/aa/hgv201422.PMC4785514.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/ m9.ﬁgshare.hgv.522.,OADS,/arxiv_data1/oa_pdf/ce/72/hgv201425.PMC4785516.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/OI IIC due to a COL1A1 C-propeptide mutation M Takagi et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14025",Non-OADS,/arxiv_data1/oa_pdf/ce/72/hgv201425.PMC4785516.pdf
"To date, 66 alleles have been described; however, many of these NAT2* alleles share sequence variations, and these sequence variations do not always lead to changes in the enzyme activity of the encoded protein (http://nat.mbg.duth.gr/Human%20NAT2% 20alleles_2013.htm).",Non-OADS,/arxiv_data1/oa_pdf/37/73/hgv201414.PMC4785517.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).The genetic variation of NAT2 in southern India S Lakkakula et al 7 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14014",Non-OADS,/arxiv_data1/oa_pdf/37/73/hgv201414.PMC4785517.pdf
Protein sequences among eight different species were aligned using the UCSC Genome Browser (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/fe/39/hgv20148.PMC4785518.pdf
The SMART site (Simple Modular Architecture Research Tool: http://smart.embl-heidelberg.de/) was used to compare the sequence of a normal protein with a mutated one.,OADS,/arxiv_data1/oa_pdf/fe/39/hgv20148.PMC4785518.pdf
"The p.Q89X was not detected in 100 ethnically matched, healthy individualsand had not been previously reported according to the HumanPAX6 mutation database (http://www.hgu.mrc.ac.uk/Softdata/ PAX6/) and LOVD (MRC Human Genetics Unit LOVD at MRCIGMM, Paired box gene 6).",Non-OADS,/arxiv_data1/oa_pdf/fe/39/hgv20148.PMC4785518.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Molecular analysis of the PAX6 gene M Chograni et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14008",Non-OADS,/arxiv_data1/oa_pdf/fe/39/hgv20148.PMC4785518.pdf
"HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.515, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ee/2e/hgv201419.PMC4785519.pdf
http://dx.doi.org/10.6084/m9.,Non-OADS,/arxiv_data1/oa_pdf/ee/2e/hgv201419.PMC4785519.pdf
"ﬁgshare.hgv.519, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ee/2e/hgv201419.PMC4785519.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)MLC1 mutations in Japanese patients S Shimada et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14019",Non-OADS,/arxiv_data1/oa_pdf/ee/2e/hgv201419.PMC4785519.pdf
"Reads were aligned and mapped to the humanreference genome sequence (UCSC Genome Browser hg19,GRCh37) using Novoalign 2.08.02 (Novocraft, Selangor, Malaysia; http://www.novocraft.com/main/index.php) and PCR duplicates were removed with Picard tools.",OADS,/arxiv_data1/oa_pdf/e4/58/hgv20145.PMC4785520.pdf
Variant calling as well ascoverage and depth calculations were performed with the Genome Analysis Toolkit 1.6-5 (http://www.broadinstitute.org/ gatk/).,OADS,/arxiv_data1/oa_pdf/e4/58/hgv20145.PMC4785520.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Human Genome Variation website (http://www.nature.com/hgv)A novel PITX2 mutation causing iris hypoplasia M Kimura et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14005",Non-OADS,/arxiv_data1/oa_pdf/e4/58/hgv20145.PMC4785520.pdf
"Although this mutation has not been reported in ARAS patients, the PolyPhen-2 score (http://genetics.bwh.harvard.edu/pph2/) is 1.000, which indicates ‘probably damaging, ’and glycine substitutions in the collagenous domain of the COL4A3 gene lead to the crucial constitutional changes resulting in the development of renal abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/d8/60/hgv20146.PMC4785521.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Protectivity of SNP rs1136410 in Hashimoto's thyroiditis A Koc et al 6 Human Genome Variation (2014) 14016 © 2014 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/07/df/hgv201416.PMC4785522.pdf
The bar chart represents the percentage of mutations reported in this study and extracted from the HGMD database (http://www.biobase-international.com/product/hgmd) in Arab populations per total reported mutations ineach gene individually.Mutation spectrum of JS and related disorders S Ben-Salem et al 8 Human Genome Variation (2014) 14020 © 2014 The Japan Society of Human Genetics,OADS,/arxiv_data1/oa_pdf/7c/fb/hgv201420.PMC4785524.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Mutation spectrum of JS and related disorders S Ben-Salem et al 10 Human Genome Variation (2014) 14020 © 2014 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/7c/fb/hgv201420.PMC4785524.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)HFE mutation in Alzheimer disease AV Artemov et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14004",Non-OADS,/arxiv_data1/oa_pdf/d7/54/hgv20144.PMC4785525.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/OPEN",Non-OADS,/arxiv_data1/oa_pdf/11/3b/srep18530.PMC4785526.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000196).,Non-OADS,/arxiv_data1/oa_pdf/f5/16/rmdopen-2015-000196.PMC4785531.pdf
"Patients who survive the neonatal period mostly haveepisodes of metabolic acidosis and hyperammonemia.4It has been shown that mutations in either the PCCA (chromosome 13q32) or PCCB (chromosome 3q21-q22) genes encoding alpha or beta subunits of the PCC enzyme, respectively, can cause propionic acidemia.5,6Mutations in PCCA are heterogeneous without a predominant mutation in the population studied,whereas PCCB has a limited number of mutations in various ethnic groups.5,7Missense mutations are the most common defects identi ﬁed in the PCCB gene.7,8The incidence of PA ranges from 1:50,000 to 1:150,000.9–11A high frequency of PA has been reported in some populations, for example, 1 in 1,000 among theGreenlandic Inuit population due to a founder effect12and 1:2,000 –5,000 live births in Saudi Arabia partly owing to a relatively high rate of consanguinity.13To date, at least 81 mutations and 17 polymorphisms have been identi ﬁed in the PCCA gene, and 86 mutations and 7 polymorphisms in the PCCB gene (http://cbs.lf1.cuni.cz/pcc/pccmain.htm, accessed on January2015).",Non-OADS,/arxiv_data1/oa_pdf/4b/9e/hgv201533.PMC4785532.pdf
HGV DATABASE The relevant data from this data report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/4b/9e/hgv201533.PMC4785532.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/PCCB mutation in patient with PA T Porntaveetus et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15033",Non-OADS,/arxiv_data1/oa_pdf/4b/9e/hgv201533.PMC4785532.pdf
"Human Genome Variation (2015) 2,15042; doi:10.1038/hgv.2015.42; published online 5 November 2015 Epileptic encephalopathies are characterized by frequent and intractable seizures associated with severe neurological developmental delay.1To date, several genetic causes have been revealed, and epileptic encephalopathies are classi ﬁed into subcategories according to the corresponding genetic alterations identi ﬁed.2At present, an Online Catalog of Human Genes and Genetic Disorders (OMIM database; http://www.omim.org/) lists a total of 23 genes that are associated with the pathogenesis of epileptic encephalopathies.3 The cyclin-dependent kinase-like 5 gene ( CDKL5 ), which maps to chromosome Xp22 and contains 20 coding exons, is recognized as one of the genes responsible for a form of epileptic encephalo- pathy classi ﬁed as early infantile epileptic encephalopathy 2 in OMIM (EIEE2; MIM#300672).",Non-OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"ﬁgshare.hgv.711, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"ﬁgshare.hgv.714, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"ﬁgshare.hgv.717, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"ﬁgshare.hgv.720, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/CDKL5 mutations in patients with epileptic encephalopathy T Yamamoto et al 4 Human Genome Variation (2015) 15042 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/14/d9/hgv201542.PMC4785533.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Cold sore susceptibility gene-1 JD Kriesel et al 6 Human Genome Variation (2014) 14024 © 2014 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/85/d9/hgv201424.PMC4785534.pdf
"Particularly, Arg632Trp was identi ﬁed in patients with both of INAD and parkinsonism.4,10 Thus, phenotypic consequence of PLA2G6 mutations may be related to the combinations of the heterozygous mutations.HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.735, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/cb/b8/hgv201548.PMC4785535.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Novel PLA2G6 mutations T Yamamoto et al 5 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15048",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/hgv201548.PMC4785535.pdf
HGV DATABASE The relevant data form this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.600, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.602, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.604, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.606, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.608, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.610, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.612, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.614, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.616, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.618, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.620, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.622, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.624, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.626, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.628, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.630, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.632, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.634, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.636, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.638, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.640, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.642, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.644, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.646, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.648, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.650, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.652, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.654, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.656, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.658, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.660, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁgshare.hgv.662, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"ﬁg share.hgv.664, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/6q21 –22 deletion syndrome A Matsumoto et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15015",Non-OADS,/arxiv_data1/oa_pdf/34/9d/hgv201515.PMC4785536.pdf
"The COILS prediction program 9(http://www.ch.embnet.org/software/COILS_ form.html), which compares the query sequence with a database of known parallel two-stranded coiled coils, suggests that L1264P affects the probability of coiled-coil formation whereas R1275Ldoes not.",OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
"The SIFT (http://sift.jcvi.org), MutationTaster (http://www.",Non-OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
mutationtaster.org) and PolyPhen-2 (http://genetics.bwh.harvard.,Non-OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
"Both variants are absent from public variant databases, such as the dbSNP (http://www.ncbi.nlm.nih.gov/SNP/),Exome Variant Server (http://evs.gs.washington.edu/EVS/), Exome Aggregation Consortium (http://exac.broadinstitute.org), and Human Genetic Variation Browser (http://www.genome.med.",OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.668.,OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Deleterious MYH11 mutation N Takeda et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15028",Non-OADS,/arxiv_data1/oa_pdf/89/79/hgv201528.PMC4785537.pdf
"Brie ﬂy, the two polymorphisms were genotyped in the Human Genome Diversity Project –Centre d’Étude du Polymorphisme Humain (HGDP –CEPH) samples (http://www.cephb.fr/en/hgdp_panel.php) by LCG Genomics (Beverly, MA, USA) by using KASP genotyping technology.The HGDP –CEPH panel includes samples for more than 1,000 individuals from 52 populations around the world.",OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
We used the program PLINK 15to perform principal component analysis (PCA) of the East-AsianCEPH –HGDP populations by using genome-wide data (Affymetrix Axiom Human Origins Array) available in the HGDP –CEPH website (http://www.cephb.fr/en/hgdp_panel.php).,OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
Figure 2 shows a visualization of the ﬁrst two axes of the PCA using the program PAST (http://folk.uio.no/ohammer/past/).,Non-OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
"In this respect, it will be important to consider not only potential selective effects but also the major population movements that have taken place in this region during the past15,000 years.HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
"ﬁg share.hgv.756, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
Preprint at http://dx.doi.org/10.1101/016477.,Non-OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Distribution of OCA2 polymorphisms N Murray et al 5 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15058",Non-OADS,/arxiv_data1/oa_pdf/57/9b/hgv201558.PMC4785538.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Interactive effect of PTGER3 SNPs and HLA-A*02:06 in CM-SJS/TEN M Ueta et al 5 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15023",Non-OADS,/arxiv_data1/oa_pdf/f0/c2/hgv201523.PMC4785539.pdf
Fastq ﬁles were aligned to the human reference sequence (GRCh37/hg19) with BWA (http://bio-bwa.sourceforge.net/) for the generation of the BAM ﬁles.,OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
"Realignment of indel regions, variant detection and recalibration of base qualitieswere performed with GATK (http://www.broadinstitute.org/gatk/) for theproduction of variant call format ﬁles.",OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
Annotation was performed with Annovar (http://annovar.openbioinformatics.org/en/latest/).,OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
"The following rules were adopted: (1) minor allelefrequency = 0 considering 1,000 Genomes (http://www.1000genomes.org/)frequencies, the Exome Variant Server (ESP6500) (http://evs.gs.washington.",Non-OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
The ﬁnal list was also evaluated considering the ExAC frequency database from the Broad Institute (http://exac.broad institute.org/).,OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
"PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), SIFT (http://sift.jcvi.org/) and MutationTaster2 (http://www.mutationtaster.org/) were used for in silico damage prediction to the protein.",OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
"Although the STRC gene has been previously related to recessive deafness, theDatabase of Genomic Variants (http://projects.tcag.ca/variation/)shows that deletions and duplications are present in the normalpopulation at a relatively high frequency.",Non-OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
Available at http://brighamandwomens.org/Research/labs/BWH_Hearing/Cochlear_ESTs.aspx.,Non-OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Novel KCNQ4 mutation and IMMP2L -DOCK4 duplication DT Uehara et al 6 Human Genome Variation (2015) 15038 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/be/0f/hgv201538.PMC4785540.pdf
(http://www.mutationtaster.org/).,Non-OADS,/arxiv_data1/oa_pdf/83/dd/hgv201532.PMC4785541.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/83/dd/hgv201532.PMC4785541.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/16/19/hgv201410.PMC4785542.pdf
"ﬁg share.hgv.507, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/16/19/hgv201410.PMC4785542.pdf
ﬁgshare.hgv.509 and http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/16/19/hgv201410.PMC4785542.pdf
"This variant is not reported in thedsSNP137 single-nucleotide poly morphism database, the exome variant server provided by the National Heart, Lung, and Blood Institute Exome Sequencing Projec t (NHLBI-ESP) 6500 (http://evs.gs.",Non-OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
"washington.edu/EVS/), or the hu man genetic variation database (HGVD; http://www.genome.med.kyoto-u.ac.jp/SnpDB).",OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
SI FT (http://sift.jc vi.org/www/SIFT_ help.html) and PolyPhen2 predication (http://genetics.bwh.harvard.,OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
"edu/pph2/) scores were tolerated (0.73) and benign (0.001); however,the CADD RawScore was 1.386821, and the CADD PHRED score was 15.4 (http://cadd.gs.washington.ed u/info).",OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
(http://www.mutationtaster.org/) de ﬁned this variant as disease causing (prob: 0.919680553678408).,Non-OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
"The ﬁltered SNV in MED12 was checked visually using integrative genomics viewer (http://www.broadinstitute.org/igv/; Figure 1b) and con ﬁrmed by the standard PCR-direct sequencing method u s i n gt h eB i gD y eT e r m i n a t o r (Life Technologies, Carlsbad, CA, USA) with speci ﬁc primers (sense 5′-CAGGCCTTCTTCAACACTAC-3 ′and antisense 5 ′-TAGTACCTCCCG GGTACCTC-3 ′; Figure 1c), as described previously.4The patient was hemizygous for this SNV, which was con ﬁrmed to be inherited from his carrier mother.",Non-OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Non-speci ﬁc X-linked intellectual disability T Yamamoto and K Shimojima 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15018",Non-OADS,/arxiv_data1/oa_pdf/9b/5f/hgv201518.PMC4785543.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/e1/f2/hgv201517.PMC4785544.pdf
"ﬁg share.hgv.588, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/e1/f2/hgv201517.PMC4785544.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Prenatal testing for familial protein C de ﬁciency S Tairaku et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15017",Non-OADS,/arxiv_data1/oa_pdf/e1/f2/hgv201517.PMC4785544.pdf
MIM Number: #151623. http://omim.org/.,Non-OADS,/arxiv_data1/oa_pdf/53/53/hgv201412.PMC4785545.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Germline mutations in patients at high-risk for HBOC GES Felix et al 8 Human Genome Variation (2014) 14012 © 2014 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/53/53/hgv201412.PMC4785545.pdf
"This novel splice-site mutation was not present in the Human Gene Mutation Database (HGMD, Version 2014.2) or in the Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP, Version ESP6500SI-V2, Seattle, WA,USA; http://evs.gs.washington.edu/EVS).",OADS,/arxiv_data1/oa_pdf/a3/3e/hgv201545.PMC4785546.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/a3/3e/hgv201545.PMC4785546.pdf
"ﬁgshare.hgv.744, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/a3/3e/hgv201545.PMC4785546.pdf
"ﬁgshare.hgv.747, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/a3/3e/hgv201545.PMC4785546.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Novel mutations in C5orf42 cause oral –facial –digital syndrome VI IM Wentzensen et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15045",Non-OADS,/arxiv_data1/oa_pdf/a3/3e/hgv201545.PMC4785546.pdf
"The sequencing data was mapped to a reference genome (GRCh37/hg19) using Burrows-Wheeler Alignment tool(ver.0.6.1; http://www.bio-bwa.sourceforge.net/), and the average read depth of targeted regions was 67.5.",OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
Variant calling was performed using SAMtools (ver.0.1.16; http://www.samtools.sourceforge.net/) and GATK (ver.1.6; http://www.broadinstitute.org/gatk/) software.,OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
"To identify the disease causative mutations, we excluded known variants found in public databases (dbSNP138, 1000 Genomes Project, and NHLBI ESP6500) and acontrol in-house database (154 Japanese individuals of normaland other diseases control), except for those also identi ﬁed as pathogenic mutations in the NCBI ClinVar (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
"nih.gov/clinvar/) and HGMD databases (http://www.hgmd.org/).We focused on non-synonymous SNVs, insertions and deletions(indels), and splice-site variants (Figure 2b).",OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.574.,OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)NFIA mutation causes brain malformation and VUR Y Negishi et al 4 Human Genome Variation (2015) 15007 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/2f/fc/hgv20157.PMC4785547.pdf
"wAnnovar was used for variant annotation (http://wannovar2.usc.edu/).23Variants not registered in either dbSNP 138 database, 1000 genome database or Figure 1.",OADS,/arxiv_data1/oa_pdf/83/0c/hgv201524.PMC4785550.pdf
NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/) are regarded as novel variants.,Non-OADS,/arxiv_data1/oa_pdf/83/0c/hgv201524.PMC4785550.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Rare variations of OXTR in ASD X Liu et al 5 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15024",Non-OADS,/arxiv_data1/oa_pdf/83/0c/hgv201524.PMC4785550.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"hgv.672, http://dx.doi.org/10.6084/m9.",Non-OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"ﬁgshare.hgv.674, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"ﬁgshare.hgv.676, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"ﬁgshare.hgv.682, http://dx.doi.org/10.6084/ m9.ﬁgshare.hgv.684, http: //dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Novel exonic MEIs in epithelial ovarian cancer T Hayano et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15030",Non-OADS,/arxiv_data1/oa_pdf/36/65/hgv201530.PMC4785551.pdf
"7 To identify single-nucleotide variations, we excluded sequencevariants with minor allele frequencies 40.05 included in the 1,000 Genomes Project database (http://www.1000 genomes.org/),NHLBI GO Exome Sequencing Project (ESP6500, http://evs.gs.washington.edu/EVS/) and Human Genetic Variation Database 1Department of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan;2Student Lab, Faculty of Medicine, Tokushima University, Tokushima, Japan;3Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan and4Department of Medical Genetics, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.",OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"(HGVD, http://www.genome.med.kyoto-u.ac.jp/SnpDB/).",OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"Although 25 point mutations, including 4 at the +3 position and 4 at the +5 position and 1 small insertion of the 73 mutations werelisted as mutations located within the ﬂanking intronic sequencesthat possibly affect normal splicing in Human Gene Mutation Database Professional 2015.2 (HGMD, http://www.hgmd.org/), this mutation is not present in HGMD and ClinVar (http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"To evaluate the pathogenicity of this mutation, we used several in silico splice site prediction programs, such as Alternative Splice Site Predictor (http://wangcomputing.com/assp/), NetGene2 (http://www.cbs.dtu.dk/services/NetGene2/), NNSPLICE0.9 (http://www.fruit ﬂy.org/seq_tools/splice.html), Human Splice Finder3 (http://www.umd.be/HSF/) and MaxEnt Scan (http://genes.",OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"In the pET01 construct, the intron containing the multiple cloning site (MCS) is ﬂanked by the 5 ʹ-donor and 3 ʹ-acceptor splice sites of pre-proinsulin 5 ʹand 3 ʹexons, respectively (http://www.mobitec.com/cms/products/bio/04_vector_sys/exontrap.html).",Non-OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Novel COL11A1 mutation in Stickler syndrome T Kohmoto et al 4 Human Genome Variation (2015) 15043 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/61/4c/hgv201543.PMC4785552.pdf
"Human Genome Variation (2015) 2,15055; doi:10.1038/hgv.2015.55; published online 10 December 2015 INTRODUCTION Fibrodysplasia ossi ﬁcans progressiva (FOP, MIM#135100, http://www.omim.org/) is a rare hereditary disease caused by aheterozygous mutation in the type I activin receptor ( ACVR1 ) gene that encodes a bone morphogenetic protein receptor.",Non-OADS,/arxiv_data1/oa_pdf/dc/ca/hgv201555.PMC4785553.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/Phenotypic differences of FOP patients with ACVR1 (p.Arg258Ser) Y Nakahara et al 4 Human Genome Variation (2015) 15055 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/dc/ca/hgv201555.PMC4785553.pdf
Exons of 122 genes known to be associated withcongenital endocrine disorders (including 9 CPHD and 12 KS/HH- related genes) were identi ﬁed in the University of California Santa Cruz table browser (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/67/19/hgv201411.PMC4785554.pdf
"The results exhibited that this mutation was predicted to cause functional damage byPolyPhen-2 http://genetics.bwh.harvard.edu/pph2/ (damage score 0.928, sensitivity 0.81 and speci ﬁcity 0.94).",Non-OADS,/arxiv_data1/oa_pdf/67/19/hgv201411.PMC4785554.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/67/19/hgv201411.PMC4785554.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)CPHD with a novel KAL1 mutation M Takagi et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14011",Non-OADS,/arxiv_data1/oa_pdf/67/19/hgv201411.PMC4785554.pdf
"tcag.ca/variation/), DECIPHER database (https://decipher.sanger.ac.uk/),Online Mendelian Inheritance in Man (http://www.omim.org), UCSC(http://genome.ucsc.edu/, hg19) and the International Standards forCytogenomic Arrays (https://www.iscaconsortium.org/) were employed.",OADS,/arxiv_data1/oa_pdf/08/8e/hgv20154.PMC4785558.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/40/fa/hgv201513.PMC4785559.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.670.,OADS,/arxiv_data1/oa_pdf/88/b1/hgv201529.PMC4785562.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/64/e9/hgv201547.PMC4785563.pdf
A full list of contributing groups can be found at http://exac.broadinstitute.org/about.,Non-OADS,/arxiv_data1/oa_pdf/64/e9/hgv201547.PMC4785563.pdf
"16 Exome Aggregation Consortium (ExAC), Cambridge, MA, USA http://exac.broad institute.org.",OADS,/arxiv_data1/oa_pdf/64/e9/hgv201547.PMC4785563.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/New mutation in corneal dystrophy P Jongkhajornpong et al 4 Human Genome Variation (2015) 15047 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/64/e9/hgv201547.PMC4785563.pdf
The variants were called using the GenomeAnalysis Toolkit 2.4 –4 (GATK; http://www.broadinstitute.org/gatk) with the GATK Best Practice Variant Detection v3 recommenda-tions (http://www.broadinstitute.org/gatk/guide/topic?name = best-practices) and annotated using ANNOVAR (8 March 2012; Figure 1.,OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
http://www.openbioinformatics.org/annovar).,Non-OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
Common variants registered in dbSNP build 137 (minor allele frequency ⩾0.01; http://genome.ucsc.edu/cgi-bin/ hgTrackUi?hgsid=316787363&g=snp137Common&hgTracksCon ﬁg Page=con ﬁgure) were excluded.,Non-OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
More than 50 mutations in RAB3GAP1 have been reported to date in the Human Genome Mutation Database (https://portal.biobase-international.com).,OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
"HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/ m9.ﬁgshare.hgv.696, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Warburg micro syndrome by novel RAB3GAP1 mutations E Imagawa et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15034",Non-OADS,/arxiv_data1/oa_pdf/de/16/hgv201534.PMC4785564.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/78/30/hgv201511.PMC4785566.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Table 1.",Non-OADS,/arxiv_data1/oa_pdf/78/30/hgv201511.PMC4785566.pdf
aThe number registered in dbSNP human Build 142 at http://www.ncbi.nlm.nih.gov/snp/.bReference sequence in human genome sequence (GRCh38).cObserved sequence in this study.AFAP with a rare APC mutation T Ikenoue et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15011,OADS,/arxiv_data1/oa_pdf/78/30/hgv201511.PMC4785566.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁg share.hgv.526, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.530, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.532, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.534, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁg share.hgv.536, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.538, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.540, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.542, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁg share.hgv.544, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.546, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.548, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.550, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁg share.hgv.552, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.554, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.556, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.558, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁg share.hgv.560, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.562, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"ﬁgshare.hgv.564, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Rare coding variants in PLD3 in Alzheimer ’s disease EC Schulte et al 4 Human Genome Variation (2015) 14028 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/ca/f9/hgv201428.PMC4785568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/CD14 ,IL18 and radiation effects on colorectal cancer risk YH u et al 9 © 2015 Of ﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2015) 15035",Non-OADS,/arxiv_data1/oa_pdf/df/b4/hgv201535.PMC4785571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Pathway activation strength predicts cetuximab sensitivity Q Zhu et al 9 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15009",Non-OADS,/arxiv_data1/oa_pdf/fb/24/hgv20159.PMC4785572.pdf
These CNVs were not found in the database of Genomic Variants (http://dgv.tcag.ca/dgv/app/ home?ref = GRCh37/hg19) or in the University of California SantaCruz Genome Browser (https://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/cd/9a/hgv201520.PMC4785576.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/cd/9a/hgv201520.PMC4785576.pdf
"ﬁg share.hgv.592, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/cd/9a/hgv201520.PMC4785576.pdf
"ﬁgshare.hgv.594, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/cd/9a/hgv201520.PMC4785576.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Rare endocrinopathies and copy-number variations M Okuno et al 4 Human Genome Variation (2015) 15020 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/cd/9a/hgv201520.PMC4785576.pdf
"(c) Cross-species multiple alignment of FRMD7 protein sequences around the pL292P variant site, showing evolutionary conservation of the altered residue in the highly conserved residues of the FERM-adjacent (FA) domain .Amino-acid sequence comparison in several related proteins using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"The missense variant c.875T 4C has a single-nucleotide polymorphism (SNP) number (rs192346335) in the reference SNP database (dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/) but was not found in our 100 unrelated control Japanese males, the1000 Genomes Project database (http://www.1000genomes.org/)or NHLBI GO Exome Sequencing Project (ESP6500, http://evs.gs.",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"However, this variant was detected in nine individuals in heterozygous state and in one individual inhomozygous or hemizygous state among 1102 individualsdescribed in the Japanese genetic variation database (the Human Genetic Variation Database, HGVD; http://www.genome.med.",OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"The c.875T 4C variant in patients with congenital nystagmus has never been reported previously in databases (Human Gene Mutation Database professional version, http://www.hgmd.cf.ac.uk/ac/index.php and ClinVar, http://www.ncbi.nlm.nih.gov/clinvar/).",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"2Among these regions, the FA domain is one in which mutations are densely concentrated.2 Moreover, 420% of known mutations have been mapped to exon 9, encoding parts of the FERM and FA domains,13and several causative missense mutations have been identi ﬁed around codon 292 (Figure 1c).14–20The effects of the mutations on protein function were assessed by various in silico prediction approaches following the Best Practice Guidelines of the Association for Clinical Genetic Science (http://www.acgs.uk.com/quality-committee/best-practice-guidelines/).",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"The FRMD7 p.L292P mutant proteinwas predicted with high con ﬁdence to be ‘damaging ’by FATHMM v2.3 (score = –2.29; http://fathmm.biocompute.org.uk/), ‘disease causing ’by Mutation Taster (phastCons = 4.574 and phyloP = 0.998; http://www.mutationtaster.org/), ‘probably damaging ’by Polyphen2 (score = 0.993, sensitivity = 0.47 and speci ﬁcity = 0.96 in HumVar model; http://genetics.bwh.harvard.edu/pph2/), ‘dama- ging ’by SIFT (score = 0.04; http://sift.jcvi.org/) and ‘pathological ’by Pmut (position-speci ﬁc independent count score = 0.8980; http:// mmb2.pcb.ub.es:8080/PMut/).",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"In addition, using the Phyre2 program (http://www.sbg.",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
2 HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.572.,OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)AFRMD7 variant in congenital nystagmus T Kohmoto et al 4 Human Genome Variation (2015) 15002 © 2015 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/29/e8/hgv20152.PMC4785577.pdf
HGV DATABASE The relevant data form this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/4b/0b/hgv201553.PMC4785578.pdf
"ﬁg share.hgv.762, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/4b/0b/hgv201553.PMC4785578.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).",Non-OADS,/arxiv_data1/oa_pdf/4b/0b/hgv201553.PMC4785578.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.576.,OADS,/arxiv_data1/oa_pdf/41/fe/hgv20158.PMC4785579.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/FOXL2 mutation with BPES H Tan et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) e ●●",Non-OADS,/arxiv_data1/oa_pdf/41/fe/hgv20158.PMC4785579.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplemental Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Laing distal myopathy in a Chinese family T Oda et al 7 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15022",Non-OADS,/arxiv_data1/oa_pdf/9d/39/hgv201522.PMC4785580.pdf
The variant was considered pathogenic by splice- site analysis with the NetGene2 Server (http://www.cbs.dtu.dk/ services/NetGene2/) and Human Splicing Finder (http://www.umd.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/hgv201537.PMC4785581.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/e3/c9/hgv201537.PMC4785581.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/A novel SLC6A8 mutation associated with motor dysfunction C Cervera-Acedo et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15037",Non-OADS,/arxiv_data1/oa_pdf/e3/c9/hgv201537.PMC4785581.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/ac/3e/hgv201549.PMC4785582.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Homozygous deletion of exon 1 in WISP3 B Neerinckx et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15049",Non-OADS,/arxiv_data1/oa_pdf/ac/3e/hgv201549.PMC4785582.pdf
Available at http://www.genet.sickkids.on.ca/ cftr.,Non-OADS,/arxiv_data1/oa_pdf/24/06/hgv201563.PMC4785583.pdf
"23 HGMD®Professional 2015, 1; Available at http://www.hgmd.cf.ac.uk/.",Non-OADS,/arxiv_data1/oa_pdf/24/06/hgv201563.PMC4785583.pdf
Available at http://www.cftr2.org/browse.php.,Non-OADS,/arxiv_data1/oa_pdf/24/06/hgv201563.PMC4785583.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Cystic ﬁbrosis in China X Tian et al 6 Human Genome Variation (2016) 15063 © 2016 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/24/06/hgv201563.PMC4785583.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/ab/62/hgv20153.PMC4785586.pdf
"ﬁg share.hgv.568, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/ab/62/hgv20153.PMC4785586.pdf
URL: http://evs.gs.washington.edu/EVS/.,Non-OADS,/arxiv_data1/oa_pdf/ab/62/hgv20153.PMC4785586.pdf
"http://www.genome.med.kyoto-u.ac.jp/SnpDB.5 Klar J, Schweiger M, Zimmerman R, Zechner R, Li H, Törmä H et al.",OADS,/arxiv_data1/oa_pdf/ab/62/hgv20153.PMC4785586.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Novel FATP4 mutations responsible for IPS I Tsuge et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15003",Non-OADS,/arxiv_data1/oa_pdf/ab/62/hgv20153.PMC4785586.pdf
The reads werealigned to GRCh37 with Novoalign (http://www.novocraft.com/).,Non-OADS,/arxiv_data1/oa_pdf/e3/90/hgv201512.PMC4785587.pdf
PCR duplicates were removed using Picard (http://picard.source forge.net/).,OADS,/arxiv_data1/oa_pdf/e3/90/hgv201512.PMC4785587.pdf
Variants were called by the Genome Analysis Toolkit(http://www.broadinstitute.org/gatk/) and annotated by usingANNOVAR (http://www.openbioinformatics.org/annovar/) after excluding the common variants registered in the common dbSNP135 database (minor allele frequency ⩾0.01).,OADS,/arxiv_data1/oa_pdf/e3/90/hgv201512.PMC4785587.pdf
HGV DATABASE HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/e3/90/hgv201512.PMC4785587.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Cerebellar phenotype in spastic paraplegia 7 H Yahikozawa et al 3 © 2015 The Japan Society of Human Genetics Human Genome Variation (2015) 15012",Non-OADS,/arxiv_data1/oa_pdf/e3/90/hgv201512.PMC4785587.pdf
Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202834lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/fb/EPI-57-243.PMC4785606.pdf
"Datasets Quality Large datasets from one resource must be used to achieve statistical signi ﬁcance and structural diver- sity.92,119While large datasets may not be readily available, it is possible to gather data from various public resources120: prepared datasets suitable for QSAR modeling such as DSSTox (www.epa.gov/ comptox/dsstox/), databases that contain toxicity data such as ECOTOX (http://cfpub.epa.gov/ecotox/),global search engines that retrieve data from several databases such as ToxNet (http://toxnet.nlm.nih.gov/), and scienti ﬁc literature.",OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.ccohs.ca/oshanswers/chemicals/poisonou.html.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.oecd.org/chemicalsafety/risk-assessment/theoecdqsartoolbox.htm.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.lhasalimited.org/products/derek-nexus.htm.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.compudrug.com/hazardexpertpro.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.lhasalimited.org/products/meteor-nexus.htm.,OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://ambit.sourceforge.net/download_ambitdiscovery.html.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.epa.gov/oppt/sf/tools/aim.htm.,OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://chem.sis.nlm.nih.gov/chemid-plus/.,OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: https://www.certara.com/products/pkpd/phx-wnl.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://bmsr.usc.edu/software/adapt/.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://www.thehamner.org/content/HTOX_ ﬂyer_10.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
Available at: http://ntp.niehs.nih.gov/ntp/about_ntp/ntpvision/ntproad-map_508.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/b5/WCMS-6-147.PMC4785608.pdf
The resulting reads and an R markdown ﬁle to reproduce the following analysis isavailable at https://github.com/FernandoLab/.,Non-OADS,/arxiv_data1/oa_pdf/51/cf/JAM-120-588.PMC4785609.pdf
"2009) and the FASTX -TOOLKIT (http://hannonlab.cshl.edu/fastx_toolkit/) were used to remove sequences <400 bp and trim remaining sequences to a ﬁxed length of 400 bp, respectively, to improve oper-ational taxonomic unit (OTU) picking (Edgar 2013).OTUs were identiﬁed by clustering reverse complementedsequences based on 97% similarity according to the UPARSE pipeline with both de novo and reference based chimera removal of nonsingleton reads (Edgar 2013).OTU clustering and all subsequent analyses were per-formed on the combined data set, which included sam-ples from both RAMP-adapted and corn-adaptedanimals.",OADS,/arxiv_data1/oa_pdf/51/cf/JAM-120-588.PMC4785609.pdf
"In the United States (US), an estimated 21 700 new cases of MM and 10710 deaths were predicted in 2012 (AmericanCancer Society 2012); in Japan, an estimated 6860 new casesof MM and 4066 deaths (http://ganjoho.jp/reg_stat/statistics/dl/) were predicted.",Non-OADS,/arxiv_data1/oa_pdf/11/58/BJH-172-745.PMC4785611.pdf
Dose (mg/m2) 15 mg/m220 mg/m220/27 mg/m2Total Patients(n=4) ( n=6) ( n=40) ( N=50) Grade All Grades ≥Grade 3 All Grades ≥Grade 3 All Grades ≥Grade 3 All Grades ≥Grade 3 Cardiovascular disorder Hypertension 2 0 2 0 6 4 10 4 Congestive Heart failure 0 0 0 0 2 0 2 0Vascular pain 0 0 0 0 2 0 2 0Hot ﬂush 0 0 0 0 2 0 2 0 Atrioventricular block ﬁrst degree 0 0 0 0 1 0 1 0 Palpitations 0 0 0 0 1 0 1 0Dyspnoea* 0 0 0 0 1 0 1 0 Vasculitis 0 0 0 0 1 0 1 0 Troponin T increased 0 0 0 0 1 0 1 0Orthostatic hypotension 1 0 0 0 0 0 1 0 Cardiomyopathy 0 0 1 1 0 0 1 1 Infections Nasopharyngitis 0 0 1 0 10 0 11 0Pharyngitis 1 0 0 0 5 0 6 0 Gingivitis 1 0 0 0 1 0 2 0 Pneumonia 0 0 1 1 1 0 2 1Bronchopneumonia 0 0 0 0 1 1 1 1 Inﬂuenza 0 0 0 0 1 0 1 0 Viral pneumonia 0 0 0 0 1 1 1 1Upper respiratory tract infection 0 0 0 0 1 0 1 0 Enteritis infection 0 0 0 0 1 0 1 0 Lip infection 0 0 0 0 1 0 1 0Oropharyngeal candidiasis 0 0 1 0 0 0 1 0Staphylococcal infection 0 0 1 1 0 0 1 1 Herpes virus infection 0 0 1 1 0 0 1 1 *Dyspnoea is classiﬁed as a respiratory adverse event according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4 ∙0 (http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4 /C103_2010-06-14_QuickReference_8 /C15x11.pdf).Phase 1/2 Study of Carﬁlzomib in Japanese Myeloma Patients ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/58/BJH-172-745.PMC4785611.pdf
Available from URL: https://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/03/ef/DOM-18-203.PMC4785614.pdf
"FDA Drug Safety Newsletter:PostmarketingReviews–Volume1,Number2,Winter2008.Avail- able from URL: http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ ucm119034.htm.Accessed25June2015.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/DOM-18-203.PMC4785614.pdf
Available from: http://www.apps.who.,Non-OADS,/arxiv_data1/oa_pdf/73/72/NJS-22-32.PMC4785689.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs104/en/.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available from: http://www.who.int/tb/ publications/global_report/gtbr14_executive_summary.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available from: http://www.tbcindia.nic.in/ rntcp.html.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available from: http://www.who.int/tb/ challenges/mdr/mdr_tb_factsheet.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available from: http://www.who.int/tb/ publications/Xpert_factsheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Av ailable from: http://www.who.int/tb/publications/tbDiagnostics_ factsheet.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available  from: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
Available from: http://www.who.int/tb/ laboratory/mtbrifrollout/en/.,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/JGID-8-32.PMC4785755.pdf
"Similarly, an  Table 2: Variants of OXA-48-like enzyme and its deviation OXA-48-like  variantsNCBI reference  sequence: Accession numberDeviation from OXA-48 OXA-54* WP_011071128 20 substitution at Phe10Leu, Leu11Val, Ile16Val, Val21Met, Lys23asn, Asn28Lys, Lys29Pro, Ala33Thr, Thr36Ser,  Ser40Ala,  Val44Ile, Thr104Ala, Asn110Asp, Glu132Gln, Val153Leu, Ile170Val, Ser171Ala, Gly201Ser, Lys218Gln, and Ser244Ala OXA-162 ADG27454 Single substitution at Thr213Ala OXA-163 ADY06444 Single substitution at Ser212Asp and four deletions at Arg214, Ile215, Glu216, and Pro217OXA-181 BAP94533 Four substitutions at Thr104Ala, Asn110Asp, Glu168Gln, and Ser171Ala OXA-199 AFC95894 Three substitutions at His38Tyr, Val44Ala, and Asp154Gly OXA-204 AJF39128 Two substitutions at Gln98His and Thr99Arg OXA-232 †AGD91915 Single substitution at Arg214Ser OXA-244 YP_009090533 Single substitution at Arg214Gly OXA-245 YP_009090534 Single substitution at Glu125Tyr OXA-247‡YP_009090726 Two substitutions at Tyr211Ser and Asp212Asn Analysis of amino acid substitution/deletion was done using the reference amino acid sequences of the respective OXA-48 variant s deposited in NCBI website  (http://www.ncbi.nlm.nih.gov/pubmed/).",Non-OADS,/arxiv_data1/oa_pdf/80/5e/JGID-8-41.PMC4785756.pdf
Available from: http://www.nhmrc.gov.au/_files_nhmrc/ publications/attachments/cp78.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/04/JLP-8-41.PMC4785764.pdf
Available at http://www.ncbi.nlm.nih.gov/books/ NBK47375/?report=reader.,Non-OADS,/arxiv_data1/oa_pdf/f0/47/JLP-8-5.PMC4785766.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/20414188.,Non-OADS,/arxiv_data1/oa_pdf/f0/47/JLP-8-5.PMC4785766.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21348065.,OADS,/arxiv_data1/oa_pdf/f0/47/JLP-8-5.PMC4785766.pdf
"International Journal of Preventive Medicine 2016, 7:39 http://www.ijpvmjournal.net/content/7/1/39INTRODUCTION During the recent two decades, more studies on the  epidemiology of mental disorders in children and  adolescents have been conducted, as the number of  10,000 papers published in this field during 1980–1993  has increased to 40,000 papers in 1993–2000.",Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
"International Journal of Preventive Medicine 2016, 7:39 http://www.ijpvmjournal.net/content/7/1/39test.",Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
"International Journal of Preventive Medicine 2016, 7:39 http://www.ijpvmjournal.net/content/7/1/39their brother or sister or friend compared with those who  did not consult  ( P  >  0.05).",Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
"International Journal of Preventive Medicine 2016, 7:39 http://www.ijpvmjournal.net/content/7/1/39disorders can also cause or aggravate physical problems  in children and adolescents, many of which have  persisted into adulthood.",Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
"International Journal of Preventive Medicine 2016, 7:39 http://www.ijpvmjournal.net/content/7/1/3933.",Non-OADS,/arxiv_data1/oa_pdf/c7/e4/IJPVM-7-39.PMC4785779.pdf
"International Journal of Preventive Medicine 2016, 7:36 http://www.ijpvmjournal.net/content/7/1/36Received:  30 Sep 15 Accepted:  17 Dec 15   Published:  08 Feb 16 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/76/4c/IJPVM-7-36.PMC4785780.pdf
Available  from: http://www.who.int/nutrition/topics/nutrition_globaltargets2025/en/.,Non-OADS,/arxiv_data1/oa_pdf/76/4c/IJPVM-7-36.PMC4785780.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/69/84/JCIS-6-4.PMC4785781.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/10/98/JCIS-6-7.PMC4785783.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/37insecurity,[5,6] low maternal education, poor access to  healthcare,[7] and burden of diseases,[8] each of which  mediates poor child nutrition status.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/37and beliefs.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/37during the training based on the information presented  in the e‑learning modules.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/37Since we used BLTA technique as the only training  method in the study, the change in the knowledge was  attributed to the same.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/37There is felt the need of innovative techniques like  BTLA in the government to help broaden the skills  of existing professionals and the reach of those who  live in geographically isolated areas thereby reducing  costs of learning‑related travel.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
Available from: https://www.uop.edu.jo/download/Research/ members/67_1262_Ahma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
Available from: http://www.trainingdailyadvisor.blr.com/2013/05/ advantages‑and‑disadvantages‑of‑classroom‑training/#.,Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
Available from: http://www.nextgenerationof  leaders.com/nextgenerationofleaders	 033.htm.,Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:37 http://www.ijpvmjournal.net/content/7/1/3727.",Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
Available from: http://www.education.mit.edu/papers/ GamesSimsSocNets_EdArcade.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/bc/IJPVM-7-37.PMC4785785.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38INTRODUCTION A large number of people coming from various ethnic  groups and all levels of social and economic status are  affected by diabetes mellitus (DM) worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38We randomly allocated and matched the two groups  according to demographics and the study main variables  [Table  1].",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38ethical issues such as obtaining informed (oral) consent  and presenting the study objectives for subjects were  followed.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38increases knowledge, health beliefs, behavior, and  improves HbA1c and HRQOL.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38In an experimental study and in accordance with  self‑efficacy theory in physical activity improvement,  Allen examined the effect of education among the  patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
"International Journal of Preventive Medicine 2016, 7:38 http://www.ijpvmjournal.net/content/7/1/38helped us with collecting the data.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
Available from: http://www.care.,Non-OADS,/arxiv_data1/oa_pdf/ae/4c/IJPVM-7-38.PMC4785788.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/62/ab/JCIS-6-6.PMC4785789.pdf
"International Journal of Preventive Medicine 2016, 7:40 http://www.ijpvmjournal.net/content/7/1/40hemodilution[3] and deficiency of Vitamin C may be  associated with some complications in pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/8c/9b/IJPVM-7-40.PMC4785790.pdf
"International Journal of Preventive Medicine 2016, 7:40 http://www.ijpvmjournal.net/content/7/1/40age of 27.2  ±  6.5  years.",Non-OADS,/arxiv_data1/oa_pdf/8c/9b/IJPVM-7-40.PMC4785790.pdf
"International Journal of Preventive Medicine 2016, 7:40 http://www.ijpvmjournal.net/content/7/1/4016.",Non-OADS,/arxiv_data1/oa_pdf/8c/9b/IJPVM-7-40.PMC4785790.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/2d/99/JCIS-6-5.PMC4785791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/3c/bhv324.PMC4785954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/a8/bhv330.PMC4785955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/2e/bhv351.PMC4785956.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/e4/bhw002.PMC4785957.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/26/bhw007.PMC4785958.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/bhw013.PMC4785960.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/8c/bhw020.PMC4785961.pdf
"Lupus (2016) 25, 346–354 http://lup.sagepub.com PAPER Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab DA Roth1, A Thompson2, Y Tang2*, AE Hammer2, CT Molta1*and D Gordon1 1Research and Development, GlaxoSmithKline, Philadelphia, PA, USA; and2Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA Introduction: Patients with systemic lupus erythematosus (SLE) with B-lymphocyte stimulator (BLyS) levels /C212 ng/mL are at increased risk of flare.",Non-OADS,/arxiv_data1/oa_pdf/ca/d4/10.1177_0961203315604909.PMC4785993.pdf
Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav 10.1177/0961203315604909,Non-OADS,/arxiv_data1/oa_pdf/ca/d4/10.1177_0961203315604909.PMC4785993.pdf
Supplemental Material The online [appendices/data supplements/etc] are available at http://jcr.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/16/40/10.1177_0022002714540470.PMC4785994.pdf
"Accessed Decem- ber 2, 2010. http://pdf.usaid.gov/pdf_docs/PNACW353.pdf.",Non-OADS,/arxiv_data1/oa_pdf/16/40/10.1177_0022002714540470.PMC4785994.pdf
"Accessed December 2, 2010. http://www.revcom.us/a/v21/1040-049/1043/interv.htm.528 Journal of Conflict Resolution 60(3)",Non-OADS,/arxiv_data1/oa_pdf/16/40/10.1177_0022002714540470.PMC4785994.pdf
"Accessed December 28, 2011. http://www.ucdp.uu.se/database.",Non-OADS,/arxiv_data1/oa_pdf/16/40/10.1177_0022002714540470.PMC4785994.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/93/nihms762733.PMC4786012.pdf
The data set can be  downloaded at https://www.cancerdata.org/10.1016/j.ijrobp.2015.02.048 .,OADS,/arxiv_data1/oa_pdf/f5/93/nihms762733.PMC4786012.pdf
The data set is publicly  available on https://www.cancerdata.org/10.1016/j.ijrobp.2015.02.048 .,OADS,/arxiv_data1/oa_pdf/f5/93/nihms762733.PMC4786012.pdf
"Intriguingly, epidemio- logical studies have revealed a reduction in overall cancer incidence in T2D patientstaking metformin, 10suggesting a promising antineoplastic effect of metformin.Through blockade of the mitochondrial © Chengkai Dai *Correspondence to: Chengkai Dai; Email: Chengkai.Dai@jax.orgSubmitted: 12/19/2014; Revised: 12/20/2014; Accepted: 12/22/2014 http://dx.doi.org/10.1080/23723556.2014.1002718 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
Cell 2009; 136:823-37; PMID:19269363; http://dx.doi.org/10.1016/j.cell.2009.02.024 2 .,OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
Cell 2007; 130:1005-18; PMID:17889646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
Science 2008; 319:916-9; PMID:18276881; http://dx.doi.org/ 10.1126/science.11414485.,OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
EMBO J 1999; 18:5943-52; PMID:10545106; http://dx.doi.org/10.1093/emboj/18.21.5943 6.,Non-OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
J Clin Invest 2012; 122:3742-54; PMID:22945628; http://dx.doi.org/10.1172/JCI62727 7.,Non-OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
Cell 2012; 150:549-62; PMID:22863008; http://dx.doi.org/10.1016/j.cell.2012.06.0318.,OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
Cell Metab 2011; 14:91-103; PMID:21723507; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/ad/kmco-02-04-1002718.PMC4786015.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/7b/amep-7-137.PMC4786058.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).advances in Medical education and Practice 2016:7 137–143submit your manuscript | www.dovepress.co m Dove press  137 http: //dx.doi.org/10.2147/AMEP .S10096 8Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/amep-7-137.PMC4786058.pdf
"Or use: http://youtu.be/_9JFIqOdMZ Ylearning approach among health sciences  students in a medical college in nepal:   a cross-sectional study Dev Kumar shah ram lochan Yadav Deepak sharma Prakash Kumar Yadav niraj Khatri sapkota rajesh Kumar Jha Md nazrul islam Department of Physiology, chitwan  Medical college, Bharatpur, chitwan,   nepal correspondence: Dev Kumar shah   Department of Physiology, chitwan  Medical college, Bharatpur-10, chitwan  44200, nepal   T el +977 98 0411 0643   Fax +977 56 532 937   email devshahdr@yahoo.co mBackground:  Many factors shape the quality of learning.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/amep-7-137.PMC4786058.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/amep-7-137.PMC4786058.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/amep-7-137.PMC4786058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/1f/ppa-10-265.PMC4786060.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 265–274submit your manuscript | www.dovepress.co m Dove press  265 http: //dx.doi.org/10.2147/PPA.S9620 1Dove press OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article Are self-stigma, quality of life, and clinical data  interrelated in schizophrenia spectrum patients?",Non-OADS,/arxiv_data1/oa_pdf/58/1f/ppa-10-265.PMC4786060.pdf
"Current research has started focusing  on the broader needs of patients.correspondence: Michaela holubova Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University Olomouc, iP Pavlova 6, 77520  Olomouc, czech republic email holubova.mi@seznam.c z Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Holubova et al Running head recto: Interrelation of self-stigma, quality of life, and clinical data in schizophrenia DOI: http://dx.doi.org/10.2147/PPA.S96201",Non-OADS,/arxiv_data1/oa_pdf/58/1f/ppa-10-265.PMC4786060.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/58/1f/ppa-10-265.PMC4786060.pdf
Available from: http://www.wma.net/ en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/58/1f/ppa-10-265.PMC4786060.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/c1/dddt-10-1019.PMC4786061.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1019–1028Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1019Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9716 1amsacrine analog-loaded solid lipid nanoparticle  to resolve insolubility for injection delivery:  characterization and pharmacokinetics Yi-Ping Fang1 chih-hung chuang2 Pao-chu Wu1 Yaw-Bin huang1 cherng-chyi Tzeng3 Yeh-long chen3 Ya-Ting liu1 Yi-hung Tsai1 Ming-Jun Tsai4–6 1school of Pharmacy, college of  Pharmacy, 2Department of Biomedical  and environment Biology, college of  life science, 3school of Medicinal and  applied chemistry, college of life  science, Kaohsiung Medical University,   Kaohsiung, 4Department of neurology,   china Medical University hospital,   5school of Medicine, Medical college,   china Medical University, Taichung,   6Department of neurology, china  Medical University an-n an hospital,   Tainan, TaiwanAbstract:  Amsacrine analog is a novel chemotherapeutic agent that provides potentially broad  antitumor activity when compared to traditional amsacrine.",Non-OADS,/arxiv_data1/oa_pdf/68/c1/dddt-10-1019.PMC4786061.pdf
"In terms correspondence: Ming-Jun Tsai school of Medicine, Medical college,  china Medical University, no 91, hsueh- shih road, Taichung, Taiwan 40402 Tel +886 4 2205 2121 ext 5039 Fax +886 4 2234 4055 email d22570@mail.tmanh.org.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Fang et al Running head recto: Amsacrine analog-loaded SLN for injection delivery DOI: http://dx.doi.org/10.2147/DDDT.S97161",Non-OADS,/arxiv_data1/oa_pdf/68/c1/dddt-10-1019.PMC4786061.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/68/c1/dddt-10-1019.PMC4786061.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/c1/dddt-10-1019.PMC4786061.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/88/copd-11-467.PMC4786062.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2016:11 467–477International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  467OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9441 0COPD disease severity and innate immune  response to pathogen-associated molecular  patterns Vincent s Fan1,2 sina a gharib2,3 Thomas r Martin1,2 Mark M Wurfel2 1Va Puget sound health Care system,   seattle, W a, Usa; 2Division of  Pulmonary & Critical Care Medicine,   Department of Medicine, University  of Washington, seattle W a, Usa;   3Computational Medicine Core,   Center for lung Biology, University of  Washington, seattle, W a, UsaAbstract:  The airways of COPD patients are often colonized with bacteria leading to increased  airway inflammation.",Non-OADS,/arxiv_data1/oa_pdf/fb/88/copd-11-467.PMC4786062.pdf
"Toll-like receptors (TLRs) constitute a family of eleven transmembrane  proteins that differentially recognize microbial products containing highly conserved  motifs known as pathogen-associated molecular patterns (PAMPs).1 PAMP recognition  through TLRs results in secretion of several cytokines including interleukin (IL)-8,  MCP-1, MIP1 α, tumor necrosis factor (TNF) α, and IL-1 β.2,3 TLR-mediated  responses are critical for innate immunity and modulation of the adaptive immune  response.4 COPD patients have increased airway inflammation5–8 as well as increased systemic  inflammation compared to those without COPD9 with elevation in levels of C-reactive  protein, fibrinogen, circulating lymphocytes, and TNF α.10 There is evidence that  the innate immune response in the airways and lung in COPD may be impaired;11,12 Correspondence: Vincent s Fan health services research and  Development (152), Va Puget sound  health Care system, 1660 s. Columbian  Way, seattle, Wa 98108-1597, Usa Tel +1 206 764 2504 Fax +1 206 764 2935 email vfan@u.washington.ed uJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Fan et al Running head recto: COPD and innate immunity DOI: http://dx.doi.org/10.2147/COPD.S94410",Non-OADS,/arxiv_data1/oa_pdf/fb/88/copd-11-467.PMC4786062.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fb/88/copd-11-467.PMC4786062.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/88/copd-11-467.PMC4786062.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/3a/dmso-9-047.PMC4786063.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 47–53Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  47Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S9756 1Metabolic syndrome and associated factors  among outpatients of Jimma University T eaching  hospital edris abda1 leja hamza2 Fasil T essema3 Waqtola cheneke4 1Department of Medicine, college  of Medicine and health Sciences,   Madda Walabu University, Bale robe,   2Department of internal Medicine,   3Department of epidemiology,   4Department of Medical laboratory  Sciences and Pathology, college of  health Sciences, Jimma University,   Jimma, ethiopia correspondence: Waqtola cheneke   Department of Medical laboratory  Sciences and Pathology, college of health  Sciences, Jimma University, PO Box 5121,  Jimma, ethiopia   T el +251 912 685 926   Fax +251 47 111 4484   email waqtolachalt@yahoo.co mBackground:  Developing countries are now experiencing the epidemiologic transition,  whereby the burden of chronic diseases, like metabolic syndrome, is increasing.",Non-OADS,/arxiv_data1/oa_pdf/41/3a/dmso-9-047.PMC4786063.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/41/3a/dmso-9-047.PMC4786063.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/3a/dmso-9-047.PMC4786063.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHepatic Medicine: Evidence and Research 2016:8 21–26Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  21REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S6201 4Daclatasvir–sofosbuvir combination therapy   with or without ribavirin for hepatitis C virus   infection: from the clinical trials to real life Stanislas Pol Marion Corouge Anaïs vallet-Pichard Université Paris Descartes, Liver  Department, Assistance Publique  Hôpitaux de Paris, Cochin Hospital,   French institute of Health and Medical  Research UMS20, institut Pasteur,   Paris, France Correspondence: Stanislas Pol   Liver Department, Hôpital Cochin,   27 rue du Faubourg Saint Jacques,   75014 Paris, France   Tel +33 01 5841 3001   Email stanislas.pol@cch.aphp.f rAbstract:  The treatment of hepatitis C virus has changed dramatically with the rapid advent  of numerous new antiviral agents, including direct-acting antivirals and agents with non-viral  targets (cyclophilin inhibitors, interferon-lambda, vaccine therapy).",Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
"Available  from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm439662.ht m. Accessed  June 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
"Recommendations for testing, managing, and treating hepatitis C. A vailable  from: http://www.hcvguidelines.or g. Accessed June 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/49/5b/hmer-8-021.PMC4786064.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/b0/opth-10-385.PMC4786065.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 385–391Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  385CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10183 6Comparison of effect of nepafenac and diclofenac  ophthalmic solutions on cornea, tear film, and  ocular surface after cataract surgery: the results  of a randomized trial atsushi Kawahara1–3 Tsugiaki Utsunomiya4 Yuji Kato2 Y oshinori Takayanagi3 1Department of Ophthalmology,   Sapporo T okushukai Hospital, Sapporo,   Hokkaido, Japan; 2Sapporo Kato eye  Clinic, Sapporo, Hokkaido, Japan;   3Takayanagi Clinic, Kushiro, Hokkaido,   Japan; 4Department of Ophthalmology,   asahikawa Medical University,   asahikawa, Hokkaido, JapanBackground:  The aim of this study was to compare the effects of nepafenac ophthalmic  suspension 0.1% (Nevanac) and diclofenac sodium ophthalmic solution 0.1% (Diclod) on the  cornea, tear film, and ocular surface after cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/87/b0/opth-10-385.PMC4786065.pdf
"Topical NSAIDs have become  widely accepted for controlling ocular inflammation and are more recommended than  topical steroids for the control of inflammation after cataract surgery.2–4 The most common adverse effects of topical NSAIDs are reported to be stinging,  irritation, superficial punctate keratitis, corneal infiltrates, and corneal melting; the Correspondence: atsushi Kawahara Takayanagi Clinic, 1-3-5, Minamiodori,  Kushiro, Hokkaido 085-0841, Japan Tel +81 154 43 0211 Fax +81 154 43 0210 email atsusi-k@coral.plala.or.j p Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Kawahara et al Running head recto: Nepafenac versus diclofenac ophthalmic solutions after cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S101836",Non-OADS,/arxiv_data1/oa_pdf/87/b0/opth-10-385.PMC4786065.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/87/b0/opth-10-385.PMC4786065.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/b0/opth-10-385.PMC4786065.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 479–487International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  479OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9734 3COPD assessment test and severity of airflow  limitation in patients with asthma, COPD, and  asthma–COPD overlap syndrome Kazuyoshi Kurashima Y otaro Takaku Chie Ohta noboru Takayanagi Tsutomu Yanagisawa Yutaka sugita Department of respiratory  Medicine, saitama Cardiovascular  and respiratory Center, Kumagaya,   saitama, JapanObjective:  The COPD assessment test (CAT) consists of eight nonspecific scores of quality  of life.",Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
"lg.jp Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kurashima et al Running head recto: Quality of life in asthma, COPD, and ACOS DOI: http://dx.doi.org/10.2147/COPD.S97343",Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
"Available from: http://www.thoracic.org/members/assemblies/ assemblies/srn/questionaires/act.ph p. Accessed January 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/0d/copd-11-479.PMC4786066.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/ott-9-1151.PMC4786067.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1151–1158submit your manuscript | www.dovepress.co m Dove press  1151 http: //dx.doi.org/10.2147/OTT .S9699 0association between l55M polymorphism in  Paraoxonase 1 and cancer risk: a meta-analysis  based on 21 studies lei chen1,* Wei lu2,* lu Fang1 hu Xiong3 Xun Wu4 Meng Zhang2 song Wu2 Dexin Yu1 1Department of Urology, The second  affiliated hospital of anhui Medical  University, 2Department of Urology,   anhui Medical University graduate  school, hefei, anhui, 3Department  of Urology, The second hospital  of lanzhou University, lanzhou,   4Department of anatomy, school of  Basic Medical sciences, southern  Medical University, guangzhou,   People’s republic of china *These authors contributed equally to  this workAbstract:  L55M polymorphism in Paraoxonase 1 (PON1) has been regarded as a risk factor for  many cancer types.",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/ott-9-1151.PMC4786067.pdf
"Studies revealed that higher PON1 activity and mRNA levels were correspondence: Dexin Yu Department of Urology, The second  Affiliated Hospital of Anhui Medical  University, Furong road 678, hefei,  anhui 230000, People’s republic of china email yudx_urology@126.co m  Meng Zhang  Department of Urology, anhui Medical  University graduate school, hefei, anhui  230000, People’s republic of china Tel +86 159 2000 6559 Fax +86 159 2000 6559 email zhangmeng1930@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Association between PON1-L55M polymorphism and cancer risk DOI: http://dx.doi.org/10.2147/OTT.S96990",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/ott-9-1151.PMC4786067.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/ott-9-1151.PMC4786067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/5f/ott-9-1151.PMC4786067.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijgm-9-053.PMC4786081.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of General Medicine 2016:9 53–64International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  53RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S8855 2Animal models of myasthenia gravis: utility and  limitations Renato Mantegazza Chiara Cordiglieri Alessandra Consonni Fulvio Baggi Neurology Iv Unit, Neuroimmunology  and Neuromuscular Disorders,   Foundation IRCCS Neurological  Institute “Carlo Besta”, Milan, Italy Correspondence: Renato Mantegazza   Neurology Iv Unit, Neuroimmunology  and Neuromuscular Disorders,  Foundation IRCCS Neurological Institute  “Carlo Besta”, via Celoria 11, 20133  Milan, Italy   T el +39 02 2394 2255   Fax +39 02 7063 3874   email rmantegazza@istituto-besta.i tAbstract:  Myasthenia gravis (MG) is a chronic autoimmune disease caused by the immune  attack of the neuromuscular junction.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijgm-9-053.PMC4786081.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijgm-9-053.PMC4786081.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijgm-9-053.PMC4786081.pdf
http://dx.doi.org/ 10.1056/NEJMsa060185 .,OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.21410 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.3322/canjclin.53.5.268 .,OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.3322/canjclin.56.6.323 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.3322/caac.21142 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1249/MSS.0b013e3181e0c112 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
Available from: http://www.survivorshipguidelines.org/pdf/DietandPhysicalActivity.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.3322/caac.20140 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.3322/canjclin.56.5.254 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
Available  from: http://www.cdc.gov/physicalactivity/everyone/guidelines/index.html# 14.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
Available  from: http://www.health.gov/paguidelines/pdf/paguide.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.1016/j.jada.2011.09.004 .,OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.23280 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/cncr.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.23010 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1159/000023566 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/mpo.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1097/00043426-200110000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1097/MPH.0b013e31817e4ad9 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/mpo.1161 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.22737 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1038/bmt.2010.326 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/cncr.24043 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1188/07.ONF.E60-E69 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.1158/1055-9965.EPI-07-0048 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1200/JCO.2010.34.4267 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.24144 35.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/cncr.24209 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pon.1654 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.23359 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.1186/1471-2431-12-40 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1371/journal.pone.0034930 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.1007/s11764-011-0187-5 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1300/ J077V16N01_04 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.21942 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1016/j.jpainsymman.2006.09.025 .,OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.10481 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/ 10.1002/pbc.22698 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1097/01.mph.0000243644.20993.54 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1055/s-2007-965571 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1097/NCC.,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/ pbc.24049 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1097/MPH.0b013e318162c476 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1249/01.mss.0000240326.54147.fc .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pon.1484 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pon.1484 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/pbc.20389 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1519/JSC.0b013e3181b22ac5 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1002/(SICI)1097-0215(1999)83:12+<138::AID-IJC24>3.0.CO;2- W. [PubMed: 10679885]  71.,OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
http://dx.doi.org/10.1188/08.ONF.121-130 .,Non-OADS,/arxiv_data1/oa_pdf/86/f2/nihms695404.PMC4786177.pdf
"4, 167~180, December , 201 5  <Review>   http://dx.doi.org/10.12717/DR.201 5.19.4.167  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received October  15, 2015, Received in revised form October  23, 2015, Accepted November  5, 2015   † Corresponding Author : Jong -Min Kim , Department  of Anatomy and Cell Biology, College of Medicine, Dong -A University, Busan 602 -714, Korea .",Non-OADS,/arxiv_data1/oa_pdf/ad/1f/DR-19-167.PMC4786478.pdf
"4, 181~187, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.181  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  20, 2015, Received in revised form November  27, 2015, Accepted December  8, 2015   † Corresponding Author : Jeong -Ho Lee, Inland Aquaculture Research Center, National Fisheries Research & Development Institute, Changwon 645 -806,  Korea .",Non-OADS,/arxiv_data1/oa_pdf/81/d6/DR-19-181.PMC4786479.pdf
"4, 189~196, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.189  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received October  10, 2015, Received in revised form October  25, 2015, Accepted November  1, 2015   † Corresponding Author : Kyeong -Ho Han, Dept.",Non-OADS,/arxiv_data1/oa_pdf/51/a9/DR-19-189.PMC4786480.pdf
"4, 197~207, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.197  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received October  3, 2015, Received in revised form October  24, 2015, Accepted November  5, 2015   † Corresponding Author : Young -Don Lee , Marine Science  Research Institute, Jeju National University , 19-5 Hamdeok  5(O)-gil, Jocheon -eup, Jeju, Jeju- si, Jeju Special Self -Governing Province, 69 5-965, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c6/61/DR-19-197.PMC4786481.pdf
"4, 209~215, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.209  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received October  10, 2015, Received in revised form November  2, 2015, Accepted November  17, 2015   † Corresponding Author : Joon Yeong Kwon , Dept.",Non-OADS,/arxiv_data1/oa_pdf/1a/31/DR-19-209.PMC4786482.pdf
"4, 217~226, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.217  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  3, 2015, Received in revised form November  10, 2015, Accepted November  20, 2015   † Corresponding Author : Ki-Ho Lee, Dept .",Non-OADS,/arxiv_data1/oa_pdf/32/41/DR-19-217.PMC4786483.pdf
"4, 227~234, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.227  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  20, 2015, Received in revised form November  30, 2015, Accepted December  5, 2015   † Corresponding Author : Jong Taek Yoon, Dept .",Non-OADS,/arxiv_data1/oa_pdf/79/41/DR-19-227.PMC4786484.pdf
"4, 235~242, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.235  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  20, 2015, Received in revised form December  6, 2015, Accepted December  12, 2015   † Corresponding Author : a,b These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/9c/e7/DR-19-235.PMC4786485.pdf
"4, 243~252, December , 201 5    http://dx.doi.org/10.12717/DR.201 5.19.4.243  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  29, 2015, Received in revised form December  8, 2015, Accepted December  15, 2015   † Corresponding Author : Hyunwon Yang , Dept .",Non-OADS,/arxiv_data1/oa_pdf/1a/be/DR-19-243.PMC4786486.pdf
"4, 253~258, December , 201 5  <Short communication>    http://dx.doi.org/10.12717/DR.201 5.19.4.253  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  10, 2015, Received in revised form November  19, 2015, Accepted December  1, 2015   † Corresponding Author : In Bon Goo, Inland Aquaculture Research Center, National Fisheries Research & Development Institute, Changwon  645-806,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/ea/aa/DR-19-253.PMC4786487.pdf
"4, 259~264, December , 201 5  <Short communication>   http://dx.doi.org/10.12717/DR.201 5.19.4.259  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received November  17, 2015, Received in revised form December  1, 2015, Accepted December  10, 2015   † Corresponding Author : Jong -Man Yoon , Dept .",Non-OADS,/arxiv_data1/oa_pdf/d4/54/DR-19-259.PMC4786488.pdf
Energy expenditure The average energy expenditure for each stage (race calories without  basic daily energy consumption) was estimated using an online tool  (http://www.kreuzotter.de/english/espeed.htm) into which the average  body mass and height (Table 1) of the athletes as well as the available  data of each stage (Table 2) were entered.,OADS,/arxiv_data1/oa_pdf/f0/e9/JBS-33-1180173.PMC4786583.pdf
(11 November 2015; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/ca/biv171.PMC4786620.pdf
Published by Elsevier B.V. http://dx.doi.org/10.1016/j.actatropica.2013.10.020Open access under CC BY-NC-SA license.,OADS,/arxiv_data1/oa_pdf/35/95/main.PMC4786622.pdf
"18 (9), http://dx.doi.org/10.3201/eid1809.120262.",Non-OADS,/arxiv_data1/oa_pdf/35/95/main.PMC4786622.pdf
(http://www.nature.com/cmi).,Non-OADS,/arxiv_data1/oa_pdf/76/b7/cmi201502a.PMC4786624.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/IRG1 induced by CO/HO-1 inhibits inflammation MJ Uddin et al 1 Cellular & Molecular Immunology79",Non-OADS,/arxiv_data1/oa_pdf/76/b7/cmi201502a.PMC4786624.pdf
"Cellular & Molecular Immunology Keywords: adjuvant effects; MERS; MERS-CoV; receptor-binding domain; subunit vaccine INTRODUCTION A newly emerged infectious disease, Middle East respiratory syndrome (MERS), was first identified in Saudi Arabia in 2012,1and has now been reported in at least 20 countries in the Middle East, Europe, Africa, Asia and North America (http://www.cdc.gov/CORONAVIRUS/MERS/), raising world- wide concerns about its pandemic potential.",Non-OADS,/arxiv_data1/oa_pdf/4e/83/cmi201503a.PMC4786625.pdf
"By 26 December 2014, MERS coronavirus (MERS-CoV), the causative agent of MERS, had infected 941 people and caused at least 347 relateddeaths (mortality rate ,37%) (http://www.who.int/csr/don/ 26-december-2014-mers/en/).",Non-OADS,/arxiv_data1/oa_pdf/4e/83/cmi201503a.PMC4786625.pdf
"For example, Freund’s adjuvant, an oil emulsion, may induce strong immune responses, but is not suitable for human use because of its toxicity.23While aluminum salts (Alum) are licensed for human use as an adjuvant in the United States, they do not efficiently enhance the Th1-type of humoral and cellular immune responses that are important to combat viral pathogens.24Adjuvant System 04, a new generation Toll-like receptor (TLR)-based adjuvant which combines the TLR4 agonist MPL (3-O-desacyl-4 9-monophosphoryl lipid A) and Alum, is licensed for use in the human papillomavirus vac- cine, Cervarix.25,26AS03, which consists of Tocopherol, Squalene, a n dP o l y s o r b a t e8 0 ,i sa p p r o v e df o ru s ew i t hh u m a ni n f l u e n z aA virus vaccines (http://www.fda.go v/BiologicsBlood Vaccines/Safety Availability/VaccineSafety/ucm376465.htm).27Monophosphoryl lipid A (mPLA), an adjuvant extra cted from lipopolysaccharide, may enhance immune responses induced by influenza vac- cines and is superior to Alum for cancer, HBV, malaria and HPV vaccines, but how to achieve the consistency of preparing mPLA-formulated vaccines remains a challenge.23,28Montanide ISA51, an adjuvant approved for use in humans in Europe, has been shown to promote antigen-sp ecific antibody responses with strong neutralizing activity ag ainst a variety of pathogens.15,29,30MF59, another adjuvant licensed for human use in Europe, has a well-established ability to promote immunogenicity of influenza v i r u sv a c c i n e sw i t has a f e t yp r o f i l ei nh u m a np o p u l a t i o n sc o m p a r - able to that of Alum or Montanide ISA51/720.",Non-OADS,/arxiv_data1/oa_pdf/4e/83/cmi201503a.PMC4786625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Adjuvant for MERS-CoV RBD subunit vaccines N Zhang et al 190 Cellular & Molecular Immunology",Non-OADS,/arxiv_data1/oa_pdf/4e/83/cmi201503a.PMC4786625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Analysis of a nation-wide population-based prospective cohort study M-J Chen et al 530 International Journal of Obesity (2016) 524 –530 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijo2015205a.PMC4786735.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.10.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/87/da/main.PMC4786753.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.003,Non-OADS,/arxiv_data1/oa_pdf/e2/35/main.PMC4786754.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,6–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e2/35/main.PMC4786754.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC4786756.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.02.013 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC4786756.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 7 (2016) 1 e6,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC4786756.pdf
Recuperado de: http://secure.medicalletter.org/ article-share?a ¼122a &p¼tg&title¼Antimicrobial%20Prophylaxis%20for% 20Surgery &cannotaccesstitle ¼1.,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC4786756.pdf
[Internet] 38 (3) (2009).Recuperado de: http://h200137217135.ufg.br/index.php/iptsp/article/view/ 8124 .,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/main.PMC4786756.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/87/main.PMC4786758.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.01.091 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/87/main.PMC4786758.pdf
"[cited 2015 Aug 8]; Available from: http://www.sciencedirect.com/science/ article/pii/S0090825815300573 : [5]A. Burleigh, A. Talhouk, C.B.",Non-OADS,/arxiv_data1/oa_pdf/c1/87/main.PMC4786758.pdf
[cited 2015 Aug 8]; Available from: http://www.sciencedirect.com/science/article/pii/ S1470204515002120 :.,Non-OADS,/arxiv_data1/oa_pdf/c1/87/main.PMC4786758.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.10.003 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/98/ed/main.PMC4786759.pdf
"Salvino).International  Blood  and  Marrow  Transplant  Research (CIBMTR), 12,047  autologous  hematopoietic  stem  cell  trans- plantations  (AHSCT)  were  carried  out  in  the  United  States  in 2011, with MM and  NHL  being  the  main  indications.12In  Brazil, data  from the  Brazilian  Transplant  Registry  show  that  1144 AHSCT  were  performed  in  2013,  slightly  higher  than  the  year before.13 http://dx.doi.org/10.1016/j.bjhh.2015.07.011 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a5/2a/main.PMC4786760.pdf
Available  from:  http://www.cibmtr.org/ReferenceCenter/ SlidesReports/SummarySlides/pages/index.aspx [cited 28.06.15].,Non-OADS,/arxiv_data1/oa_pdf/a5/2a/main.PMC4786760.pdf
Available  from:  http://www.abto.org.br/abtov03/ Upload/ﬁle/RBT/2013/rbt2013-parcial(1).pdf [cited  28.06.15].,OADS,/arxiv_data1/oa_pdf/a5/2a/main.PMC4786760.pdf
"The  expert  group  of  the  ABHH mainly  focused  on  issues  related  to  chemotherapy  and  the http://dx.doi.org/10.1016/j.bjhh.2016.01.001 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/19/58/main.PMC4786761.pdf
Available  from:  http://www.cebm.net  [cited 21.11.12] [Internet].,Non-OADS,/arxiv_data1/oa_pdf/19/58/main.PMC4786761.pdf
"Because  of  the  form  of  presentation,  the  list  of differential diagnoses  is  long,  and  mainly  includes  inﬂamma- tory/infectious diseases  particularly  of  the  central  nervous http://dx.doi.org/10.1016/j.bjhh.2015.12.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/4e/62/main.PMC4786762.pdf
"Immunohematologic  serological  tests  were  performed using  commercial  monoclonal  antibodies  (MoAbs)  MS- 26 +  TH-28  and  ESD1  by  classical  serology  techniques, hemagglutination in gel  cards  (DiaMed,  Latino  América  S.A.) and  by the  tube  methods  with  anti-D  MoAbs  IgM  (HM10,  P3X61, P3X21211F1,  P3X21223B10;  Diagast,  Loos,  France)  and  anti-D http://dx.doi.org/10.1016/j.bjhh.2015.10.001 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ea/a5/main.PMC4786763.pdf
"Once oxyhemoglobin has  reacted  with  NO  in  the  blood vessel,  Hb-Fe3+is  formed  and  can  accumulate  both  in  the  cir- culation  and  in  tissues.9In  a  secondary  Hb-mediated  toxic mechanism, Hb-Fe3+releases  damaging  hemin,  a  hydrophobic http://dx.doi.org/10.1016/j.bjhh.2015.10.004 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/18/d9/main.PMC4786764.pdf
"Received  18  December  2015 Accepted 9  January  2016 Available  online  9  February  2016 http://dx.doi.org/10.1016/j.bjhh.2016.01.003 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/63/c9/main.PMC4786765.pdf
Available  from: http://www.paho.org/hq/index.php?option=com  docman &task=doc view&Itemid=270&gid=32021&lang=en [cited 18.12.15].,OADS,/arxiv_data1/oa_pdf/70/7c/main.PMC4786766.pdf
Available  from:  http://www.hygiene-publique.gov.pf/ IMG/pdf/no13 -  mai  2015  -  zika.pdf  [cited  18.12.15].,Non-OADS,/arxiv_data1/oa_pdf/70/7c/main.PMC4786766.pdf
"Received 18  December  2015 Accepted 6  January  2016 Available online  4  February  2016 http://dx.doi.org/10.1016/j.bjhh.2016.01.002 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/70/7c/main.PMC4786766.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.12.002 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ca/c6/main.PMC4786767.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.10.005 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/e6/36/main.PMC4786768.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.11.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ff/e3/main.PMC4786769.pdf
"Tropical  spastic paraparesis/HTLV-1-associated  myelopathy  (TSP/HAM)  more frequently affects  women,  with  onset  ranging  from  years to decades  after  infection,  at  an  average  age  of  40  years.1 With  an  insidious  manifestation  and  chronic  evolution, HAM/TSP  takes  years  to  progress  from  the  onset  of  symp- toms, such  as  weakness  and  spasticity  of  one  or  both  legs and minor  sensory  changes,  to  wheelchair  conﬁnement  and http://dx.doi.org/10.1016/j.bjhh.2015.08.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ca/de/main.PMC4786770.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.11.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/99/f8/main.PMC4786771.pdf
"Marburg, 2012, http://www.audiotranskription.de/download/Handbuch-f4.pdf (accessed 5 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/21/10.1177_0969733014557719.PMC4786778.pdf
"NVivo 9-getting-started-guide , http://download.qsrinternationa l.com/Document/NVivo9/NVivo9- Getting-Started-Guide.pdf (2011, accessed 5 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/21/10.1177_0969733014557719.PMC4786778.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.11.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/1a/71/main.PMC4786779.pdf
"http://dx.doi.org/10.1080/01490451.2015.1052118 © 2016 Barbara Blasi, Caroline Poyntner, Tamara Rudavsky, Francesc X. Prenafeta-Bold /C19u, Sybren De Hoog, Hakim Tafer, and Katja Ster ﬂinger Published with license by Taylor and Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.GEOMICROBIOLOGY JOURNAL 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/91/f0/ugmb-33-308.PMC4786828.pdf
"3 –4, 308 –317 http://dx.doi.org/10.1080/01490451.2015.1052118",Non-OADS,/arxiv_data1/oa_pdf/91/f0/ugmb-33-308.PMC4786828.pdf
"Allthe annotated genomes of the black fungi group were searchedthrough NCBI BLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ) for a peptide sequence, SQEEIDAVI, that has been found inthe toluene monooxygenase of C. saturnica (CBS 114326) with a similarity of 89% with different cytochrome P450 (Luykx et al.",OADS,/arxiv_data1/oa_pdf/91/f0/ugmb-33-308.PMC4786828.pdf
"22, 5537 –5556, http://dx.doi.org/10.1080/01431161.2015.1101505 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/tres-36-5537.PMC4786860.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduc- tion in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/tres-36-5537.PMC4786860.pdf
United States Geological Survey Alaska The United States Geological Survey (USGS) vegetation map of Alaska includes 19 vegetation classes ( http://agdc.usgs.gov/data/usgs/erosafo/veg/vegetation.html ) and has a resolution of 1 km.,Non-OADS,/arxiv_data1/oa_pdf/6a/2e/tres-36-5537.PMC4786860.pdf
"According to the Annotated Ramsar List of Wetlands of International Importance – CANADA ( http://www.ramsar.org/countries/canada?page = 5 ), it is ‘an intertidal zone with a series of raised beaches and a marshy plain of mosses and sedges, dotted with shallow lakes and swamps, drained by many small, slow-flowing streams ’.",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/tres-36-5537.PMC4786860.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/4c/rjw030.PMC4786864.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/c1/ofw017.PMC4786867.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/cf/1f/mt2015164a.PMC4786910.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ 498 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/bb/d0/mt2015202a.PMC4786915.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/ by-nc-nd/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/1b/0c/mt2015220a.PMC4786918.pdf
"Pathway analysis showed that 10 dysregulated transcripts mapped to cytokine–cytokine receptor interaction by DAVID analysis 28 (Benjamini-corrected P   = 0.011)   (Supplementary Figure S9), consistent with PPP1R12C’s role  in inflammation.29 Although seven dysregulated genes were  potential proto-oncogenes in a consolidated catalogue of more  than 1,600 oncogenes (http://www.bushmanlab.org/links/ genelists), none mapped to any of the canonical cancer path-ways in KEGG.",Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
DNA encoding the wild-type catalytic domain of Fok I  (pST1374; Addgene; http://www.addgene.org) was mutagenized for het- erodimerization.20 The OH (obligate heterodimer) ZFN had two amino  acid changes in the Fok I monomer fused to the right AAVS1 homology  arm (E490K and I538K) and in the monomer fused to the left homology  arm (Q468E and I499L).,Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
As SVDetect (version r0.08; http://svdetect.sourceforge.,Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
net) 59 and BreakDancer (version 1.4.4; http://breakdancer.sourceforge.,Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
"net/)60 require only abnormally mapped reads, the raw reads were first  preprocessed with SAMtools (version 0.1.19; http://samtools.sourceforge.net/) and Picard.",Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
Filtering was done with in-house Perl script and BEDtools  (version 2.17.0; http://bedtools.readthedocs.org/en/latest/).62 BED files of  these regions needed for filtering were extracted as described61 from the  UCSC genome browser (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
"DAVID (Database  for Annotation, Visualization and Integrated Discovery) 2.1 Functional  Annotation Tool (http://david.abcc.ncifcrf.gov) 28 was used to annotate sig- nificantly altered transcripts and for pathway mapping.",OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
Altered transcripts  were also referenced to an aggregated compilation of oncogenes and tumor  suppressor genes (http://www.bushmanlab.org/links/genelists).,OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
"Intron-spanning exonic primers were used to amplify the  endogenous PPP1R12C transcript (exons 4–6), neighboring genes within  a 1-Mb interval centered on the AAVS1 integration site (LILRB4, ISOC2,  PPP6R1, NAT14, ZNF579, FIZ1, and RDH13), potential interacting part- ners of PPP1R12C predicted by Gene Network Central (http://www.sabio-sciences.com) and Human Protein–Protein Interaction Prediction (http://www.compbio.dundee.ac.uk) that were significantly altered by RNA-seq  analysis (DUSP1, DUSP6, CDC6, and DUSP16), and a housekeeping gene,  GAPDH.",OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/89/5c/mt2015223a.PMC4786920.pdf
"A list  of 3,165 cancer-related genes was downloaded from http://cbio.mskcc.org/CancerGenes.",OADS,/arxiv_data1/oa_pdf/bf/14/mt201611a.PMC4786924.pdf
Sequence data is accessible in the GEO data- base at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=wtsfakacnvyfroz&acc=GSE58744.,OADS,/arxiv_data1/oa_pdf/bf/14/mt201611a.PMC4786924.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ 606 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/bf/14/mt201611a.PMC4786924.pdf
"Official journal of the American Society of Gene & Cell TherapyNuclease Target Site Selection in Genome EditingTable 1 Nuclease design tools Design toolNuclease  designOff-target  searchMax # of  mismatchActivity  analysis Functionality CRISPR/Cas9 tools Benchling;  https://benchling.com√ √ 4 X Web tools for molecular biology and CRISPR applications, including gRNA design for a gene or genome coordinates.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
Cas-OFFinder; http://www.rgenome.net/cas-offinder/X √ 9 X Web site or downloadable program that searches for potential off-target sites for input gRNA and protospacer adjacent motifs (PAMs) in the requested genome or user-defined sequence.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
CCTop; http://crispr.cos.uni-heidelberg.de√ √ 5 X CRISPR/Cas9 Target online predictor evaluates target sites within an input sequence giving a ranking of the candidates based on the possible off-target sites it identifies in a number of genomes.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
111 CHOPCHOP; https://chopchop.rc.fas.harvard.edu√ √ 2 X A web tool for selecting target sites for CRISPR/Cas9- or TALEN-directed targeting from within an input sequence or chromosomal coordinates in a number of genomes.,Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"35 COSMID; https://crispr.bme.gatech.eduX √ 3 X CRISPR Off-target Sites with Mismatches, Insertions, and Deletions.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"48 CRISPR design; http://crispr.mit.edu√ √ 4 X Designs gRNA by evaluating possible off-target sites in a number of genomes and outputs with scoring, highlighting gRNA that may have higher specificity.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
52 CRISPR MultiTargeter; http://www.multicrispr.net√ X n/a X Users can input sequences to search for unique CRISPR target sites or highly similar or identical target sites in multiple genes or transcripts or within a single gene.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"Also has UCSC tracks for high and low scoring gRNAs 43 CRISPR-Plant; http://www.genome.arizona.edu/crispr/  CRISPRsearch.html√ X n/a X A CRISPR search tool targeting a range of plant species, identifying spacer sequences located in a selected gene region, gene or larger chromosomal region.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"CRISPRdirect; http://crispr.dbcls.jp√ X 2 X Selects target sites from accession numbers, genome locations or input sequences.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"113 CRISPRfinder; http://crispr.u-psud.fr/ Server/X X n/a X Locates CRISPR (repeat) structures in published microbial genomes or in small to very large user-submitted sequences, also can extract the spacer sequences.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"114 CRISPRseek; http://www.bioconductor.org/packages/release/bioc/html/CRISPRseek.html√ √ 4 X Open source software to identify target-specific gRNAs, minimizing off-target cleavage at other sites within any selected genome outputs a list of all possible sgRNAs for a given PAM sequence.. 115 CROP-IT; http://cheetah.bioch.virginia.edu/AdliLab/CROP-IT/ homepage.html √ √ 6, 9 X CRISPR/Cas9 Off-target Prediction and Identification Tool assists biologists in designing CRISPR/CAS9.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"DESKGEN; https://www.deskgen.com/landing/√ √ 3 X Allows designing gene editing experiments through a full range of genome-editing tools, including providing gRNAs, vectors, donors, and target activity scores and library designs.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"Dharmacon Configurator; http://dharmacon.gelifesciences.com/gene-editing/crispr-rna-configurator/√ X n/a X Designs gRNA targeting sequences based on Entrez Gene ID or Gene symbol, with links to order synthesized RNAs.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
DNA 2.0 Design Tool; https://www.dna20.com/eCommerce/cas9/input√ X n/a X Allows testing user supplied gRNAs or designs gRNA or pairs of gRNAs targeting a user-specified gene or chromosomal site.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"E-CRISP; http://www.e-crisp.org/E-CRISP/√ √ 10 X Designs and evaluates CRISPR target sites from a gene symbol, an ENSEMBL ID or a FASTA sequence and designs gRNAs, allowing for a number of different CRISPR uses.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
116 flyCRISPR Optimal Target Finder; http://tools.flycrispr.molbio.wisc.edu/targetFinder/√ √ 6 X Identifies target sites and evaluates their specificity for use targeting Drosophila melanogaster.,Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
Official journal of the American Society of Gene & Cell TherapyNuclease Target Site Selection in Genome Editing GT-Scan;  http://gt-scan.braembl.,Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
118 Jack Lin’s gRNA finder; http://spot.colorado.edu/~slin/cas9.html√ X n/a X CRISPR target site locator that searches the sense strand of DNA sequences for PAM sequences and returns the sites target sites of a specified length.,Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
Microhomology-associated Score Calculator; http://www.rgenome.net/mich-calculator/√ X n/a X Evaluates microhomology in input sequences to evaluate potential for induced frame shifts and knockouts.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"119 sgRNAcas9; http://www.biootools.com√ √ 5 X A downloadable program software package that designs CRISPR gRNAs, provides cloning sequences with minimized off-target effects and searches for potential off-target cleavage.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
120 sgRNA Designer; http://www.broadinstitute.org/rnai/public/ analysis-tools/sgrna-design√ X n/a Prediction A web-based tool for designing sgRNAs targeting the human or mouse gene.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"41 sgRNA Scorer; https://crispr.med.harvard.edu/sgRNAScorer/√ X n/a Prediction A sgRNA design tool that was developed using results from an in vivo  library-on-library  methodology that simultaneously assessed sgRNA activity across ~1,400 genomic loci.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"42 WGE; http://www.sanger.ac.uk/htgt/wge/√ √ 4 X A series of tools using a database of determined single and paired guide strands, including a genome browser environment and pre-scored off-target information.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"121 ZFN and TALEN tools PROGNOS;  http://bao.rice.edu/Research/BioinformaticTools/prognos.htmlX √ 20 X Predicted report of genome-wide nuclease off-target sites exhaustively identifies off-target sites for TALENs or ZFNs, provides a ranked list and designs primers for downstream applications, such as mutation detection or NGS.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"46 SAPTA; http://bao.rice.edu/Research/BioinformaticTools/TAL_targeter.html√ X n/a X Scoring algorithm for predicting TALE(N) Activity scans an input DNA sequence and designs TAL effectors or TALENs predicted to have the highest activity, particularly when using the di-residues NK that provide more specifically within a supplied gene sequence.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"39 TAL Plasmids Sequence Assembly Tool; http://bao.rice.edu/Research/BioinformaticTools/assembleTALSequences.htmlX X n/a X Facilitates cloning and sequencing of TAL and TALEN plasmids, by generating vector sequence after a user enters target sequences or repeat variable diresidues and assembly method.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"TALE-N Effector Nuclease Targeter; https://tale-nt.cac.cornell.edu√ √ X Tools for designing, evaluating, and assembling custom single and paired TAL effector constructs and TALENs.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
33 TALgetter/TALENoffer; http://galaxy2.informatik.uni-halle.de:8976√  √  10 X Predicts off-target sites for TALEN sites identified in an input sequence.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"Available as web site, command line program and as a Galaxy server 122 ZiFiT; http://zifit.partners.org/ZiFiT/√ X blast X Zinc finger targeter originally a tool for identifying of potential zinc finger nuclease (ZFN) sites, but ZiFit has been extended to also contain tools for TALENs and CRISPR nucleases.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
75 CRISPResso; http://crispresso.rocksX X n/a Quantification Provides analysis of CRISPR-Cas9 genome editing outcomes (nonhomologous end joining or homology-directed repair) from NGS single or paired reads when compared to uploaded reference sequence.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"EENdb; http://eendb.zfgenetics.orgX X n/a X Databases of target sites for reported TALENs, ZFNs and CRISPR/Cas systems in different organisms.",OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
123 Gibson Designer; http://www.sanger.ac.uk/htgt/wge/gibson_designerX X n/a X  Designs human or mouse amplification primers to create targeting vectors by Gibson assembly.,Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
121 TIDE; http://tide.nki.nlX X n/a Quantification Tracking of indels by decomposition (TIDE) is a web tool to determine the level and type of mutations introduced by genome editing.,OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0// Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/mt20161a.PMC4786925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ 526 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/1e/b1/mt201624a.PMC4786927.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ 654 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/7c/8d/mt20168a.PMC4786937.pdf
"Moreover, DQ data have been  recorded using a driving simulation software (accessible at  http://opends.de/).",Non-OADS,/arxiv_data1/oa_pdf/6f/87/JMSS-6-39.PMC4786962.pdf
"For ICA calculation,  the FASTICA toolbox (accessible at http://research.ics.aalto.",OADS,/arxiv_data1/oa_pdf/6f/87/JMSS-6-39.PMC4786962.pdf
Available from: http://www.isi.uu.nl/Research/Databases/DRIVE/.,OADS,/arxiv_data1/oa_pdf/20/19/JMSS-6-57.PMC4786964.pdf
Available from: http://www.misp.mui.ac.ir/en/Angio -fundus.,Non-OADS,/arxiv_data1/oa_pdf/20/19/JMSS-6-57.PMC4786964.pdf
Available from: http://www.ibridges.org/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.bridge2014.org/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.sbs.ox.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: https://www.facebook.com/ fbFund/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.digikala.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.aparat.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.takhfifan.com/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.bayer.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.betahaus.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.factoryberlin.com/.,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
Available from: http://www.plugandplaytechcenter.,OADS,/arxiv_data1/oa_pdf/b9/4d/JMSS-6-64.PMC4786965.pdf
"for example, http://www.southportvisiter.co.uk/southport-news/southport-southport-news/ 2009/11/20/whistleblower-how-i-exposed-southport-fraud-vet-russell-lewis- oakes-101022-25209814/  .",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"In  humans, a 2010 review by the Royal College of Obstetricians and Gynaecologists into foetal  awareness ( http://www.rcog.org.uk/fetal-awareness-review-research-and-recommendations- practice ) concluded that it was difficult to extrapolate and apply the findings of work on  neonatal pain ( Derbyshire and Fitzgerald 2010 ) to foetuses because, though nervous  connections from the periphery to the central cortex are present from 24 weeks of  development onwards, foetuses remain in a “continuous sleep-like (state of)  unconsciousness or sedation” and are therefore unlikely to perceive pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"training and qualification criteria (see, for example, http://www.beva.org.uk/useful-info/ Directories/Musculo-Skeletal-Paras ) could also be adopted by non-veterinarians undertaken  ARTs.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"The  issue of the need to ensure clinical competence is one which occurs at all levels of veterinary  practice and which has been reflected in the RCVS’ increased emphasis on ‘Continued  Professional Development’ and the introduction of a compulsory ‘Professional Development  Phase’ (see http://www.rcvs.org.uk/education/professional-development-phase-pdp ) In the  absence of a register of procedures performed or of those undertaking such procedures, the  number of animals being subjected to ART procedures in the UK is unclear.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
This fundamental question of the welfare and ethical implications of  veterinary specialisation vs standard qualification is one which is not particular to ARTs (see  the RCVS Consultation on Specialisation http://www.rcvs.org.uk/news-and-events/news/the-Campbell Page 14 Anim Welf .,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"A reporting function could be incorporated into  the current regulation of veterinary ARTs without the need for new primary legislation, by  adopting a voluntary reporting system for veterinarians practicing ARTs which could be  adapted to fit within and be administrated under the RCVS’ existing Practice Standards  Scheme ( http://www.rcvs.org.uk/practice-standards-scheme/about-the-practice-standards- 10There is an associated issue of who trains the specialists in a country where there are very few specialists.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
2004. http://www.fawc.org.uk/pdf/ breedingreport.pdf FAWC.,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"2012. http://www.defra.gov.uk/fawc/files/ Opinion-on-the-welfare-implications-of-breeding-and-breeding-technologies-in-commercial- livestock-agriculture.pdf Fovargue S. Oh pick me, pick me: selecting participants for xenotransplant clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
http://dx.doi.org/10.1093/medlaw/fwm005 .,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
http://dx.doi.org/10.1093/medlaw/ fwq017 .,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"[PubMed: 20719758]  Harvey, C. [accessed 02.02.2013] 2010. http://www.telegraph.co.uk/family/pets/8157908/The-Bionic- Vet-he-can-rebuild-them.html House of Commons Select Committee.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
2005. http://www.publications.parliament.uk/pa/cm200405/cmselect/cmsctech/491/491.pdfCampbell Page 17 Anim Welf .,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"2009. http://archive.defra.gov.uk/foodfarm/policy/animalhealth/vservices/pdf/lowe- vets090806.pdf Mellor D. Galloping colts, fetal feelings and reassuring regulations: Putting farm animal welfare  science into practice.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
1984. p. p62 http://www.hfea.gov.uk/docs/ Warnock_Report_of_the_Committee_of_Inquiry_into_Human_Fertilisation_and_Embryology_19 84.pdfCampbell Page 18 Anim Welf .,Non-OADS,/arxiv_data1/oa_pdf/e7/97/emss-67514.PMC4786995.pdf
"Madeleine Campbell is funded by The Wellcome Trust as a Biomedical Ethics Fellow, Grant number  095920/Z/11/Z References Animal Health And Protection Act R.S.P.E.. [Accessed 12 June 2014] 1988. http://www.gov.pe.ca/law/ regulations/pdf/A&11-1-1.pdf Animal Welfare Act s(1)(3-4).",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
[Accessed 12 June 2014] 2006. http://www.legislation.gov.uk/ukpga/ 2006/45/contents Baars BJ.,Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
2012. http://www.defra.gov.uk/fawc/files/ Opinion-on-the-welfare-implications-of-breeding-and-breeding-technologies-in-commercial- livestock-agriculture.pdfCampbell et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
"2005.  http://www.nuffieldbioethics.org/sites/default/files/The%20ethics%20of%20research%20involving %20animals%20-%20full%20report.pdf Ousey JC, Fowden AL, Wilsher S, Allen WR.",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
"2010. http://www.rcog.org.uk/fetal-awareness- review-research-and-recommendations-practice Rutherford K, Donald R, Arnott G, Rooke J, Dixon L, Mehers J, Turnbull J, Lawrence A.",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
1966. p. 89-544. http://en.wikipedia.org/wiki/Animal_Welfare_Act_of_1966 The Law for the Humane Treatment and Management of Animals.,Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
"[Accessed 12 June 2014] 1966. https://www.rcvs.org.uk/document- library/veterinary-surgeons-act-1966/ Vander Heyden L, Lejeune J-P, Caudron I, Detilleux J, Sandersen C, Chavatte P, Paris J, Deliège B,  Serteyn D. Association of breeding conditions with prevalence of osteochondrosis in foals.",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/emss-67507.PMC4786996.pdf
"unpublished, available from http://www.botanik.univie.ac.at/systematik/pro-jects/dactylorhiza/downloads.html).",OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
"2.3.3 (Pritchard et al., 2000) implemented on the Lifeportal of the University of Oslo (https://lifeportal.uio.no/).",Non-OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
DATA ARCHIVING Data accessibility Source data and R scripts used for this work are available from the Dryad Digital Repository (http://dx.doi.org/10.5061/ dryad.9hb89).,OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
Sequencingthe reference transcriptomes for microsatellite development has been done atthe CSF Vienna (http://ngs.csf.ac.at).,OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
Available at http://CRAN.R-project.org/package =pgirmess.,Non-OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
Available at http://CRAN.R-project.org/package =lmodel2.,Non-OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
Available at https://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Allopolyploid differentiation in Dactylorhiza FB a l a o et al 361 Heredity",Non-OADS,/arxiv_data1/oa_pdf/e0/0c/hdy201598a.PMC4787024.pdf
Available from: http://www.idf.org/diabetesatlas/5e/the- global-burden.,Non-OADS,/arxiv_data1/oa_pdf/57/21/IJPI-6-1.PMC4787057.pdf
Available from: http://www.bd.com/aboutbd/ history/.,Non-OADS,/arxiv_data1/oa_pdf/57/21/IJPI-6-1.PMC4787057.pdf
Available from: http://www.islet.org/forum029/messages/26908.,Non-OADS,/arxiv_data1/oa_pdf/57/21/IJPI-6-1.PMC4787057.pdf
Available from: http://www.prnewswire.com/news-releases/ generex-provides-update-on-generex-oral-lyn-conference- call-225497092.html.,Non-OADS,/arxiv_data1/oa_pdf/57/21/IJPI-6-1.PMC4787057.pdf
Available from: http://www.diapedia.org/type- 1-diabetes-mellitus/2104588419/intraperitoneal-insulin.,Non-OADS,/arxiv_data1/oa_pdf/57/21/IJPI-6-1.PMC4787057.pdf
Available from: http://www.naturalhealthresearch.,Non-OADS,/arxiv_data1/oa_pdf/7a/11/IJPI-6-10.PMC4787058.pdf
Elemental Impurities: Standards-Setting Record Available from:  http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/	 2012- 12 20_elemental_impurities_standards-setting_record-full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/11/IJPI-6-10.PMC4787058.pdf
Available from: http://www2.chemistry.,OADS,/arxiv_data1/oa_pdf/7a/11/IJPI-6-10.PMC4787058.pdf
Available from: http://www.uobabylon.edu.iq/uobcoleges/ad_ downloads/6_28118_901.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/11/IJPI-6-10.PMC4787058.pdf
Available from: http://db.cbg-meb.nl/Pars/h106659.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/11/IJPI-6-10.PMC4787058.pdf
http://www.articlesbase.com/visionarticles/ ophthalmic-nanoparticles-drug-deliverysystems-1273176.html.,Non-OADS,/arxiv_data1/oa_pdf/0d/9b/IJPI-6-56.PMC4787063.pdf
"The nomenclatural update was realized  in Lista de Espécies da Flora do Brazil (http://floradobrasil.jbrj.gov.br/ jabot/listaBrasil/PrincipalUC/PrincipalUC.do), and the plant list: A  working list of all plant species (http://www.theplantlist.org/).",OADS,/arxiv_data1/oa_pdf/67/d8/PM-11-533.PMC4787084.pdf
Available from:  http://www.floradobrasil.jbrj.gov.br/jabot/floradobrasil/FB217 .,Non-OADS,/arxiv_data1/oa_pdf/67/d8/PM-11-533.PMC4787084.pdf
Available from: http://www.floradobrasil.jbrj.gov.br/jabot/floradobrasil/ FB14473.,Non-OADS,/arxiv_data1/oa_pdf/67/d8/PM-11-533.PMC4787084.pdf
The homology models obtained so were checked for the stereochemical  viability using RAMPAGE server[42]  (http://mordred.bioc.cam.ac.uk/ rapper/rampage.php) [Table 1].,OADS,/arxiv_data1/oa_pdf/09/73/PM-11-570.PMC4787090.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs297/en.,Non-OADS,/arxiv_data1/oa_pdf/8f/7f/PM-11-598.PMC4787095.pdf
"Further, the model  was validated by RAMPAGE (Ramachandran plot) (http://mordred.bioc.",Non-OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
Available from: http://www.chemspider.com/Chemical‑Structure.,OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
Available from: http://www.chemspider.com/Chemical‑Structure.,OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
Available from: http://www.chemspider.com/Chemical‑Structure.,OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
Available from: http://www.chemspider.com/Chemical‑Structure.,OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
Available from: http://www.chemspider.com/Chemical‑Structure.,OADS,/arxiv_data1/oa_pdf/39/c8/PM-11-606.PMC4787096.pdf
http://www.unaids.org/sites/default/ﬁles/en/media/unaids/ contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.,Non-OADS,/arxiv_data1/oa_pdf/b9/0b/cohiv-11-s52.PMC4787103.pdf
"4.HIV data, 2014. http://www.bdnasp.org/home/general/128.",Non-OADS,/arxiv_data1/oa_pdf/b9/0b/cohiv-11-s52.PMC4787103.pdf
http://www.bmet.gov.bd/BMET/viewStatReport.action?reportnumber=28.,Non-OADS,/arxiv_data1/oa_pdf/b9/0b/cohiv-11-s52.PMC4787103.pdf
http://www.unaids.org/en/media/un aids/contentassets/documents/factsheet/2014/20140716_FactSheet_en.,Non-OADS,/arxiv_data1/oa_pdf/c6/dc/cohiv-11-s13.PMC4787105.pdf
http://bdnews24.com/health/2014/12/01/hiv-cases-on-rise-in-bangladesh.,Non-OADS,/arxiv_data1/oa_pdf/c6/dc/cohiv-11-s13.PMC4787105.pdf
Geneva: UNAIDS; 2015. http://www.unaidsstrate gy2021.org/wp-content/uploads/2015/08/UNAIDS-Strategy-2016–2021_ Draft-for-review_3-August.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/75/cohiv-11-s37.PMC4787106.pdf
32.UNAIDS All In to #EndAdolescentAIDS (2015) http://www.unaids.org/sites/ default/ﬁles/media_asset/20150217_ALL_IN_brochure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/1f/cohiv-11-s01.PMC4787107.pdf
http://www.unaids.org/ globalreport/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/11/fe/cohiv-11-s21.PMC4787108.pdf
Geneva: UNAIDS; 2014. http://www.unaids.org/sites/default/ﬁles/en/media/unaids/ contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.,Non-OADS,/arxiv_data1/oa_pdf/34/ff/cohiv-11-s06.PMC4787109.pdf
http://www.o3interfaces.com/unodc/ info_briefs_pdf/unodc_info_brief_3.pdf.HIV testing for people who inject drugs Shahid et al.,Non-OADS,/arxiv_data1/oa_pdf/34/ff/cohiv-11-s06.PMC4787109.pdf
Islamabad: Government of Pakistan; 2012. http://www.pbs.gov.pk/ sites/default/ﬁles/pslm/publications/hies11_12/tables/table25.pdf.Testing and exploring vulnerabilities among HIV-positive individuals S12 www.co-hivandaids.com Volume 11 /C15Supplement 1 /C15March 2016,Non-OADS,/arxiv_data1/oa_pdf/34/ff/cohiv-11-s06.PMC4787109.pdf
[http://www.unicef.org/publications/index_46585.html] webcite.2.,Non-OADS,/arxiv_data1/oa_pdf/4c/84/cohiv-11-s46.PMC4787110.pdf
Progress Report [http://www.who.int/hiv/pub/2010progressreport/report/en/index.html] webcite.,Non-OADS,/arxiv_data1/oa_pdf/4c/84/cohiv-11-s46.PMC4787110.pdf
Available from: http://www.indiaenvironmentportal.org.,Non-OADS,/arxiv_data1/oa_pdf/d3/1f/IJA-60-108.PMC4787121.pdf
"Medical College & Teaching Hospital, Nizamabad Organising Secretary:  Dr. Chintala Kishan Contact:  +91 98480 71377 & 99490 46637 E-mail: isacontelangana2016@gmail.com, chintala_kishan@yahoo.in Website: www.isatelangana.org Name of the conference: ISACON MP - 2016   30th Annual State Conference of ISA MP State Chapter Date:  10th September 2016 Venue:  Hotel Jabali Palace, Jabalpur Organising Secretary:  Dr. Ashish Sethi Contact:  +91 98261 68747 E-mail: ashsethi64@yahoo.com Website: http://www.isampchapter.com Name of the conference: 4th World Congress of Ophthalmic Anaesthesia  (WCOA), 2016 Organized by:  Sankara Nethralaya and British Ophthalmic Anaesthesia Society Date:  3rd & 4th September, 2016 Venue:  ITC Grand Chola, Chennai Organising Secretary:  Dr. Jaichandran V V Contact:  +91 98840 96860 E-mail: wcoa2016@gmail.com Website: www.sankaranethralaya.org/wcoa2016Announcement",Non-OADS,/arxiv_data1/oa_pdf/99/49/IJA-60-127.PMC4787124.pdf
Available from: http://www2.kidney.org/professionals/KDOQI/ guidelines_ckd/toc.htm.,Non-OADS,/arxiv_data1/oa_pdf/eb/80/IJA-60-131.PMC4787125.pdf
"[5]  However, a high quality video recording was obtained  in most of the mobile devices that we tested, by using  “CameraFi” (Vault Micro Inc., Seoul, Korea) app freely  downloaded from the online Google Play Store at  https://play.google.com/store/apps/details?id=com.",Non-OADS,/arxiv_data1/oa_pdf/1a/a8/IJA-60-143.PMC4787131.pdf
"Newer USB endoscope cameras of 5.5 mm  diameter, 2 m cable length are available from  online retailers, which are inexpensive, costing  <10$, for example, at http://www.tomtop.com/ product?q=endoscope+borescope.",Non-OADS,/arxiv_data1/oa_pdf/1a/a8/IJA-60-143.PMC4787131.pdf
Available from: http://www.prehospitalmed.com/2015/08/20/ evolution‑of‑inexpensive‑videolaryngoscopy‑from‑concept‑  to‑practice/.,Non-OADS,/arxiv_data1/oa_pdf/1a/a8/IJA-60-143.PMC4787131.pdf
Available from: http://www.prehospitalmed.com/2015/08/20/ evolution‑of‑inexpensive‑videolaryngoscopy‑from‑concept‑  to‑practice/.,Non-OADS,/arxiv_data1/oa_pdf/49/b9/IJA-60-145.PMC4787132.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/96/63/IJA-60-151.PMC4787136.pdf
"See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.How to cite this article:  Samuel SR, Maiya AG, Varghese N.  Effectiveness of transcutaneous electrical nerve stimulation as a  supplement to multimodal analgesia for acute post‑operative pain  following abdominal surgery.",Non-OADS,/arxiv_data1/oa_pdf/96/63/IJA-60-151.PMC4787136.pdf
"[2] We suggest clinicians to install the freely  available application on “magnifying lens and  microscope” (e.g., Cozy Magnifier and Microscope:  https://play.google.com/store/apps/details?id=com.",Non-OADS,/arxiv_data1/oa_pdf/a8/70/IJA-60-153.PMC4787137.pdf
Available from: http://www.promedmail.org/direct.,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from: http://www.who.int/emergencies/mers‑cov/ en/.,OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from: http://www.who.int/csr/disease/coronavirus_,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from: http://www.news.nationalgeographic.com/news/2014/05/140 523‑mers‑vaccine‑camels‑virus‑flu‑saudi‑pandemic‑science/.,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from: http://www.who.int/csr/disease/ coronavirus_infections/MERS_CoV_RA_20140613.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from:  http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/ Documents/Guidelines for Corona Patients.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/02/8e/IJA-60-85.PMC4787138.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/5a/47/IJA-60-94.PMC4787140.pdf
These both used the Nextera capture method (Illumina Inc.) designed to focus on disease-causing genes including those in HGMD (http://www.hgmd.org/) and OMIM (http://www.omim.org/).,OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"Alignment was undertaken using NextGene software (v2.4.1, 2015, SoftGenetics, PA, http://www.softgenetics.com/NextGENe .html), and this was also used for variant identiﬁcation.",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"openbioinformatics.org) and Alamut-Batch (Version 1.4, 2015; Interactive Biosoftware, Rouen, France, http://www.interactive- biosoftware.com/alamut-batch/) (Table 1).",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"Variants were annotated for minor allele frequencies in the dbSNP [Smigielski et al., 2000] (Build 144, May 2015, http://www.ncbi.nlm.nih.gov /projects/SNP), 1000genomes [Abecasis et al., 2012] (Phase 3, 2013, http://www.1000genomes.org/), Exome Variant Server (NHLBI GO Exome Sequencing Project [ESP], Seattle, WA; Version 2, July 2013, http://evs.gs.washington.edu/EVS/) and Exome Aggregation Consortium (ExAC) databases (Version 0.3, January 2015, Cambridge, MA, http://exac.broadinstitute.",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"The computational calculations of SIFT, MutationTaster, PolyPhen, and PhyloP were performed in Alamut-Visual (Version 2.6, Jan 2015; Interactive Biosoft ware, http://www.interactive-biosoftware.com/alamut-visual/).",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"Alamut Visual (Version 2.6, Jan 2015; Interactive Biosoftware, http://www.interactive-biosoftware.com/alamut-visual/) was used for the individual variant analyses, providing computational algorithms for SIFT [Ng and Henikoff, 2001] (Version 1, http://sift.jcvi.org/), PolyPhen-2 [Adzhubei et al., 2010] (Ver- sion 2.2.2, 2012, http://genetics.bwh.harvard.edu/pph2/) and MutationTaster [Schwarz et al., 2010] (Version 2, 2012, http://www.mutationtaster.org/), as well as conservation with PhyloP scores [Pollard et al., 2010].",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
"Primers for Sanger sequencing were designed on Primer3 (http://biotools.umassmed.edu/bioapps/primer3_www.cgi), and are available upon request.",OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
All variants reported in this manuscript have been submitted to ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/).,Non-OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
A curated database of PAX6 mutations can be found at LOVD (http://www.lovd.nl/PAX6).,Non-OADS,/arxiv_data1/oa_pdf/02/f3/HUMU-37-371.PMC4787201.pdf
Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201511809 .,Non-OADS,/arxiv_data1/oa_pdf/5b/89/ANIE-55-3120.PMC4787208.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/3b/TOBEJ-9-326.PMC4787273.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/68/TOBEJ-9-330.PMC4787274.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/58/TOBEJ-9-347.PMC4787276.pdf
"Drug Alcohol Rev., 2014, 33 ( 1 ) ,  4-12. http://dx.doi.org/10.1111/ dar.12088 [2] Degenhardt, L.; Whiteford, H. A.; Ferrari, A. J.; Baxter, A. J.; Charlson, F. J.; Hall, W. D.; Freedman, G.; Burstein, R.; Johns, N.; Engell, R. E.; Flaxman, A.; Murray, C. J.; Vos, T. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2 0 1 0 .",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Lancet, 2013, 382 (9904), 1564-1574. http://dx.doi.org/10.1016/S0140-6736(13)61530-5 [3] Cadet, J. L.; Bisagno, V. The primacy of cognition in the manifestations of substance use disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurol., 2013, 4, 189. http://dx.doi.org/10.3389/fneur.2013.00189 [4] Cadet, J. L.; Bisagno, V.; Milroy, C. M. Neuropathology of substance use disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Acta Neuropathol., 2014, 127 (1), 91-107. http://dx.doi.org/10.1007/s00401-013-1221-7 [5] Cafforio, G.; Morelli, N.; Rota, E.; Piane, R. M.; Mazzoni, M. Cocaine-induced cluster-like headache.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Sci., 2014, 35 (2), 319-321. http://dx.doi.org/10.1007/s10072-013-1540-4 [6] Maceira, A. M.; Ripoll, C.; Cosin-Sales, J.; Igual, B.; Gavilan, M.; Salazar, J.; Belloch, V.; Pennell, D. J.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Reson., 2014, 16, 26. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Med., 2011, 18 ( 4 ) ,  2 0 8-214. http://dx.doi.org/10.1097/MEJ.0b013e3283440f25 [8] Phillips, K.; Luk, A.; Soor, G. S.; Abraham, J. R.; Leong, S.; Butany, J.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Drugs, 2009, 9 (3), 177-196. http://dx.doi.org/10.1007/BF03256574 [9] Cadet, J. L.; Bisagno, V. Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"2014, 5, 204. http://dx.doi.org/10.3389/fphar.2014.00204 [10] Callaghan, R. C.; Cunningham, J. K.; Sykes, J.; Kish, S. J.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Drug Alcohol Depend., 2012, 120 ( 1-3), 35-40. http://dx.doi.org/10.1016/j.drugalcdep.2011.06.013 [11] Cadet, J. L.; Brannock, C.; Jayanthi, S.; Krasnova, I. N.  Trans- criptional and Epigenetic Substrates of Methamphetamine Addiction and Withdrawal: Evidence from a Long-Access Self-Administration Model in the Rat.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"BMC Genom., 2013, 14, 606. http://dx.doi.org/10.1186/1471-2164-14-606 [13] Nestler, E. J. Transcriptional mechanisms of drug addiction.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2012, 10 ( 3), 136-143. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Genet., 2010, 70, 101-141. http://dx.doi.org/ 10.1016/B978-0-12-380866-0.60005-8 [15] Allfrey, V. G.; Pogo, B. G.; Littau, V. C.; Gershey, E. L.; Mirsky, A. E. Histone acetylation in insect chromosomes.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Science, 1968, 159 (3812), 314-316. http://dx.doi.org/10.1126/science.159.3812.314 [16] Choudhary, C.; Weinert, B. T.; Nishida, Y.; Verdin, E.; Mann, M. The growing landscape of lysine acetylation links metabolism and cell signalling.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell Biol., 2014, 15 ( 8 ) ,  5 3 6-550. http://dx.doi.org/10.1038/nrm3841 [17] Yang, X. J.; Seto, E.  HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Oncogene, 2007, 26 ( 3 7 ) ,  5 3 1 0-5318. http://dx.doi.org/10.1038/sj.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell Biol., 2001, 79 (3), 253-266. http://dx.doi.org/10.1139/o01-076 [19] Nagy, Z.; Tora, L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Oncogene, 2007, 26 ( 3 7 ) ,  5 3 4 1-5357. http://dx.doi.org/10.1038/sj.onc.1210604 [20] Valor, L. M.; Viosca, J.; Lopez-Atalaya, J. P.; Barco, A. Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Des., 2013, 19 (28), 5051-5064. http://dx.doi.org/10.2174/13816128113199990382 [21] Parthun, M. R. Hat1: the emerging cellular roles of a type B histone acetyltransferase.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"1998, 273 (20), 12599-12605. http://dx.doi.org/10.1074/jbc.273.20.12599 [23] Allis, C. D.; Berger, S. L.; Cote, J.; Dent, S.; Jenuwien, T.; Kouzarides, T., et al.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell, 2007, 131 ( 4 ) ,  6 3 3-636. http://dx.doi.org/10.1016/ j.cell.2007.10.039 [24] Doi, M.; Hirayama, J.; Sassone-Corsi, P. Circadian regulator CLOCK is a histone acetyltransferase.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell, 2006, 125 ( 3 ) ,  4 9 7-508. http://dx.doi.org/10.1016/j.cell.2006.03.033 [25] Kawasaki, H.; Taira, K.; Yokoyama, K. Histone acetyltransferase (HAT) activity of ATF-2 is necessary for the CRE-dependent transcription.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Ser., 2000, (44), 259-260. http://dx.doi.org/10.1093/nass/44.1.259 [26] Stashi, E.; York, B.; O'Malley, B. W.  Steroid receptor coactivators: servants a n d  m a s t e r s  f o r  c o n t r o l  o f  s y s t e m s  m e t a b o l i s m .",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"2014, 25 ( 7 ) ,  3 3 7-347. http://dx.doi.org/ 10.1016/j.tem.2014.05.004 [27] Thiagalingam, S.; Cheng, K. H.; Lee, H. J.; Mineva, N.; Thiagalingam, A.; Ponte, J. F. Histone deacetylases: unique players in shaping the epigenetic histone code.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Sci., 2003, 983, 84-100. http://dx.doi.org/10.1111/j.1749-6632.2003.tb05964.x [28] Mottet, D.; Castronovo, V. Histone deacetylases: target enzymes for cancer therapy.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Metastasis, 2008, 25 ( 2 ) ,  1 8 3-189. http://dx.doi.org/10.1007/s10585-007-9131-5 [29] Codd, R.; Braich, N.; Liu, J.; Soe, C. Z.; Pakchung, A.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell Biol., 2009, 41 (4), 736-739. http://dx.doi.org/10.1016/j.biocel.2008.05.026 [30] Neugebauer, R. C.; Sippl, W.; Jung, M. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"2008, 14 (6), 562-573. http://dx.doi.org/10.2174/138161208783885380 [31] Parra, M. Class IIa HDACs - n e w  i n s i g h t s  i n t o  t h e i r  f u n c t i o n s  i n  physiology and pathology.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Life Sci., 2012, 69 (13), 2173-2187. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2011, 31 ( 4 7 ) ,  1 6 9 4 1-16948. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Psycho- pharmacology (Berl), 2012, 219 (3), 699-713. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"2013, 58, 132-143. http://dx.doi.org/10.1016/j.nbd.2013.05.009 [37] Chrivia, J. C.; Kwok, R. P.; Lamb, N.; Hagiwara, M.; Montminy, M. R.; Goodman, R. H. Phosphorylated CREB binds specifically to the nuclear protein CBP.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Nature, 1993, 365 ( 6 4 4 9 ) ,  8 5 5-859. http://dx.doi.org/10.1038/365855a0 [38] Kwok, R. P.; Lundblad, J. R.; Chrivia, J. C.; Richards, J. P.; Bächinger, H .",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"2011, 2011, 129383. http://dx.doi.org/10.1038/370223a0 [40] Schroeder, F. A.; Penta, K.L.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuropsychopharmacology, 2008, 33 (12), 2981-2992. http://dx.doi.org/10.1038/npp.2008.15 [41] Chaudhury, D.; Damez-Werno, D. M.; Haggarty, S. J.; Han, M. H.; Bassel-Duby, R.; Olson, E. N.; Nestler, E. J.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2013, 16 ( 4 ) ,  4 3 4-440. http://dx.doi.org/10.1038/nn.3354 [42] Host, L.; Dietrich, J.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Psychopharmacol., 2011, 25 ( 2 ) ,  2 2 2-229. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell 2009, 138 (5), 1019-1031. http://dx.doi.org/10.1016/j.cell.2009.06.049 [44] Deschatrettes, E.; Jouvert, P.; Zwiller, J.  Overexpression of cyclic GMP-dependent protein kinase reduces MeCP2 and HDAC2 expression.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Brain Behav., 2012, 2 ( 6 ) ,  7 3 2-740. http://dx.doi.org/ 10.1002/brb3.92 [45] Deschatrettes, E.; Romieu, P.; Zwiller, J.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuropsychopharmacol., 2013, 16 (7), 1587-1597. http://dx.doi.org/10.1017/S1461145712001630 [46] Malvaez, M.; McQuown, S. C.; Rogge, G. A.; Astarabadi, M.; Jacques, V.; Carreiro, S.; Rusche, J. R.; Wood, M. A. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2013, 33 ( 1 5 ) ,  6 6 2 3-6632. http://dx.doi.org/10.1523/ JNEUROSCI.4472-12.2013 [48] Martin, T. A.; Jayanthi, S.; McCoy, M. T.; Brannock, C.; Ladenheim, B.; Garrett, T.; Lehrmann, E.; Becker, K. G.; Cadet, J. L. Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"BMC Genom., 2013, 14, 545. http://dx.doi.org/10.1186/1471-2164-14-545 [50] Jayanthi, S.; McCoy, M. T.; Chen, B.; Britt, J. P.; Kourrich, S.; Yau, H. J.; Ladenheim, B.; Krasnova, I. N.; Bonci, A.; Cadet, J. L. Methamphetamine downregulates striatal glutamate r e c e p t o r s  via diverse epigenetic mechanisms.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Oncogene, 2007, 26 ( 3 7 ) ,  5 4 5 0-5467. http://dx.doi.org/10.1038/sj.onc.1210613 [53] Wang, L.; Lv, Z.; Hu, Z.; Sheng, J.; Hui, B.; Sun, J.; Ma, L. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuropsychopharmacology, 2010, 35 (4), 913-928. http://dx.doi.org/10.1038/npp.2009.193 [54] Renthal, W.; Maze, I.; Krishnan, V.; Covington, H. E. 3rd, Xiao, G.; Kumar, A.; Russo, S. J.; Graham, A.; Tsankova, N.; Kippin, T. E.; Kerstetter, K. A.; Neve, R. L.; Haggarty, S. J.; McKinsey, T. A.; Bassel-Duby, R.; Olson, E. N.; Nestler, E. J. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuron, 2007, 56 ( 3 ) ,  5 1 7-529. http://dx.doi.org/10.1016/ j.neuron.2007.09.032 [55] Dietrich, J.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Synapse, 2012, 66 (1), 61-70. http://dx.doi.org/10.1002/syn.20988 [56] Taniguchi, M.; Carreira, M. B.; Smith, L. N.; Zirlin, B. C.; Neve, R. L.; Cowan, C. W. Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuron, 2012, 73 (1), 108-120. http://dx.doi.org/10.1016/j.neuron.2011.10.032 [57] Renthal, W.; Kumar, A.; Xiao, G.; Wilkinson, M, Covington, H. E.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuron, 2009, 62 (3), 335-348. http://dx.doi.org/10.1016/j.neuron.2009.03.026 [58] Ferguson, D.; Koo, J. W.; Feng, J.; Heller, E.; Rabkin, J.; Heshmati, M.; Renthal, W.; Neve, R.; Liu, X.; Shao, N.; Sartorelli,V.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2013, 33 (41), 16088-16098. http://dx.doi.org/10.1523/JNEUROSCI.1284-13.2013 [59] Gao, L.; Cueto, M. A.; Asselbergs, F.; Atadja, P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Chem., 2002, 277 (28), 25748-25755. http://dx.doi.org/10.1074/jbc.M111871200 [60] Takase, K.; Oda, S.; Kuroda, M.; Funato, H.  Monoaminergic and neuropeptidergic neurons have distinct expression profiles of histone deacetylases.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Glia, 2009, 57 ( 1), 1-12. http://dx.doi.org/10.1002/glia.20729 [62] George, O.; Mandyam, C. D.; Wee, S.; Koob, G. F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuro- psychopharmacology, 2008, 33 (10), 247 4-2482. http://dx.doi.org/ 10.1038/sj.npp.1301626 [63] Kalda, A.; Heidmets, L. T.; Shen, H. Y.; Zharkovsky, A.; Chen, J. F.  Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Brain Res., 2007, 181 (1), 76-84. http://dx.doi.org/10.1016/ j.bbr.2007.03.027 [64] Kim, W. Y.; Kim, S.; Kim, J. H.  Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Lett., 2008, 432 (1), 54-57. http://dx.doi.org/10.1016/j.neulet.2007.12.005 [65] Shen, H. Y.; Kalda, A.; Yu, L.; Ferrara, J.; Zhu, J.; Chen, J. F., Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuroscience, 2008, 157 (3), 644-655. http://dx.doi.org/10.1016/j.neuroscience.2008.09.019 [66] Kumar, A.; Choi, K. H.; Renthal, W.; Tsankova, N. M.; Theobald, D. E.; Truong, H. T.; Russo, S. J.; Laplant, Q.; Sasaki, T. S.; Whistler, K. N.; Neve, R. L.; Self, D. W.; Nestler, E. J. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neuron, 2005, 48 ( 2 ) ,  3 0 3-314. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurosci., 2008, 28 (38), 9342-9348. http://dx.doi.org/10.1523/JNEUROSCI.0379-08.2008 [68] Close, P.; Creppe, C.; Gillard, M.; Ladang, A.; Chapelle, J. P.; Nguyen, L.; Chariot, A.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Life Sci., 2010, 67 (8), 1255-1264. http://dx.doi.org/10.1007/s00018-009-0252-7 [69] Spange, S.; Wagner, T.; Heinzel, T.; Kramer, O. H. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Cell Biol., 2009, 41 ( 1 ) ,  1 8 5-198. http://dx.doi.org/10.1016/j.biocel.2008.08.027 [70] An, W.  Histone acetylation and methylation: combinatorial players for transcriptional regulation.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Biochem., 2007, 41, 351-369. http://dx.doi.org/10.1007/1-4020-5466-1_16 [71] Wang, Z.; Zang, C.; Rosenfeld, J.",OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Genet., 2008, 40 (7), 897-903. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"Neurobiol., 2014. http://dx.doi.org/ 10.1007/s12035-014-9040-y   Received: December 06, 2014 Revised: January 07, 2015 Accepted: January 20, 2015",Non-OADS,/arxiv_data1/oa_pdf/55/92/CN-14-10.PMC4787278.pdf
"I Mitteilung Pflugers Arch., 1921, 189, 239-242. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1983, 216, 53-68. http://dx.doi.org/10.1002/cne.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 2011, 221, 488-498. http://dx.doi.org/10.1016/j.bbr.2009.12.046 [4] Houser, C.R.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1983, 266, 97-119. http://dx.doi.org/10.1016/0006-8993(83)91312-4 [5] Kimura, H.; McGeer, P.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1981, 200, 151-201. http://dx.doi.org/10.1002/cne.902000202 [6] Lucas-Meunier, E.; Fossier, P.; Baux, G.; Amar, M. Cholinergic modulation of the cortical neuronal network.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pflugers Arch., 2003, 446, 17-29. http://dx.doi.org/10.1007/s00424-002-0999-2 [7] Woolf, N.J. Cholinergic systems in mammalian brain and spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol., 1991, 37, 475-524. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Interact., 2013, 203, 361-364. http://dx.doi.org/10.1016/j.cbi.2012.09.016 [11] Bracco, L.; Bessi, V.; Padiglioni, S.; Marini, S.; Pepeu, G. Do cholinesterase inhibitors act primarily on attention deficit?",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1997, 81, 331-343. http://dx.doi.org/10.1016/S0306-4522(97)00208-X [13] Miranda, M.I.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Rev., 1997, 23, 28-46. http://dx.doi.org/10.1016/S0165-0173(96) 00009-4 [17] Blokland, A.; Honig, W.; Raaijmakers, W.G.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychopharmacology (Berl), 1992, 109, 373-376. http://dx.doi.org/10.1007/BF02245886 [18] Winters, B.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2005, 21, 2263-2270. http://dx.doi.org/10.1111/j.1460-9568.2005.04055.x [19] Power, A.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol  Learn Mem., 2003, 80, 178-193. http://dx.doi.org/10.1016/S1074-7427(03)00086-8 [20] Boccia, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 2004, 124, 735-741. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Mem., 2009, 91, 93-97. http://dx.doi.org/10.1016/j.nlm.2008.07.012 [22] Boccia, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lett., 2003, 345, 97-100. http://dx.doi.org/10.1016/S0304-3940(03)00493-2 [23] Whitehouse, P.J.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1981, 10, 122-126. http://dx.doi.org/10.1002/ana.410100203 [24] Whitehouse, P.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1982, 215, 1237-1239. http://dx.doi.org/10.1126/science.7058341 [25] Janowsky DS, R.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Res., 1984, 4, 17. http://dx.doi.org/10.1002/ddr.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychiatry, 2001, 25, 609-620. http://dx.doi.org/10.1016/S0278-5846(00)00178-0 [27] Matta, S.G.; Fu, Y.; Valentine, J.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psycho- neuroendocrinology, 1998, 23, 103-113. http://dx.doi.org/10.1016/ S0306-4530(97)00079-6",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1971, 172, 601-602. http://dx.doi.org/10.1126/science.172.3983.601 [29] Baghdoyan, H.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1987, 408, 367-371. http://dx.doi.org/10.1016/0006-8993(87)90407-0 [31] Metherate, R.; Cox, C.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1988, 70, 276-286. http://dx.doi.org/10.1007/BF00248353 [33] Sillito, A.M.; Kemp, J.A.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1983, 289, 143-155. http://dx.doi.org/10.1016/0006-8993(83)90015-X [34] Paez-Gonzalez, P.; Asrican, B.; Rodriguez, E.; Kuo, C.T.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2014, 17, 934-942. http://dx.doi.org/10.1038/nn.3734 [35] Potter, L.T.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1970, 206, 145-166. http://dx.doi.org/10.1113/jphysiol.1970.sp009003 [36] Nachmansohn, D.; Machado, A.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1981, 36, 732-740. http://dx.doi.org/10.1111/j.1471-4159.1981.tb01649.x [40] Rylett, R.J. Synaptosomal “membrane-bound” choline acetyltrans ferase is most sensitive to inhibition by choline mustard.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1989, 52, 869-875. http://dx.doi.org/10.1111/j.1471-4159.1989.tb02535.x [41] Misawa, H.; Matsuura, J.; Oda, Y.; Takahashi, R.; Deguchi, T. Human choline acetyltransferase mRNAs with different 5'-region produce a 69-kDa major translation product.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1997, 44, 323-333. http://dx.doi.org/10.1016/S0169-328X(96) 00231-8 [42] Oda, Y.; Nakanishi, I.; Deguchi, T. A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1992, 16, 287-294. http://dx.doi.org/10.1016/0169-328X(92) 90237-6 [43] Resendes, M.C.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 1999, 274, 19417-19421. http://dx.doi.org/10.1074/jbc.274.27.19417 [44] Gill, S.K.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 2003, 278, 20217-20224. http://dx.doi.org/10.1074/jbc.M213153200 [45] Gill, S.K.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Aging, 2007, 28, 1028-1040. http://dx.doi.org/10.1016/j.neurobiolaging.2006.05.011 [46] Bruce, G.; Hersh, L.B.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1993, 61, 1774-1781. http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"J., 2000, 349, 141-151. http://dx.doi.org/ 10.1042/bj3490141 [49] Collier, B.; Katz, H.S.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1974, 238, 639-655. http://dx.doi.org/10.1113/jphysiol.1974.sp010548 [50] Simon, J.R.; Kuhar, M.G.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1975, 255, 162-163. http://dx.doi.org/10.1038/255162a0 [51] Roghani, A.; Feldman, J.; Kohan, S.A.; Shirzadi, A.; Gundersen, C.B.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1998, 70, 2227-2240. http://dx.doi.org/10.1046/j.1471-4159.1998.70062227.x [56] Kitamoto, T.; Wang, W.; Salvaterra, P.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 1998, 273, 2706-2713. http://dx.doi.org/10.1074/jbc.273.5.2706 [57] Misawa, H.; Ishii, K.; Deguchi, T. Gene expression of mouse choline acetyltransferase.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 1995, 270, 24654-24657. http://dx.doi.org/10.1074/ jbc.270.42.24654 [59] Usdin, T.B.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Trends Neurosci., 1995, 18, 218-224. http://dx.doi.org/10.1016/0166-2236(95)93906-E [60] Holler, T.; Berse, B.; Cermak, J.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lett., 1996, 212, 107-110. http://dx.doi.org/10.1016/ 0304-3940(96)12808-1 [61] Alfonso, A.; Grundahl, K.; Duerr, J.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"FEBS Lett., 1994, 342, 97-102. http://dx.doi.org/10.1016/0014-5793(94)80592-X [63] Whittaker, V.P.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Sci., 1987, 493, 77-91. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biochemistry, 1980, 19, 1240-1248. http://dx.doi.org/10.1021/bi00547a031 [65] Anderson, D.C.; King, S.C.; Parsons, S.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 1998, 273, 9094-9098. http://dx.doi.org/ 10.1074/jbc.273.15.9094 [68] Krantz, D.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Cell Biol., 2000, 149, 379-396. http://dx.doi.org/ 10.1083/jcb.149.2.379 [69] Santos, M.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 2001, 78, 1104-1113. http://dx.doi.org/10.1046/ j.1471-4159.2001.00494.x [70] Ferreira, L.T.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 2005, 94, 957-969. http://dx.doi.org/10.1111/j.1471-4159.2005.03244.x [71] Barbosa, J., Jr.; Clarizia, A.D.; Gomez, M.V.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1997, 69, 2608-2611. http://dx.doi.org/ 10.1046/j.1471-4159.1997.69062608.x [72] Cho, G.W.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Chem., 2000, 275, 19942-19948. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuron, 2006, 51, 601-612. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1949, 110, 98-99. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol., 1973, 4, 343-361. http://dx.doi.org/10.1002/ neu.480040404 [76] McMahan, U.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1978, 271, 172-174. http://dx.doi.org/10.1038/271172a0 [77] Potter, P.E.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1984, 43, 288-290. http://dx.doi.org/10.1111/j.1471-4159.1984.tb06712.x [78] Soreq, H.; Seidman, S. Acetylcholinesterase--new roles for an old actor.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2001, 2, 294-302. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuron, 1990, 4, 289-301. http://dx.doi.org/10.1016/0896-6273(90)90103-M [81] Seidman, S.; Sternfeld, M.; Aziz-Aloya, R.; Timberg, R.; Kaufer-Nachum, D.; Soreq, H. S y n a p t i c  a n d  e p i d e r m a l  a c c u m u l a t ions of human acetylcholinesterase are encoded by alternative 3'-terminal exons.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Cell Biol., 1995, 15, 2993-3002. http://dx.doi.org/ 10.1128/MCB.15.6.2993 [82] Roberts, W.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Acta, 2006, 366, 1-13. http://dx.doi.org/10.1016/j.cca.2005.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"J. Psychiatry, 1999, 174, 476-479. http://dx.doi.org/10.1192/ bjp.174.6.476 [89] Davis, K.L.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1978, 201, 272-274. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1961, 39, 787-827. http://dx.doi.org/10.1139/ o61-081 [91] Tucek, S. Regulation of acetylcholine synthesis in the brain.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1985, 44, 11-24. http://dx.doi.org/10.1111/j.1471-4159.1985.tb07106.x [92] Vickroy, T.W.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1985, 329, 368-373. http://dx.doi.org/10.1016/0006-8993(85)90553-0 [93] Misawa, H.; Nakata, K.; Matsuura, J., Kobayashi, Y., Okuda, T., Fujioka, Y., Matsumura, G., Nishimura, Y., Haga, T. Distribution of the high-affinity choline transporter in the central nervous system of the rat.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1971, 18, 781-798. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1978, 30, 15-21. http://dx.doi.org/10.1111/ j.1471-4159.1978.tb07029.x [97] Ferguson, S.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 2003, 87, 136-146. http://dx.doi.org/10.1046/j.1471-4159.2003.01974.x [100] Nakata, K.; Okuda, T.; Misawa, H. Ultrastructural localization of high-affinity choline transporter in the rat neuromuscular junction: enrichment on synaptic vesicles.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Synapse, 2004, 53, 53-56. http://dx.doi.org/10.1002/syn.20029 [101] Ribeiro, F.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 2005, 94, 86-96. http://dx.doi.org/ 10.1111/j.1471-4159.2005.03171.x",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2007, 26, 3437-3448. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1981, 36, 420-430. http://dx.doi.org/10.1111/ j.1471-4159.1981.tb01610.x [104] Saltarelli, M.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pharmacol., 1987, 135, 35-40. http://dx.doi.org/ 10.1016/0014-2999(87)90754-0 [105] Apparsundaram, S.; Martinez, V.; Parikh, V.; Kozak, R.; Sarter, M. Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2005, 25, 3851-3856. http://dx.doi.org/10.1523/JNEUROSCI.0205-05.2005 [106] Levey, A.I.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Bull., 1981, 7, 487-507. http://dx.doi.org/10.1016/0361-9230(81)90004-6 [108] Bolam, J.P.; Wainer, B. h.; Smith, A.D.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1984, 12, 711-718. http://dx.doi.org/10.1016/0306-4522(84)90165-9 [109] Mesulam, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1983, 214, 170-197. http://dx.doi.org/10.1002/cne.902140206 [110] Mesulam, M.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1983, 10, 1185-1201. http://dx.doi.org/10.1016/0306-4522(83)90108-2 [111] Mesulam, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 2004, 145, 67-78. http://dx.doi.org/ 10.1016/S0079-6123(03)45004-8 [112] Richardson, R.T.; DeLong, M.R.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Trends Neurosci., 1988, 11, 264-267. http://dx.doi.org/10.1016/0166-2236(88)90107-5 [113] Everitt, B.J.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Mem., 2003, 80, 268-284. http://dx.doi.org/10.1016/S1074-7427(03)00072-8 [115] Jones, B.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 2004, 145, 15 7-169. http://dx.doi.org/10.1016/S0079-6123(03) 45011-5 [116] Rye, D.B.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1987, 259, 483-528. http://dx.doi.org/10.1002/ cne.902590403 [117] Hobson, J.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1975, 189, 55-58. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Cell Biol., 1990, 111, 2623-2635. http://dx.doi.org/10.1083/jcb.111.6.2623 [119] Brisson, A.; Unwin, P.N.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1985, 315, 474-477. http://dx.doi.org/10.1038/ 315474a0 [120] Brisson, A.; Unwin, P.N.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Cell Biol., 1984, 99, 1202-1211. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1991, 350, 235-238. http://dx.doi.org/10.1038/ 350235a0 [122] Nai, Q.; McIntosh, J.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pharmacol., 2003, 63, 311-324. http://dx.doi.org/10.1124/mol.63.2.311 [123] Seguela, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuron, 1996, 16, 1077-1085. http://dx.doi.org/10.1016/S0896-6273(00)80134-8 [126] Whyte, J.; Harrison, R.; Lunt, G.G.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Res., 1986, 11, 1011-1023. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1996, 383, 713-716. http://dx.doi.org/10.1038/ 383713a0 [129] Radcliffe, K.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1995, 269, 1692-1696. http://dx.doi.org/10.1126/science.7569895 [131] Wilkie, G.I.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Res., 1996, 21, 1141-1148. http://dx.doi.org/10.1007/BF02532425 [132] Clarke, P.B.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pharmacol., 1996, 117, 595-606. http://dx.doi.org/10.1111/ j.1476-5381.1996.tb15232.x [133] Nisell, M.; Nomikos, G.G.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Synapse, 1994, 16, 36-44. http://dx.doi.org/10.1002/syn.890160105 [134] Yang, X.; Criswell, H.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol., 1992, 34, 283-384. http://dx.doi.org/10.1016/ S0074-7742(08)60100-2 [136] Wonnacott, S. Presynaptic nicotinic ACh receptors.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Trends Neurosci., 1997, 20, 92-98. http://dx.doi.org/10.1016/S0166-2236(96)10073-4 [137] Kim, J.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1996, 725, 231-240. http://dx.doi.org/10.1016/0006-8993(96)00213-2 [138] Levin, E.D.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychopharmacology (Berl), 1998, 138, 217-230. http://dx.doi.org/10.1007/s002130050667 [139] Levin, E.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychopharmacology (Berl), 1996, 123, 88-97. http://dx.doi.org/10.1007/BF02246285",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1997, 81, 1009-1017. http://dx.doi.org/10.1016/ S0306-4522(97)00224-8 [141] Dajas-Bailador, F.A.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuropharmacology, 2000, 39, 2799-2807. http://dx.doi.org/10.1016/S0028-3908(00) 00127-1 [142] O'Neill, M.J.; Murray, T.K.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Disord., 2002, 1, 399-411. http://dx.doi.org/10.2174/ 1568007023339166 [143] Hsu, Y.N.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1997, 69, 2427-2431. http://dx.doi.org/10.1046/j.1471-4159.1997.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2005, 25, 3712-3723. http://dx.doi.org/10.1523/ JNEUROSCI.5389-03.2005 [145] Swope, S.L.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Second Messenger Phosphoprotein Res., 1999, 3 3, 49-78. http://dx.doi.org/10.1016/S1040-7952(99)80005-6 [146] Charpantier, E.; Wiesner, A.; Huh, K. h., Ogier, R., Hoda, J.C., Allaman, G., Raggenbass, M., Feuerbach, D., Bertrand, D. Fuhrer C. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2005, 25, 9836-9849. http://dx.doi.org/10.1523/JNEUROSCI.3497-05.2005 [147] Mulle, C.; Lena, C.; Changeux, J.P. Potentiation of nicotinic receptor response by external calcium in rat central neurons.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuron, 1992, 8, 937-945. http://dx.doi.org/10.1016/0896-6273(92) 90208-U [148] Glushakov, A.V.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Syst., 1999, 75, 16-22. http://dx.doi.org/10.1016/S0165-1838(98)00165-9 [149] Luetje, C.W.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1987, 237, 527-532. http://dx.doi.org/10.1126/ science.3037705 [154] Kubo, T.; Maeda, A.; Sugimoto, K., Akiba, I., Mikami, A., Takahashi, H., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., et al.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"FEBS Lett., 1986, 209, 367-372. http://dx.doi.org/10.1016/0014-5793(86)81144-9 [155] Caulfield, M.P.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1980, 283, 90-92. http://dx.doi.org/10.1038/ 283090a0 [157] Ehlert, F.J.; Delen, F.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biol., 1991, 287, 301-312. http://dx.doi.org/10.1007/978-1-4684-5907-4_25 [158] Egan, T.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1986, 319, 405-407. http://dx.doi.org/10.1038/319405a0 [159] Felder, C.C.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1971, 215, 247-268. http://dx.doi.org/10.1113/jphysiol.1971.sp009467 [161] Brown, D.A.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lett., 1988, 85, 345-350. http://dx.doi.org/10.1016/0304-3940(88)90590-3 [163] Levey, A.I.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 2002, 944, 82-89. http://dx.doi.org/10.1016/S0006-8993(02)02721-X [166] Douglas, C.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Synapse, 1989, 4, 305-312. http://dx.doi.org/10.1002/syn.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol., 1999, 58, 409-471. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1982, 250, 71-92. http://dx.doi.org/10.1016/0006-8993(82)90954-4 [170] Nakajima, Y.; Nakajima, S.; Leonard, R.J.; Yamaguchi, K. Acetylcholine raises excitability by inhibiting the fast transient potassium current in cultured hippocampal neurons.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"U.S.A, 1986, 83, 3022-3026. http://dx.doi.org/10.1073/ pnas.83.9.3022 [171] Madison, D.V.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1978, 62, 787-797. http://dx.doi.org/10.1016/0014-4886(78)90284-4 [173] Segal, M. Rat hippocampal neurons in culture: responses to electrical and chemical stimuli.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1992, 447, 513-533. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Physiol., 1986, 375, 169-194. http://dx.doi.org/10.1113/jphysiol.1986.sp016112 [176] Rovira, C.; Ben Ari, Y.; Cherubini, E.; Krnjevic, K.; Ropert, N. Pharmacology of the dendritic action of acetylcholine and further observations on the somatic disinhibition in the rat hippocampus in situ.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1983, 8, 97-106. http://dx.doi.org/10.1016/ 0306-4522(83)90028-3",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lett., 1987, 76, 301-306. http://dx.doi.org/10.1016/0304-3940(87)90419-8 [178] Adem, A.; Karlsson, E. Muscarinic receptor subtype selective toxins.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Life Sci., 1997, 60, 1069-1076. http://dx.doi.org/10.1016/ S0024-3205(97)00049-0 [179] Wilcock, G.K.; Esiri, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Sci., 1982, 57, 407-417. http://dx.doi.org/10.1016/0022-510X(82)90045-4 [180] Muir, J.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Behav., 1997, 56, 687-696. http://dx.doi.org/ 10.1016/S0091-3057(96)00431-5 [181] Bartus, R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2000, 163, 495-529. http://dx.doi.org/10.1006/exnr.2000.7397 [182] Muir, J.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1992, 89, 611-622. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Aspects Med., 2015. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"org/10.1016/j.mam.2015.05.005 [185] Martorana, A.; Koch, G. “Is dopamine involved in Alzheimer's disease?”Front Aging Neurosci., 2014, 6, 252. http://dx.doi.org/ 10.3389/fnagi.2014.00252 [186] Jeon, J.; Dencker, D.; Wortwein, G., Woldbye, D.P., Cui, Y., Davis, A.A., Levey, A.I., Schütz, G., Sager, T.N., Mørk, A., Li, C., Deng, C.X., Fink-Jensen, A., Wess, J.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2010, 30, 2396-2405. http://dx.doi.org/10.1523/JNEUROSCI.3843-09.2010 [187] Mesulam, M.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2013, 521, 4124-4144. http://dx.doi.org/10.1002/cne.23415 [188] Sarter, M.; Lustig, C.; Howe, W.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2014, 39, 1912-1920. http://dx.doi.org/10.1111/ejn.12515 [189] Nauta, W.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1978, 3, 385-401. http://dx.doi.org/10.1016/ 0306-4522(78)90041-6 [190] Arendt, T.; Bigl, V.; Arendt, A.; Tennstedt, A.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Acta Neuropathol., 1983, 61, 101-108. http://dx.doi.org/10.1007/BF00697388 [191] Dubois, B.; Ruberg, M.; Javoy-Agid, F.; Ploska, A.; Agid, Y.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1983, 288, 213-218. http://dx.doi.org/10.1016/ 0006-8993(83)90096-3 [192] Yates, C.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lancet, 1980, 2, 979. http://dx.doi.org/10.1016/S0140-6736(80)92137-6 [193] Barron, S.A.; Mazliah, J.; Bental, E. Sympathetic cholinergic dysfunction in amyotrophic lateral sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Scand., 1987, 75, 62-63. http://dx.doi.org/10.1111/j.1600-0404.1987.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurochem., 1989, 52, 636-640. http://dx.doi.org/10.1111/j.1471-4159.1989.tb09167.x [195] Ruberg, M.; Javoy-Agid, F.; Hirsch, E., Scatton, B, L. Heureux, R., Hauw, J.J., Duyckaerts, C., Gray, F., Morel-Maroger, A., Rascol, A. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lett., 1984, 44, 37-42. http://dx.doi.org/10.1016/0304-3940(84)90217-9 [197] Kish, S.J.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1988, 24, 200-206. http://dx.doi.org/ 10.1002/ana.410240205 [198] Ferrante, R.J.; Beal, M.F.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1987, 411, 162-166. http://dx.doi.org/10.1136/jnnp.38.7.669 [199] Aquilonius, S.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychiatry, 1975, 38, 669-677. http://dx.doi.org/10.1136/jnnp.38.7.669 [200] Alzheimer, A. Uber eine eigenartige Erkrankung der Hirnrinde.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Lancet, 2005, 366, 2112-2117. http://dx.doi.org/10.1016/S0140-6736(05)67889-0 [202] Plassman, B.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2007, 14, 1-26. http://dx.doi.org/ 10.1111/j.1468-1331.2006.01605.x [204] Qiu, C.; Kivipelto, M.; von Strauss, E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biochem., 2012, 65, 329-352. http://dx.doi.org/10.1007/978-94-007-5416-4_14 [206] Armstrong, R.A. Factors determining disease duration in Alzheimer's disease: a postmortem study of 103 cases using t h e  Kaplan-Meier estimator and Cox regression.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Acta Neuropathol., 2009, 1 1 8,  5-36. http://dx.doi.org/10.1007/s00401-009-0532-1 [209] Taipa, R.; Pinho, J.; Melo-Pires, M. Clinico-pathological correlations of the most common neurodegenerative dementias.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2012, 3, 68. http://dx.doi.org/10.3389/fneur.2012.00068 [210] Glenner, G.G.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Commun., 1984, 120, 885-890. http://dx.doi.org/10.1016/S0006-291X(84)80190-4 [211] Kang, J.; Lemaire, H.G.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1987, 325, 733-736. http://dx.doi.org/10.1038/325733a0 [212] Esch, F.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1990, 248, 1122-1124. http://dx.doi.org/10.1126/science.2111583 [213] Terry, R.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1991, 30, 572-580. http://dx.doi.org/10.1002/ana.410300410",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychiatry Neurol., 2006, 19, 125-128. http://dx.doi.org/10.1177/ 0891988706291079 [215] Kosik, K.S.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1993, 50, 349-358. http://dx.doi.org/10.1001/archneur.1993.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Aging, 2006, 27, 1644-1657. http://dx.doi.org/10.1016/j.neurobiolaging.2005.09.034 [220] Selkoe, D.J.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 2002, 298, 789-791. http://dx.doi.org/10.1126/science.1074069 [221] Sze, C.I.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1997, 56, 933-944. http://dx.doi.org/10.1097/00005072-199708000-00011 [222] Counts, S.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2006, 65, 592-601. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Transm., 2006, 113, 1625-1644. http://dx.doi.org/10.1007/s00702-006-0579-2 [226] Bowen, D.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain, 1976, 99, 459-496. http://dx.doi.org/10.1093/brain/99.3.459 [227] Strada, O.; Vyas, S.; Hirsch, E.C., Ruberg, M., Brice, A., Agid, Y., Javoy-Agid, F. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hy bridization stu dy.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pathol.Int., 1999, 49, 921-937. http://dx.doi.org/10.1046/j.1440-1827.1999.00977.x [229] Mesulam, M.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuroscience, 1986, 17, 275-276. http://dx.doi.org/ 10.1016/0306-4522(86)90242-3 [230] Lahiri, D.K.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Sci., 2002, 965, 364-372. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Psychiatry, 2001, 6, 520-528. http://dx.doi.org/10.1038/sj.mp.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biochemistry, 2001, 40, 10447-10457. http://dx.doi.org/10.1021/bi0101392 [233] Apelt, J.; Kumar, A.; Schliebs, R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 2002, 953, 17-30. http://dx.doi.org/ 10.1016/S0006-8993(02)03262-6 [234] Raina, P.; Santaguida, P.; Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., Oremus, M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Med., 2008, 148, 379-397. http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00009 [235] Sun, Y.; Lai, M.S.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2008, 15, 278-283. http://dx.doi.org/10.1111/j.1468-1331.2007.02049.x [236] Howard, R.; McShane, R.; Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., Hughes, A., Jacoby, R., Jones, R., Jones, R., McKeith, I., Macharouthu, A., O'Brien, J., Passmore, P., Sheehan, B., Juszczak, E., Katona, C., Hills, R., Knapp, M., Ballard, C., Brown, R., Banerjee, S., Onions, C., Griffin, M., Adams, J.,Gray, R., Johnson, T., Bentham, P., Phillips, P. Donepezil and memantine for moderate-to-severe Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Med., 2012, 366, 893-903. http://dx.doi.org/10.1056/NEJMoa1106668 [237] Hager, K.; Baseman, A.S.; Nye, J.S., Brashear, H.R., Han, J., Sano, M., Davis, B., Richards, H.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Drugs, 2011, 71, 1209-1231. http://dx.doi.org/10.2165/11206380-000000000-00000 [239] Guay, D.R.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pharm., 2008, 23, 598-609. http://dx.doi.org/10.4140/TCP.n.2008.598 [240] Galimberti, D.; Ghezzi, L.; Scarpini, E. Immunotherapy against amyloid pathology in Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Sci., 2013, 333, 50-54. http://dx.doi.org/10.1016/j.jns.2012.12.013 [241] Giacobini, E.; Becker, R.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurobiol Aging, 2006, 27, 1216-1223. http://dx.doi.org/10.1016/j.neurobiolaging.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Science, 1992, 258, 304-307. http://dx.doi.org/10.1126/science.1411529 [245] Fisher, A. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurodegener Dis, 2008, 5, 237-240. http://dx.doi.org/10.1159/ 000113712 [246] Fisher, A.; Brandeis, R.; Bar-Ner, R. h., Kliger-Spatz, M., Natan, N., Sonego, H., Marcovitch, I., Pittel, Z.A.F.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2002, 19, 145-153. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neuron, 2006, 49, 671-682. http://dx.doi.org/10.1016/j.neuron.2006.01.020",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Transm., 2000, 107, 1201-1212. http://dx.doi.org/10.1007/s007020070034 [249] Jones, C.K.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2008, 28, 10422-10433. http://dx.doi.org/10.1523/JNEUROSCI.1850-08.2008 [250] Boyle, C.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Res., 2002, 56, 310-320. http://dx.doi.org/10.1002/ddr.10084 [251] Zuchner, T.; Perez-Polo, J.R.; Schliebs, R. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Res., 2004, 77, 250-257. http://dx.doi.org/ 10.1002/jnr.20152 [252] Dineley, K.T.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biosci., 2007, 12, 5030-5038. http://dx.doi.org/10.2741/2445 [253] Bodick, N.C.; Offen, W.W.; Levey, A.I., Cutler, N.R., Gauthier, S,G., Satlin, A., Shannon, H.E,, Tollefson, G.D., Rasmussen, K., Bymaster, F.P., Hurley, D.J., Potter, W.Z., Paul, S.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 1997, 54, 465-473. http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurosci., 2009, 29, 14271-14286. http://dx.doi.org/10.1523/JNEUROSCI.3930-09.2009 [255] Conn, P.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Sci., 2009, 30, 148-155. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Biol., 2008, 4, 42-50. http://dx.doi.org/10.1038/nchembio.2007.55 [257] Brady, A.E.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Ther., 2008, 327, 941-953. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"CNS Drug Rev., 2003, 9, 275-308. http://dx.doi.org/10.1111/j.1527-3458.2003.tb00254.x [260] Wenk, G.L.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Pharmacol., 2006, 17, 411-424. http://dx.doi.org/10.1097/00008877-200609000-00007 [261] Ong, W.Y.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Brain Res., 1993, 57, 255-261. http://dx.doi.org/ 10.1016/0166-4328(93)90141-C [263] Eriksdotter, J.M.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Med., 2005, 11, 551-555. http://dx.doi.org/10.1038/nm1239 [265] Fischer, W.; Wictorin, K.; Bjorklund, A., Williams, L.R., Varon, S., Gage, F.H.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1987, 329, 65-68. http://dx.doi.org/10.1038/329065a0 [266] Geylis, V.; Steinitz, M. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Rev., 2006, 5, 33-39. http://dx.doi.org/10.1016/j.autrev.2005.06.007 [267] Janus, C.; Pearson, J.; McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St. George-Hyslop, P., Westaway, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 2000, 408, 979-982. http://dx.doi.org/ 10.1038/35050110 [268] Morgan, D.; Diamond, D.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 2000, 408, 982-985. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Nature, 1999, 400, 173-177. http://dx.doi.org/10.1038/22124 [270] Bales, K.R.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Invest., 2006, 116, 825-832. http://dx.doi.org/10.1172/ JCI27120 [271] Gilman, S.; Koller, M.; Black, R.S., Jenkins, L., Griffith, S.G., Fox, N.C., Eisner, L., Kirby, L., Rovira, M.B., Forette, F., Orgogozo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurology, 2005, 64, 1553-1562. http://dx.doi.org/10.1212/01.WNL.0000159740.16984.3C [272] Farlow, M.; Arnold, S.E.",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Alzheimers Dement, 2012, 8, 261-271. http://dx.doi.org/10.1016/j.jalz.2011.09.224 [273] Nicoll, J.A.",OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Neurol., 2006, 65, 1040-1048. http://dx.doi.org/10.1097/01.jnen.0000240466.10758.ce   Received: December 15, 2014 Revised: July 01, 2015 Accepted: July 14, 2015",Non-OADS,/arxiv_data1/oa_pdf/5d/49/CN-14-101.PMC4787279.pdf
"Proc., 2000, 75 (7), 711-21. http://dx.doi.org/ 10.1016/S0025-6196(11)64618-1 [2] Hamedi, M.; Mohammdi, M.; Ghaleiha, A.; Keshavarzi, Z.; Jafarnia, M.; Keramatfar, R.; Alikhani, R.; Ehyaii, A.; Akhondzadeh, S. Bupropion in adults with A t t e n t i o n-Deficit/Hyperactivity Disorder: a randomized, double-blind study.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Gen. Psychiatry, 1993, 50 (7), 565-76. http://dx.doi.org/10.1001/archpsyc.1993.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2000, 2 (5), 159-164. http://dx.doi.org/10.4088/PCC.v02n0502 [5] Polanczyk, G.; de Lima, M.S.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"J. Psychiatry, 2007, 164 (6), 942-8. http://dx.doi.org/10.1176/ajp.2007.164.6.942 [6] Kooij, S.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"BMC Psychiatry, 2010, 10, 67. http://dx.doi.org/10.1186/1471-244X-10-67 [7] Barbaresi, W.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 2002, 156 (3), 217-24. http://dx.doi.org/10.1001/ archpedi.156.3.217 [8] Lange, K.W.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Disord., 2010, 2, 241-55. http://dx.doi.org/10.1007/ s12402-010-0045-8 [9] Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Exper., 2004, 19 (3), 151-180. http://dx.doi.org/10.1002/hup.579 [10] Zito, J.M.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"JAMA, 2000, 283 (8), 1025-30. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Drug Saf., 2001, 10 (2), 85-94. http://dx.doi.org/10.1002/pds.564 [17] Mott, T.F.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"J.  Psychiatry, 1937, 94 (3), 577-585. http://dx.doi.org/10.1176/ajp.94.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"J. Psychiatry, 1995, 152 (2), 298-9. http://dx.doi.org/10.1176/ajp.152.2.298b [20] Conners, C.K.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 1957, 19 (1), 38-49. http://dx.doi.org/10.1097/00006842-195701000-00005 [22] Giacobini, M.; Medin, E.; Ahnemark, E.; Russo, L.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Disord., 2014. http://dx.doi.org/10.1177/ 1087054714554617 [23] Arnsten, A.F.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2005, 57 (11), 1377-84. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pediatr., 1997, 18 (4), 271-279. http://dx.doi.org/10.1097/ 00004703-199708000-00009 [26] Corbett, B.A.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry Res., 2009, 166 (2-3), 210-222. http://dx.doi.org/10.1016/j.psychres.2008.02.005 [27] Alloway, T.P.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Dev., 2009, 40 (3), 353-366. http://dx.doi.org/10.1007/s10578-009-0131-3 [28] Rapport, M.D.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychol., 2008, 36 (6), 825-837. http://dx.doi.org/10.1007/s10802-008-9215-y [29] Dovis, S.; Van der Oord, S.; Wiers, R.W.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Child Psychol., 2012, 40 (5), 669-681. http://dx.doi.org/10.1007/s10802-011-9601-8 [30] Barkley, R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Bull., 1997, 121 (1), 65-94. http://dx.doi.org/10.1037/ 0033-2909.121.1.65 [31] Berridge, C.W.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neuropsychopharmacology, 2002, 27 (5), 699-711. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"http://dx.doi.org/10.1038/sj.bjp.0706428 [34] Gatley, S.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychopharmacology (Berl), 1999, 146 (1), 93-100. http://dx.doi.org/10.1007/s002130051093 [35] Volkow, N.D.; Wang, G.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"CNS Drugs, 2006, 20 (9), 713-38. http://dx.doi.org/10.2165/00023210-200620090-00002 [37] Spencer, R.C.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2012, 72 (3), 221-7. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2010, 49 (10), 1011-23. http://dx.doi.org/10.1016/ j.jaac.2010.06.015 [41] Arnsten, A.F.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Brain Funct., 2005, 1 (1), 2. http://dx.doi.org/10.1186/1744-9081-1-2 [42] Gronier, B.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neuropsychopharmacol., 2011, 21 (2), 192-204. http://dx.doi.org/10.1016/j.euroneuro.2010.11.002 [43] Andrews, G.D.; Lavin, A. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neuropsychopharmacology, 2006, 31 (3), 594-601. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"http://dx.doi.org/10.1371/journal.pone.0051910 [45] Polanczyk, G.; Zeni, C.; Genro, J.P.; Guimarães, A.P.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Gen. Psychiatry, 2007, 64 (2), 218-24. http://dx.doi.org/10.1001/archpsyc.64.2.218 [46] Solanto, M.; Newcorn, J.; Vail, L.; Gilbert, S.; Ivanov, I.; Lara, R. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychopharmacol., 2009, 19 (6), 663-671. http://dx.doi.org/10.1089/cap.2009.0033 [47] Pietrzak, R.H.; Goldstein, R.B.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Soc., 2012, 60 (2), 296-303. http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Nature (Lond), 1995, 376 (6541), 572-575. http://dx.doi.org/10.1038/ 376572a0 [49] Bedard, A.C.; Martinussen, R.; Ickowicz, A.; Tannock, R. Methylphenidate improbe visual-spatial memory in children with attention-deficit/hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2004, 43 (3), 260-268. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Health, 2014, 8 (1), 273. http://dx.doi.org/10.1186/s13034-014-0032-5 [52] Childress, A.; Sallee, F.R.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neurother., 2013, 13 (9), 979-88. http://dx.doi.org/10.1586/14737175.2013.833002 [53] Maldonado, R. Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Toxicol., 2013, 9 (8), 1001-14. http://dx.doi.org/10.1517/17425255.2013.786041 [54] Mardomingo-Sanz, M.J. Clinical use of 30:70 controlled-release methylphenidate in the treatment of attention deficit hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"CNS Drugs, 2014, 28 (11), 1005-33. http://dx.doi.org/ 10.1007/s40263-014-0175-1 [56] Sugrue, D.; Bogner, R.; Ehret, M.J. Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharm., 2014, 71 (14), 1163-70. http://dx.doi.org/10.2146/ajhp130638 [57] Coghill, D.; Banaschewski, T.; Zuddas, A.; Pelaz, A.; Gagliano, A.; Doepfner, M. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"BMC Psychiatry, 2013, 13, 237. http://dx.doi.org/10.1186/1471-244X-13-237 [58] Findling, R.L.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"CNS Drugs, 2014, 28 (3), 217-28. http://dx.doi.org/10.1007/s40263-014-0141-y [59] Faraj, B.A.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_ docs/nda/2000/21-121_Concerta.cfm (accessed Mar 24, 2015).",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Biochem., 1980, 13 (6), 266-72. http://dx.doi.org/10.1016/S0009-9120(80)80007-5 [62] Ding, Y.S.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Chem., 1981, 24 (10), 1237-40. http://dx.doi.org/10.1021/jm00142a021 [64] Bartlett, M.F.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacol., 2000, 40 (4), 379-88. http://dx.doi.org/10.1177/ 00912700022009080 [69] Modi, N.B.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Drug Dispos., 2000, 21 (1), 23-31. http://dx.doi.org/10.1002/1099-081X(200001)21:1<23::AID-BDD212>3.0.CO;2-V [70] Modi, N.B.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacol., 1998, 38 (3), 276-82. http://dx.doi.org/10.1002/j.1552-4604.1998.tb04425.x [72] Markowitz, J.S.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacotherapy, 2003, 23 (10), 1281-99. http://dx.doi.org/10.1592/phco.23.12.1281.32697 [73] Froehlich, T.E.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"http://dx.doi.org/10.1016/j.jaac.2011.08.002 [74] Greenhill, L.L.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 1996, 35 (10), 1304-13. http://dx.doi.org/10.1097/00004583-199610000-00017 [75] Vitiello, B.; Severe, J.B.; Greenhill, L.L.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2001, 40 (2), 188-96. http://dx.doi.org/10.1097/00004583-200102000-00013 [76] Jaanus, S.D.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"J Child Adolesc Psychopharmacol., 2009, 19 (4), 329-339. http://dx.doi.org/10.1089/cap.2008.0137 [79] Rappley, M.D.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Drug Saf., 1997, 17 (3), 143-8. http://dx.doi.org/10.2165/00002018-199717030-00001 [80] Firestone, P.; Musten, L.M.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychopharmacol., 1998, 8 (1), 13-25. http://dx.doi.org/10.1089/ cap.1998.8.13 [81] Auger, R.R.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neuropharmacol., 2010, 33 (4), 204-6. http://dx.doi.org/10.1097/WNF.0b013e3181e29174 [83] Cooper, W.O.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 2011, 365 (20), 1896-1904. http://dx.doi.org/10.1056/NEJMoa1110212 [84] Habel, L.A.; Cooper, W.O.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"JAMA, 2011, 306 (24), 2673-2683. http://dx.doi.org/10.1001/ jama.2011.1830 [85] Arcieri, R.; Germinario, E.A.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychopharmacol., 2012, 22 (6), 423-431. http://dx.doi.org/10.1089/cap.2012.0014 [86] Martinez-Raga, J.; Knecht, C.; Szerman, N.; Martinez, M.I.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"CNS Drugs, 2013, 27 (1), 15-30. http://dx.doi.org/10.1007/s40263-012-0019-9 [87] Aktepe, E.; Ozkorumak, E.; Tanriover-Kandil, S. Pregnancy and delivery complications and treatment approach in attention deficit hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
http://dx.doi.org/10.1016/j.jpurol.,OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacother., 2014, 48 (10), 1350-5. http://dx.doi.org/10.1177/1060028014541791 [91] Tong, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pediatr., 2015, 437298. http://dx.doi.org/10.1155/2015/ 437298 [92] Franke, A.G.; Bagusat, C.; Rust, S.; Engel, A.; Lieb, K. Substances used and prevalence rates of pharmacological cognitive enhancement am ong h ealthy subje cts.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
http://dx.doi.org/10.1007/ s00406-014-0537-1 [93] Erowid Experience Vaults.,Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Available from: https://www.erowid.org/experiences/subs/exp_ Pharms_Methylphenidate.shtml (accessed Mar 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 1972, 286 (16), 880-1. http://dx.doi.org/ 10.1056/NEJM197204202861607 [97] Lucas, A.R.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Jama, 1971, 217 (8), 1079-81. http://dx.doi.org/10.1001/jama.1971.031900800 41008 [98] Bloom, A.S.; Russell, L.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 1988, 27 (1), 88-9. http://dx.doi.org/10.1097/ 00004583-198801000-00013 [99] Corrigall, R.; Ford, T. Methylphenidate euphoria.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 1996, 3 5  ( 1 1 ), 1421. http://dx.doi.org/ 10.1097/00004583-199611000-00005 [100] Willey, R.F.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 1971, 285 (8), 464. http://dx.doi.org/10.1056/NEJM197108192 850819 [101] Parran, T.V., Jr.; Jasinski, D.R.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 1991, 151 (4), 781-3. http://dx.doi.org/10.1001/archinte.1991.00400040119027 [102] Grund, T.; Lehmann, K.; Bock, N.; Rothenberger, A.; Teuchert-Noodt, G. Influence of methylphenidate on brain development--an update of recent animal experiments.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Brain Funct., 2006, 2, 2. http://dx.doi.org/10.1186/1744-9081-2-2 [103] Outram, S.M.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Ethics, 2010, 36 (4), 198-202. http://dx.doi.org/10.1136/jme.2009.034421 [104] Teter, C.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacotherapy, 2006, 26 (10), 1501-10. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacotherapy, 2003, 23 (5), 609-17. http://dx.doi.org/10.1592/phco.23.5.609.34187 [109] White, B.P.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Health, 2006, 54 (5), 261-8. http://dx.doi.org/10.3200/JACH.54.5.261-268 [110] Volkow, N.D.; Ding, Y.S.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Gen. Psychiatry, 1995, 52 (6), 456-63. http://dx.doi.org/10.1001/ archpsyc.1995.03950180042006 [111] Jaffe, S.L.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 1991, 30 (5), 773-5. http://dx.doi.org/ 10.1097/00004583-199109000-00012 [112] Levine, B.; Caplan, Y.H.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Toxicol., 1986, 10 (5), 209-10. http://dx.doi.org/10.1093/jat/10.5.209 [113] Clemow, D.B.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Med., 2014, 126 (5), 64-81. http://dx.doi.org/10.3810/pgm.2014.09.2801 [114] Shanks, R.A.; Ross, J.M.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Brain Res., 2015, 281, 116-24. http://dx.doi.org/10.1016/j.bbr.2014.12.002 [115] Pauly, V.; Lapeyre-Mestre, M.; Braunstein, D.; Rueter, M.; Thirion, X.; Jouanjus, E.; Micallef, J.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Pharmacol., 2015, 71 (2), 229-36. http://dx.doi.org/10.1007/ s00228-014-1783-x [116] Viggiano, D.; Vallone, D.; Sadile, A. Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neural Plast., 2004, 11 (1-2), 9 7-114. http://dx.doi.org/10.1155/NP.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neurochem., 2011, 116 (2), 164-76. http://dx.doi.org/10.1111/j.1471-4159.2010.07109.x [118] Markowitz, J.S.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychopharmacol., 2006, 16 (6), 687-98. http://dx.doi.org/10.1089/ cap.2006.16.687 [119] Mehta, M.A.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2003, 54(12), 1465-8. http://dx.doi.org/10.1016/S0006-3223(03)00609-7 [122] Lee, M.J.; Yang, P.B.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Neuropharmacology, 2009, 57 (3), 201-7. http://dx.doi.org/10.1016/j.neuropharm.2009.06.008 [123] Urban, K.R.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2012, 72 (10), 880-8. http://dx.doi.org/ 10.1016/j.biopsych.2012.04.018 [124] Hart, H.; Radua, J.; Nakao, T.; Mataix-Cols, D.; Rubia, K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"JAMA Psychiatry, 2013, 70 (2), 185-98. http://dx.doi.org/10.1001/ jamapsychiatry.2013.277 [125] Spencer, T.J.; Brown, A.; Seidman, L.J.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2013, 74 (9), 902-917. http://dx.doi.org/10.4088/ JCP.12r08287 [126] Frodl, T.; Skokauskas, N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Scand., 2012, 125 (2), 114-26. http://dx.doi.org/10.1111/j.1600-0447.2011.01786.x [127] Huang, Y. S.; Tsai, M.H.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"CNS Drugs, 2011, 25 (7), 539-54. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Psychiatry, 2003, 54 (12), 1317-29. http://dx.doi.org/10.1016/ S0006-3223(03)00570-5",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Child, 2014, 99 (9), 866-72. http://dx.doi.org/10.1136/archdischild-2013-304170 [131] Bihlar, M.B.",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"J. Dual Diagn., 2014, 10 (1), 32-8. http://dx.doi.org/10.1080/15504263.2013.867657 [133] Lakhan, S.E.",OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Health, 2007, 3, 21. http://dx.doi.org/10.1186/1745-0179-3-21 [134] Frati, P.; Kyriakou, C.; Del R i o ,  A .",Non-OADS,/arxiv_data1/oa_pdf/30/97/CN-14-17.PMC4787280.pdf
"Science, 1966, 152(3722), 604-619. http://dx.doi.org/10.1126/science.152.3722.604 [3] Frank, M .",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Sleep Res., 2003, 12(1), 25-34. http://dx.doi.org/10.1046/j.1365-2869.2003.00339.x [4] Mirmiran, M.; Yolanda, M.G.H.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Trends Neurosci., 2005, 28(8), 408-415. http://dx.doi.org/10.1016/j.tins.2005.06.004 [7] Stickgold, R. Sleep-dependent memory consolidation.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Nature, 2005, 437(7063), 1272-1278. http://dx.doi.org/10.1038/nature04286 [8] Matos, G.; Tufik, S.; Scorza, F.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Epilepsy Behav., 2013, 26(3), 405-409. http://dx.doi.org/10.1016/j.yebeh.2012.12.003 [9] Lima, M.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Rev., 2013, 17(5), 367-375. http://dx.doi.org/10.1016/j.smrv.2012.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Dis., 2013, 201(3), 251-257. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Des., 2008, 14(32), 3430-3445. http://dx.doi.org/10.2174/ 138161208786549353 [12] Kushida, C.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Biosci., 2002, 27(5), 539-551. http://dx.doi.org/ 10.1007/BF02705052 [14] Powledge, T.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Bioscience, 2011, 61(8), 588-592. http://dx.doi.org/ 10.1525/bio.2011.61.8.4 [15] Keverne, E.B.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroendocrinol., 2008, 29(3), 398-412. http://dx.doi.org/10.1016/j.yfrne.2008.03.001",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Rep., 2014, 14(3), 432. http://dx.doi.org/ 10.1007/s11910-013-0432-6 [17] McNamara, P. Genomic Imprinting and Neurodevelopmental Disorders of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Plos Genet., 2012, 8(5), e1002706  http://dx.doi.org/10.1371/ journal.pgen.1002706 [20] Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Rev., 2011, 15(3), 165-178. http://dx.doi.org/10.1016/ j.smrv.2010.11.001 [21] Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1990, 515(1-2), 94-98. http://dx.doi.org/10.1016/0006-8993(90)90581-U [22] Porkka-Heiskanen, T.; Smith, S.E.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"I n ;  Cambridge University Press; 2011. http://dx.doi.org/10.1017/ CBO9780511921179 [25] McCarley, R.W.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci Res, 1996, 24(3), 227-235. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Lett., 1997, 223(2), 105-108. http://dx.doi.org/10.1016/S0304-3940(97)13410-3 [28] Kaur, S.; Panchal, M.; Faisal, M.; Madan, V.; Nangia, P.; Mallick, B.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 2004, 151(1-2), 185-190. http://dx.doi.org/10.1016/j.bbr.2003.08.011 [29] Kaur, S.; Saxena, R.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Synapse, 2001, 42(3), 141-150. http://dx.doi.org/10.1002/syn.1109 [30] Jaiswal, M.K.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Sleep Res., 2010, 19, 183-191. http://dx.doi.org/10.1111/j.1365-2869.2009.00781.x [31] Pal, D.; Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2010, 13(12), 1526-1533. http://dx.doi.org/10.1038/nn.2682 [33] Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurobiol., 2012, 97(3), 259-276. http://dx.doi.org/10.1016/j.pneurobio.2012.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 1993, 55(3), 677-683. http://dx.doi.org/10.1016/0306-4522(93)90433-G [35] Tellioglu, T.; Robertson, D. Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1983, 277(1), 109-118. http://dx.doi.org/10.1016/0006-8993(83)90912-5 [37] Mallick, B.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Scand., 1988, 132(2), 191-198. http://dx.doi.org/10.1111/j.1748-1716.1988.tb08317.x [39] Basheer, R.; Magner, M.; McCarley, R.W.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1998, 57(2), 235-240. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurochem., 1996, 67(2), 443-462. http://dx.doi.org/10.1046/j.1471-4159.1996.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2004, 25(3), 536-547. http://dx.doi.org/10.1016/ j.mcn.2003.10.010 [44] Michelotti, G.A.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"2007, 21(9), 1979-1993. http://dx.doi.org/10.1096/fj.06-7118com [45] Razik, M.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Chem., 1997, 272(45), 28237-28246. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"http://dx.doi.org/10.1038/tp.2013.120 [48] Berger, S.L.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Nature, 2007, 447(7143), 407-412. http://dx.doi.org/ 10.1038/nature05915 [49] Vinci, M.C.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Stem Cell Rev., 2013, 9(3), 241-253. http://dx.doi.org/10.1007/s12015-012-9398-z [50] Law, J.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Genet., 2010, 11(3), 204-220. http://dx.doi.org/10.1038/nrg2719 [51] Prokhortchouk, E.; Defossez, P.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell Res., 2008, 1783(11), 2167-2173. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Genet., 2003, 33, 245-254. http://dx.doi.org/10.1038/ng1089 [54] Robertson, K.D.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Oncogene, 2002, 21(35), 5361-5379. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Biotechnol., 2010, 28(10), 1057-1068. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Learn Mem., 2013, 105, 125-132. http://dx.doi.org/10.1016/j.nlm.2013.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Aspects Med., 2013, 34(4), 875-882. http://dx.doi.org/10.1016/j.mam.2012.06.011 [58] Peterson, C.L.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"http://dx.doi.org/ 10.1016/S0960-9822(02)00782-0 [59] Kouzarides, T. Chromatin modifications and their function.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell, 2007, 128(4), 693-705. http://dx.doi.org/10.1016/j.cell.2007.02.005 [60] Choi, J.K.; Howe, L.J.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell Biol., 2009, 87(1), 139-150. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"(Berl)., 2010, 88(12), 1213-1220. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Dev., 2002, 12(2), 142-148. http://dx.doi.org/ 10.1016/S0959-437X(02)00279-4 [63] Day, J.J.; Sweatt, J.D.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2010, 13(11), 1319-1323. http://dx.doi.org/10.1038/ nn.2666 [64] Pirooznia, S.K.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell Neurosci., 2013, 7, 30. http://dx.doi.org/10.3389/fncel.2013.00030 [65] Mehler, M.F.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurobiol., 2008, 86(4), 305-341. http://dx.doi.org/10.1016/j.pneurobio.2008.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Pharmacol., 2010, 79(6), 801-809. http://dx.doi.org/10.1016/j.bcp.2009.10.004 [67] Adolfsson, R.; Gottfries, C.G.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"J. Psychiatry, 1979, 135, 216-223. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Suppl, 2006, (70), 349-355. http://dx.doi.org/10.1007/978-3-211-45295-0_53 [69] Sanchez, C.; Brennum, L.T.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Behav., 2007, 86(3), 468-476. http://dx.doi.org/10.1016/j.pbb.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Sci., 2012, 323(1-2), 25-32. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2006, 314(5800), 777-781. http://dx.doi.org/10.1126/ science.1132814 [72] Roberson, E.D.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2006, 314(5800), 781-784. http://dx.doi.org/10.1126/science.1132813 [73] Lee, J.; H., R. Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"BMB Reports, 2010, 43(10), 649-655. http://dx.doi.org/10.5483/BMBRep.2010.43.10.649 [74] Tohgi, H.; Utsugisawa, K.; Nagane, Y.; Yoshimura, M.; Ukitsu, M.; Genda, Y.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Lett., 1999, 275(2), 89-92. http://dx.doi.org/10.1016/S0304-3940(99)00731-4 [75] Tohgi, H.; Utsugisawa, K.; Nagane, Y.; Yoshimura, M.; Genda, Y.; Ukitsu, M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1999, 70(2), 288-292. http://dx.doi.org/10.1016/S0169-328X(99)00163-1 [76] Cao, X.; Sudhof, T.C.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2001, 293(5527), 115-120. http://dx.doi.org/10.1126/science.1058783 [77] Saura, C.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuron, 2004, 42(1), 23-36. http://dx.doi.org/10.1016/S0896-6273(04)00182-5 [78] Kang, J.E.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2009, 326(5955), 1005-1007. http://dx.doi.org/10.1126/ science.1180962 [79] Biswas, S.; Mishra, P.; Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 2006, 142(2), 315-331. http://dx.doi.org/10.1016/j.neuroscience.2006.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2006, 26(5), 1343-1354. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1993, 631(1), 147-150. http://dx.doi.org/10.1016/0006-8993(93)91201-3 [83] Francis, B.M.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuropsycho- pharmacology, 2012, 37(8), 1934-1944. http://dx.doi.org/10.1038/ npp.2012.40 [84] Menke, A.; Klengel, T.; Binder, E.B.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Des., 2012, 18(36), 5879-5889. http://dx.doi.org/10.2174/138161212803523590 [85] Dwivedi, Y.; Rizavi, H.S.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Gen. Psychiatry, 2003, 60(8), 804-815. http://dx.doi.org/10.1001/archpsyc.60.8.804 [86] Martinowich, K.; Hattori, D.; Wu, H.; Fouse, S.; He, F.; Hu, Y.; Fan, G.; Sun, Y.E.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2003, 302(5646), 890-893. http://dx.doi.org/10.1126/science.1090842 [87] Benraiss, A.; Chmielnicki, E.; Lerner, K.; Roh, D.; Goldman, S.A. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2009, 29(37), 11451-11460. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 2011, 174, 104-114. http://dx.doi.org/ 10.1016/j.neuroscience.2010.10.077 [91] Roy, A.; Pickar, D.; De Jong, J.; Karoum, F.; Linnoila, M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Gen. Psychiatry, 1988, 45(9), 849-857. http://dx.doi.org/10.1001/archpsyc.1988.01800330081010 [92] Benca, R.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuropsychobiology, 2004, 49(4), 174-177. http://dx.doi.org/10.1159/000077361 [95] Akbarian, S.; Cheung, I.; Connor, C.; Jakovcevski, M.; Jiang, Y. Posttranslational Histone Modifications and the Neurobiology of Psychosis.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"1-21. http://dx.doi.org/10.1007/978-3-642-17426-1_1 [96] Belforte, J.E.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"http://dx.doi.org/10.1038/ nn.2447 [97] Lewis, D.A.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"J. Psychiatry, 2008, 165(12), 1585-1593. http://dx.doi.org/ 10.1176/appi.ajp.2008.08030395 [98] Akbarian, S.; Kim, J.J.; Potkin, S.G.; Hagman, J.O.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"General Psychiatry, 1995, 52(4), 258-266. http://dx.doi.org/10.1001/archpsyc.1995.03950160008002 [99] Dong, E.; Agis-Balboa, R.C.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2007, 27(42), 11254-11262. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"http://dx.doi.org/10.1038/ tp.2011.61 [102] Tremolizzo, L.; Carboni, G.; Ruzicka, W.B.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"CNS Drugs, 2008, 22(11), 939-962. http://dx.doi.org/10.2165/00023210-200822110-00004 [104] Nitz, D.; Siegel, J.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 1997, 78(3), 795-801. http://dx.doi.org/10.1016/S0306-4522(96)00549-0 [105] Watson, C.J.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 2007, 144(1), 375-386. http://dx.doi.org/10.1016/j.neuroscience.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Lett., 2003, 338(3), 193-196. http://dx.doi.org/10.1016/ S0304-3940(02)01404-0 [107] Zovkic, I.B.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuropsychopharmacology, 2013, 38(1), 77-93. http://dx.doi.org/10.1038/npp.2012.79 [108] Levenson, J.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2005, 6(2), 108-118. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Chem., 2009, 390(11), 1145-1153. http://dx.doi.org/10.1515/BC.2009.131 [110] Zovkic, I.B.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Memory, 2013, 20(2), 61-74. http://dx.doi.org/10.1101/lm.026575.112 [111] Miller, C.A.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuron, 2007, 53(6), 857-869. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain, 2010, 3, 15. http://dx.doi.org/10.1186/1756-6606-3-15 [113] Koshibu, K.; Graff, J.; Mansuy, I.M.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 2011, 173, 30-36. http://dx.doi.org/ 10.1016/j.neuroscience.2010.11.023 [114] Lubin, F.D.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2008, 28(42), 10576-10586. http://dx.doi.org/10.1523/ JNEUROSCI.1786-08.2008 [115] Penner, M.R.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Commun., 2012, 3, 991. http://dx.doi.org/10.1038/ncomms1997 [117] Stickgold, R.; Hobson, J.A.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2001, 294(5544), 1052-1057. http://dx.doi.org/10.1126/science.1063530 [118] Maquet, P. The role of sleep in learning and memory.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 2001, 294(5544), 1048-1052. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell, 2007, 131(1), 160-173. http://dx.doi.org/10.1016/j.cell.2007.09.017 [120] Lenartowski, R.; Goc, A. Epigenetic, transcriptional and posttranscriptional regulation of the tyrosine hydroxylase gene.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2011, 29(8), 873-883. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Cell Cycle, 2010, 9(22), 4600-4601. http://dx.doi.org/10.4161/cc.9.22.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
http://dx.doi.org/10.1161/ATVBAHA.,Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Immun., 2011, 25(3), 408-415. http://dx.doi.org/10.1016/j.bbi.2010.10.019 [124] Jiang, Q.; Yuan, H.; Xing, X.; Liu, J.; Huang, Z.; Du, X. Methylation of adrenergic beta1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Trends Neurosci, 1995, 18(2), 89-98. http://dx.doi.org/10.1016/0166-2236(95)80030-6 [126] Hardingham, G.E.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuron, 1999, 22(4), 789-798. http://dx.doi.org/ 10.1016/S0896-6273(00)80737-0",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuron, 1991, 7(4), 625-635. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Glia, 2012, 60(9), 1330-1344. http://dx.doi.org/10.1002/glia.22352 [132] Tinti, C.; Conti, B.; Cubells, J.F.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Chem., 1996, 271(41), 25375-25381. http://dx.doi.org/10.1074/ jbc.271.41.25375 [133] Pellegrino, M.J.; Parrish, D.C.; Zigmond, R.E.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurosci., 2011, 46(3), 671-680. http://dx.doi.org/10.1016/j.mcn.2011.01.008 [134] Mallick, B.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 1996, 75(3), 729-736. http://dx.doi.org/10.1016/ 0306-4522(96)00177-7 [135] Gulyani, S.; Mallick, B.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuroscience, 1995, 64(1), 255-260. http://dx.doi.org/ 10.1016/0306-4522(94)00333-Z [136] Hagenston, A.M.; Bading, H. Calcium Signaling in Synapse-to-Nucleus Communication.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Genet., 2006, 42(7), 795-801. http://dx.doi.org/10.1134/S1022795406070155 [138] Zhou, Z.L.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neuron, 2006, 52(2), 255-269. http://dx.doi.org/10.1016/j.neuron.2006.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Genet., 1998, 19(2), 187-191. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"http://dx.doi.org/10.1016/ S0893-133X(01)00322-0 [141] Davis, C.J.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Applied Physiol., 2011, 111(3), 665-672. http://dx.doi.org/ 10.1152/japplphysiol.00517.2011 [142] Davis, C.J.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Lett., 2007, 422(1), 68-73. http://dx.doi.org/10.1016/j.neulet.2007.06.005 [143] Aghajanian, G.K.; VanderMaelen, C.P.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Science, 1982, 215(4538), 1394-1396. http://dx.doi.org/10.1126/science.6278591 [144] Aghajanian, G.K.; Cedarbaum, J.M.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Brain Res., 1977, 136(3), 570-577. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Int., 1999, 34(6), 499-507. http://dx.doi.org/10.1016/S0197-0186(99)00025-X [146] Mallick, B.N.",OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Neurochem., 2000, 74(4), 1574-1578. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Taiwanese J. Obstetrics  Gynecol., 2010, 49(4), 468-472. http://dx.doi.org/10.1016/S1028-4559(10) 60099-X [149] Simonini, M.V.",Non-OADS,/arxiv_data1/oa_pdf/88/66/CN-14-28.PMC4787282.pdf
"Clin., 2011, 29, 207-217. http://dx.doi.org/ 10.1016/j.ncl.2010.12.010 [3] Koch-Henriksen, N.;Sørensen, P.S.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Lancet Neurol., 2010, 9, 520-532. http://dx.doi.org/10.1016/S1474-4422(10)70064-8 [4] Kurtzke, J.F.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Risk factors for MS. Neurology, 1997, 48, 204-213. http://dx.doi.org/10.1212/WNL.48.1.204 [5] Goodin, D.S.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2014, 122, 231-266. http://dx.doi.org/10.1016/B978-0-444-52001-2.00010-8 [6] Weiner, H.L.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2004, 61, 1613-1615. http://dx.doi.org/10.1001/archneur.61.10.1613 [7] Compston, A.; Coles, A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"L a n c e t ,  2008, 372, 1502-1517. http://dx.doi.org/10.1016/S0140-6736(08)61620-7 [8] Ontaneda, D.; Hyland, M.; Cohen, J.A.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Med., 2012, 63, 389-404. http://dx.doi.org/10.1146/annurev-med-042910-135833 [9] Popescu, B.F; Lucchinetti, C.F.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Pathol., 2012, 7, 185-217. http://dx.doi.org/ 10.1146/annurev-pathol-011811-132443 [10] Frohman, E.M.; Racke, M.K.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Med., 2006, 354, 942-955. http://dx.doi.org/10.1056/NEJMra052130 [11] Calabrese, M.; Filippi, M.; Gallo, P. Cortical lesions in multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2010, 6, 438-444. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2008, 7, 841-851. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2001, 50, 389-400. http://dx.doi.org/10.1002/ana.1123 [14] Pirko, I.; Lucchinetti, C.F.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurology, 2007, 68, 634-642. http://dx.doi.org/10.1212/01.wnl.0000250267.85698.7a [15] Popescu, B.F.; Pirko, I.; Luccinetti, C.F.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Continuum (MinneapMinn) 2013, 19, 901-921. http://dx.doi.org/10.1212/01.CON.0000433291.23091.65 [16] Siegert, R.J.; Abernethy, D.A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurosurg.Psychiatry., 2005, 76, 469-475. http://dx.doi.org/10.1136/jnnp.2004.054635 [17] Kosmidis, M. h.; Giannakou, M.; Messinis, L. Papathanasopoulos, P. Psychotic features associated with multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Psychiatry, 2010, 22, 55-66. http://dx.doi.org/10.3109/ 09540261003589612 [18] Filippi, M.; Rocca, M.A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Radiology, 2011, 259, 659-681. http://dx.doi.org/10.1148/radiol.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2011, 69, 292-302. http://dx.doi.org/10.1002/ana.22366 [21] Kupersmith, M.J.; Kaufman, D.; Paty, D, W.; Ebers, G., McFarland, H., Johnson, K., Reingold, S., Whitaker, J. Megadose corticosteroids in multiple sclerosis.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurology, 1994, 44, 1-4. http://dx.doi.org/10.1212/WNL.44.1.1 [22] Murray, T.J.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Hypotheses., 2005, 64, 215. http://dx.doi.org/10.1016/j.mehy.2004.09.003 [27] Peedicayil, J.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Epidemiol., 2006, 35, 490-491. http://dx.doi.org/10.1093/ije/dyi297 [28] Ober, C., Vercelli, D. Gene-environment interactions in human disease: Nuisance or opportunity?",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Trends Genet., 2011, 27, 107-115. http://dx.doi.org/10.1016/j.tig.2010.12.004 [29] Zhou, Y., Simpson, S., Holloway, A.F., Charlesworth, J., van der Mei, I., Taylor, B.V.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Mult.Scler., 2014, 20, 135-140. http://dx.doi.org/10.1177/1352458514520911 [30] Kürtüncü, M., Tüzün, E. Multiple sclerosis: Could it be an epigenetic disease?",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"hypotheses, , 2008, 71, 945-947. http://dx.doi.org/10.1016/j.mehy.2008.06.034 [31] Chao, M.J., Herrera, B.M., Ramagopalan, S.V., Deluca, G., Handunetthi, L., Orton, S.M., Lincoln, M.R., Sadovnick, A.D., Ebers, G.C.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Genet., 2010, 19, 3679-3689. http://dx.doi.org/10.1093/hmg/ddq282 [32] Petronis, A. human morbid genetics revisited: Relevance of epigenetics.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Genet., 2001, 17, 142-146. http://dx.doi.org/ 10.1016/S0168-9525(00)02213-7 [33] Casaccia-Bonnefil, P., Pandozym, G., Mastronardim, F. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Med., 2011, 60, 10-16. http://dx.doi.org/10.2302/kjm.60.10 [35] Burrell, A.M., Handel, A.E., Ramagopalan, S.V., Ebers, G.C., Morahan, J.M.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2013, 9, 35-43. http://dx.doi.org/10.1038/nrneurol.2012.226 [37] Huynh, J.L., Casaccia, P. Epigenetic mechanisms in multiple sclerosis: Implications for pathogenesis and treatment.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2013, 12, 195-206. http://dx.doi.org/10.1016/S1474-4422(12)70309-5 [38] Kücükali, C.İ., Kürtüncu, M., Coban, A., Cebi, M., Tüzün, E. Epigenetics of multiple sclerosis: An updated review.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"http://dx.doi.org/10.1007/s12017-014-8298-6 [39] Mastronardi, F.G., Wood, D.D., Mei, J., Raijmakers, R., Tseveleki, V., Dosch, H-M., Probert, L., Casaccia-Bonnefil, P., Moscarello, M.A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurosci., 2006, 26, 11387-11396. http://dx.doi.org/10.1523/ JNEUROSCI.3349-06.2006 [40] Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., Meinl, E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Brain, 2009, 132, 3342-3352. http://dx.doi.org/10.1093/brain/awp300 [41] Pedre, X., Mastronardi, F., Bruck, W., López-Rodas, G., Kuhlmann, T., Casaccia, P. Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurosci., 2011, 31, 3435-3445. http://dx.doi.org/10.1523/ JNEUROSCI.4507-10.2011 [42] Noorbakhsh, F., Ellestad, K.K., Maingat, F., Warren, K.G., Han, M. h., Steinman, L., Baker, G.B., Power, C. Impaired neurosteroid synthesis in multiple sclerosis.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Brain, 2011, 134, 2703-2721. http://dx.doi.org/10.1093/brain/awr200 [43] Huynh, J.L., Garg, P., Thin, T. h., Yoo, S., Dutta, R., Trapp, B.D., Haroutunian, V., Zhu, J., Donovan, M.J., Sharp, A.J., Casaccia, P. Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurosci., 2014, 17, 121-130. http://dx.doi.org/10.1038/nn.3588 [44] Tegla, C.A., Azimzadeh, P., Andrian-Albescu, M., M a r t i n ,  A .",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Pathol., 2014, 96, 139-148. http://dx.doi.org/10.1016/j.yexmp.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Genet, 2008, 9, 63. http://dx.doi.org/10.1186/1471-2350-9-63 [46] Baranzini, S.E., Mudge, J., van Velkinburgh, J.C., Khankhanian, P., Khrebtukova, I., Miller, N.A., Zhang, L., Farmer, A.D., Bell, C.J., Kim, R.W., May, GD, Woodward J.E., Caillier, S.J., McElroy, J. P., Gomez, R., Pando, M.J., Clendenen, L.E., Ganusova, E.E., Schilkey, F.D., Ramaraj, T., Khan, O.A., Huntley, J.J., Luo, S., Kwok, P-Y., Wu, F.D., Schroth, G.P., Oksenberg, J.R., Hauser, S.L., Kingsmore, S.F.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Nature, 2010, 464, 1351-1356. http://dx.doi.org/10.1038/nature08990 [47] Cox, M.B., Cairns, M.J., Gandhi, K.S., Carroll, A.P., Moscovis, S., Stewart, G.J., Broadley, S., Scott.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
http://dx.doi.org/10.1371/journal.pone.0012132,Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Scler., 2012, 18, 2 9 9-304. http://dx.doi.org/10.1177/1352458511421055 [49] Kumagai, C., Kalman, B., Middleton, F.A., Vyshkina, T., Massa, P.T.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neuroimmunol., 2012, 246, 51-57. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Scler., 2013, 20, 1033-1041. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Pharmacogenomics, 2008, 9, 1785-1786. http://dx.doi.org/10.2217/ 14622416.9.12.1785 [53] Peedicayil, J.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Ther., 2013, 93, 149-150. http://dx.doi.org/10.1038/ clpt.2012.177 [54] Peedicayil, J. Epigenetic therapy – A  n e w  development in pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Cell, 2009, 139, 1029-1031. http://dx.doi.org/10.1016/j.cell.2009.11.038 [56] Ransohoff, R.M.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurosci., 2012, 15, 1074-1077. http://dx.doi.org/10.1038/nn.3168  [57] Camelo, S., Iglesias, A.H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S.G., Imitola, J., Duran, G., Assaf, B., Langley, B., Khoury, S.J., Stephanopoulos, G., De Girolami, U., Ratan, R.R., Ferrante, R.J., Dangond, F. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neuroimmunol., 2005, 164, 10-21. http://dx.doi.org/10.1016/j.jneuroim.2005.02.022 [58] Kalinin, S., Polak, P.E., Lin, S.X., Braun, D., Guizzetti, M., Zhang, X., Rubinstein, I., Feinstein, D.L.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neuroimmunol., 2013, 263, 13-19. http://dx.doi.org/10.1016/j.jneuroim.2013.07.007 [59] Ge, Z., Da, Y., Xue, Z., Zhang, K., Zhuang, H., Peng, M., Li, Y., Li, W., Simard, A., Hao, J., Yao, Z., Zhang, R. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Neurol., 2013, 241, 56-66. http://dx.doi.org/10.1016/j.expneurol.",OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Physiol., 2014, 229, 1918-1925. http://dx.doi.org/ 10.1002/jcp.24641 [62] Gray, S.G.; Dangond, F. Rationale for the use of histone deacetylase inhibitors as a duel therapeutic modality in multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Epigenetics, 2006, 1, 67-75. http://dx.doi.org/10.4161/ epi.1.2.2678 [63] Shuttleworth, S.J.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"D r u g Targets, 2010, 11, 1430-1438. http://dx.doi.org/10.2174/1389450111009011430 [64] Faraco, G.; Cavone, L.; Chiarugi, A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Med., 2011, 17, 442-447. http://dx.doi.org/10.2119/molmed.2011.00077 [65] Kundakovic, M. DNA methyltransferase inhibitors and psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Peedicayil, J., Grayson, D.R., Avramopoulos, D., Eds; Elsevier: Waltham, MA, USA, 2014, pp 497-514. http://dx.doi.org/10.1016/b978-0-12-417114-5.00024-3 [66] Chakravarty, S.; Bhat, U.A.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Peedicayil, J., Grayson, D.R., Avramopoulos, D. Eds; Elsevier: Waltham, MA, USA, 2014, pp 515-544. http://dx.doi.org/10.1016/b978-0-12-417114-5.00025-5 [67] Peedicayil, J. Epigenetic management of major psychosis.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Epigenetics, 2011, 2, 249-256. http://dx.doi.org/10.1007/s13148-011-0038-2 [68] Peedicayil, J. Epigenetic drugs in cognitive disorders.",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Des., 2014, 20, 1840-1846. http://dx.doi.org/10.2174/ 13816128113199990526   Received: November 30, 2014 Revised: January 19, 2015 Accepted: February 09, 2015",Non-OADS,/arxiv_data1/oa_pdf/db/4d/CN-14-3.PMC4787283.pdf
"Psychopharmacology, 2005, 180, 191-205. http://dx.doi.org/ 10.1007/s00213-005-2212-8 [2] Grayson, D.R.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"1    45 pharmacology, 2013, 38, 138-166. http://dx.doi.org/10.1038/npp.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Sci., 2009, 30, 55-60. http://dx.doi.org/10.1016/j.tips.2008.10.010 [5] Haig, D. The (dual) origin of epigenetics.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Biol., 2004, 69, 67-70. http://dx.doi.org/10.1101/sqb.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Biol., 2014, 24, 664-674. http://dx.doi.org/10.1016/j.tcb.2014.08.004 [7] McGowan, P.O.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Essays Biochem., 2010, 48, 275-287. http://dx.doi.org/10.1042/bse0480275 [8] Razin, A. CpG methylation, chromatin structure and gene silencing-a three-way connection.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"EMBO J., 1998, 17, 4905-4908. http://dx.doi.org/10.1093/emboj/17.17.4905 [9] Bergmann, A.; Lane, M.E.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Trends Biochem Sci., 2003, 28, 461-463. http://dx.doi.org/10.1016/S0968-0004(03)00175-0 [10] Kuo, M. h.; Allis, C.D.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Bioessays, 1998, 20, 615-626. http://dx.doi.org/10.1002/(SICI)1521-1878(199808)20:8%3C615:: AID-BIES4%3E3.0.CO;2-H [11] Nestler, E.J.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"JAMA Psychiatry, 2014, 71, 454-456. http://dx.doi.org/10.1001/ jamapsychiatry.2013.4291 [12] Veldic, M.; Kadriu, B.; Maloku, E.; Agis-Balboa, R.C.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Schizophr Res., 2007, 91, 51-61. http://dx.doi.org/ 10.1016/j.schres.2006.11.029 [13] Costa, E.; Grayson, D.R.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Interv., 2003, 3, 220-229. http://dx.doi.org/10.1124/mi.3.4.220 [14] Grayson, D.R.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Environ Health Prev Med., 2008, 13, 16-24. http://dx.doi.org/10.1007/ s12199-007-0002-0 [17] Weinberger, D.R.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Gen. Psychiatry, 1987, 44, 660-669. http://dx.doi.org/10.1001/archpsyc.1987.01800190080012 [18] Keshavan, M.S.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychopathol., 1999, 11, 525-543. http://dx.doi.org/10.1017/S0954579499002199 [19] Fatemi, S. h.; Folsom, T.D.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Bull., 2009, 35, 528-548. http://dx.doi.org/10.1093/schbul/sbn187 [20] Markham, J.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychopharmacology, 2011, 214, 89-106. http://dx.doi.org/10.1007/s00213-010-2035-0 [21] Khashan, A.S.; Abel, K.M.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Gen. Psychiatry, 2008, 65, 146-152. http://dx.doi.org/10.1001/archgenpsychiatry.2007.20 [22] Giovanoli, S.; Engler, H.; Engler, A.; Richetto, J.; Voget, M.; Willi, R.; Winter, C.; Riva, M.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Science, 2013, 339, 1095-1099. http://dx.doi.org/10.1126/ science.1228261 [23] Matrisciano, F.; Tueting, P.; Dalal, I.; Kadriu, B.; Grayson, D.R.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuropharmacology, 2013, 68, 184-194. http://dx.doi.org/10.1016/j.neuropharm.2012.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychoneuroendocrinology, 2013, 38, 509-521. http://dx.doi.org/10.1016/j.psyneuen.2012.07.011 [25] Fine, R.; Zhang, J.; Stevens, H,E.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychiatry, 2014, 19, 641-651. http://dx.doi.org/10.1038/mp.2014.35 [26] Lisman, J.E.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Trends Neurosci., 2008, 31, 234-242. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Bull., 2008, 34, 944-961. http://dx.doi.org/10.1093/schbul/sbn070 [28] Dickerson, D.D.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychiatry, 2014, 4, 418. http://dx.doi.org/10.1038/tp.2014.64 [29] Matrisciano, F.; Tueting, P.; Maccari, S.; Nicoletti, F.; Guidotti, A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuropsychopharmacology, 2012, 37, 929-938. http://dx.doi.org/10.1038/npp.2011.274 [30] Dong, E.; Dzitoyeva, S.G.; Matrisciano, F.; Tueting, P.; Grayson, D.R.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuropsycho- pharmacology, 2013, 38, 183-197. http://dx.doi.org/10.1038/npp.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuropharmacology, 2011, 60, 1007-1016. http://dx.doi.org/10.1016/j.neuropharm.2010.10.021 [34] Mill, J.; Tang, T.; Kaminsky, Z.; Khare, T.; Yazdanpanah, S.; Bouchard, L.; Jia, P.; Assadzadeh, A.; Flanagan, J.; Schumacher, A., Wang, S.C.; Petronis, A. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Genet., 2008, 82, 696-711. http://dx.doi.org/10.1016/j.ajhg.2008.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Dis., 2012, 46, 255-262. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychiatry, 2012, 2, 159. http://dx.doi.org/10.1038/tp.2012.86 [38] Guidotti, A.; Auta, J.; Davis, J.M.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neurogenet., 2014, 28, 41-52. http://dx.doi.org/10.3109/ 01677063.2014.892485 [39] Meyer, U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Res., 2013, 151, 12-19. http://dx.doi.org/10.1016/j.schres.2013.10.040 [41] Nicoletti, F.; Bockaert, J.; Collingridge, G.L.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuro- pharmacology, 2011, 60, 1017-1041. http://dx.doi.org/10.1016/ j.neuropharm.2010.10.022 [42] (Schoepp) DD, D.D.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Disord., 2002, 1, 215-225. http://dx.doi.org/10.2174/1568007024606177 [43] Cartmell, J.; Monn, J.A.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychopharmacology, 2000, 148, 423-429. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Pharmacol., 2000, 400, 221-224. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Science, 1998, 281, 1349-1352. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Res., 2012, 136, 160-161. http://dx.doi.org/10.1016/j.schres.2012.01.007 [47] Carter, K.; Dickerson, J.; Schoepp, D.D.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neuropharmacology, 2004, 47, 1135-1145. http://dx.doi.org/10.1016/j.neuropharm.2004.08.018 [48] Ago, Y.; Araki, R.; Yano, K.; Hiramatsu, N.; Kawasaki, T.; Chaki, S.; Nakazato, A.; Onoe, H.; Hashimoto, H.; Baba, A.; Takuma, K.; Matsuda, T. Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psycho- pharmacology, 2011, 217, 443-452. http://dx.doi.org/10.1124/ mol.107.035170 [49] Benneyworth, M.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Pharmacol., 2007, 72, 477-484. http://dx.doi.org/10.1124/mol.107.035170 [50] Marek, G.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychopharmacology, 2004, 172, 233-240. http://dx.doi.org/10.1007/s00213-003-1636-2 [52] Moreno, J.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"C h e m ., 2012, 287, 44301-44319http://dx.doi.org/10.1074/jbc.M112.413161 [53] Patil, S.T.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Med., 2007, 13, 1102-1107. http://dx.doi.org/10.1038/nm1632 [54] Kinon, B,J,; Zhang, L,; Millen, B,A,; Osuntokun, O.O.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Psychopharmacol., 2011, 31, 349-355. http://dx.doi.org/10.1097/ JCP.0b013e318218dcd5 [55] Stauffer, V.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Res., 2013, 150, 434-441. http://dx.doi.org/10.1016/j.schres.2013.08.020 [56] Kurita, M.; Holloway, T.; García-Bea, A.; Kozlenkov, A.; Friedman, A.K.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neurosci., 2012, 15, 1245-1254. http://dx.doi.org/ 10.1038/nn.3181 [57] Kurita, M.; Moreno, J.L.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Pharmacol., 2013, 83, 1166-1175. http://dx.doi.org/10.1124/ mol.112.084582 [58] Matrisciano, F.; Dong, E.; Gavin, D.P.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Pharmacol., 2011, 80, 174-182. http://dx.doi.org/10.1124/mol.110.070896 [59] Phiel, C.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Chem., 2001, 276, 36734-36741. http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Rev., 2000, 31, 302-312. http://dx.doi.org/10.1016/S0165-0173(99) 00046-6 [61] González-Maeso, J.; Ang, R.L.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Nature, 2008, 452, 93-97. http://dx.doi.org/10.1038/ nature06612 [62] Fribourg, M.; Moreno, J.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Cell, 2011, 147, 1011-1023. http://dx.doi.org/10.1016/j.cell.2011.09.055 [63] Moreno, J.L.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Chem., 2012, 287, 44301-44319. http://dx.doi.org/10.1074/jbc.M112.413161 [64] Moreno, J.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neurosci., 2011, 31, 1863-1872. http://dx.doi.org/10.1523/ JNEUROSCI.4230-10.2011 [65] Holloway, T.; Moreno, J.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Neurosci., 2013, 33, 1088-1098. http://dx.doi.org/10.1523/JNEUROSCI.2331-12.2013 [66] Chiechio, S.; Caricasole, A.; Barletta, E.; Storto, M.; Catania, M.V.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Pharmacol., 2002, 61, 989-996. http://dx.doi.org/10.1124/ mol.61.5.989 [67] Chiechio, S.; Copani, A.; Zammataro, M.; Battaglia, G.; Gereau, R.W.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Sci., 2010, 31, 153-160. http://dx.doi.org/10.1016/j.tips.2009.12.003 [68] Nasca, C.; Xenos, D.; Barone, Y.; Caruso, A.; Scaccianoce, S.; Matrisciano, F.; Battaglia, G.; Mathé, A.A.; Pittaluga, A.; Lionetto, L.; Simmaco, M.; Nicoletti, F. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.",OADS,/arxiv_data1/oa_pdf/cc/fc/CN-14-41.PMC4787284.pdf
"Sci U. S. A., 2005, 102(10), 3697-702. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"J, 2003, 370(Pt 3), 737-49. http://dx.doi.org/10.1042/bj20021321 [3] Berndsen, C.E.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Biol., 2008, 18(6), 682-9. http://dx.doi.org/10.1016/j.sbi.2008.11.004 [4] Berndsen, C.E., Tsubota, T., Lindner, S.E., Lee, S., Holton, J.M.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Biol., 2008, 15(9), 948-56. http://dx.doi.org/ 10.1038/nsmb.1459 [5] Haberland, M., Montgomery, R.L., and Olson, E.N.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Genet., 2009, 10(1), 32-42. http://dx.doi.org/10.1038/nrg2485 [6] Minucci, S. and Pelicci, P.G.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer, 2006, 6(1), 38-51. http://dx.doi.org/10.1038/nrc1779 [7] Lin, R.J., et al.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Nature, 1998, 391(6669), 811-4. http://dx.doi.org/10.1038/35895 [8] Marks, P., Rifkind, R.A., Richon, V.M., Breslow, R., Miller, T. and Kelly, W.K.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer, 2001, 1(3), 194-202. http://dx.doi.org/10.1038/ 35106079 [9] Marks, P.A., Richon, V.M., Miller, T., and Kelly, W.K.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Res., 2004, 91, 137-68. http://dx.doi.org/10.1016/S0065-230X(04)91004-4 [10] Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., Volinia, S., Guler, G., Morrison, C.D., Chan, K.K., Marcucci, G., Calin, G.A., Huebner, K., and Croce C.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Cell, 2012, 22(4), 506-23. http://dx.doi.org/10.1016/j.ccr.2012.09.003 [12] Zhao, J.J., Lin, J. Lwin, T. Yang, H. Guo, J. Kong, W. Dessureault, S., Moscinski, L.C.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Blood, 2010, 115(13), 2630-9. http://dx.doi.org/10.1182/blood-2009-09-243147 [13] Bolden, J.E., M.J. Peart, and R.W.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Drug Discov., 2006, 5(9), 769-84. http://dx.doi.org/10.1038/nrd2133 [14] Azad, N., Zahnow, C.A., Rudin, C.M., and Baylin, S.B.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncol., 2013, 10(5), 256-66. http://dx.doi.org/10.1038/ nrclinonc.2013.42 [15] Bruzzone, S., Parenti, M.D., Grozio, A. Ballestrero, A., Bauer, I., Del Rio, A., and Nencioni, A. Rejuvenating sirtuins: the rise of a new family of cancer drug targets.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Des., 2013, 19(4), 614-23. http://dx.doi.org/10.2174/138161213804581954 [16] Jung-Hynes, B., Reiter, R.J. and Ahmad, N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"J. Pineal Res., 2010, 48(1), 9-19. http://dx.doi.org/10.1111/j.1600-079X.2009.00729.x [17] Butler, L.M., Zhou, X., Xu, W.S., Scher, H.I., Rifkind, R.A., Marks, P.A., and Richon, V.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Anticancer Drugs, 2011, 22(6), 494-9. http://dx.doi.org/10.1097/CAD.0b013e32834631e0 [20] Scandura, J.M., Roboz, G.J., Moh, M., Morawa, E., Brenet, F., Bose, J.R., Villegas, L., Gergis, U.S., Mayer, S.A., Ippoliti, C.M., Curcio, T.J., Ritchie, E.K., and Feldman, E.J.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Blood, 2011, 118(6), 1472-80. http://dx.doi.org/10.1182/blood-2010-11-320093 [21] Huang, S.K., Scruggs, A.M., Donaghy, J., Horowitz, J.C., Zaslona, Z., Przybranowski, S., White, E.S.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"http://dx.doi.org/10.1038/cddis.2013.146 [22] Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C. Bontempo, P., Alvarez, R., Schiavone, E.M., Ferrara, F., Bresciani, F., Weisz, A., de Lera, A.R., Gronemeyer, H., and Altucci, L.Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2005, 11(1), 77-84. http://dx.doi.org/10.1038/nm1161 [23] Rahmani, M., Yu, C., Reese, E., Ahmed, W., Hirsch, K., Dent, P., and Grant, S. Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncogene, 2003, 22(40), 6231-42. http://dx.doi.org/10.1038/sj.onc.1206646 [24] Shankar, S., Singh, T.R., Fandy, T.E., Luetrakul, T., Ross, D.D.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2005, 16(6), 1125-38. http://dx.doi.org/10.3892/ ijmm.16.6.1125 [25] Van Meir, E.G., Hadjipanayis, C.G.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Clin., 2010, 60(3), 166-93. http://dx.doi.org/10.3322/caac.20069 [26] Hanahan, D, and Weinberg, R.A. Hallmarks of cancer: the next generation.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cell, 2011, 144(5), 646-74. http://dx.doi.org/10.1016/ j.cell.2011.02.013 [27] Jain, R.K., di Tomaso, E., Duda, D.G., Loeffler, J.S., Sorensen, A.G. and Batchelor, T.T.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurosci., 2007, 8(8), 610-22. http://dx.doi.org/10.1038/nrn2175 [28] Rao, J.S.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer, 2003, 3(7), 489-501. http://dx.doi.org/ 10.1038/nrc1121 [29] Di Micco, R., Sulli, G. Dobreva, M., Liontos, M., Botrugno, O.A., Gargiulo, G., dal Zuffo, R., Matti, V., d'Ario, G., Montani, E., Mercurio, C., Hahn, W.C., Gorgoulis, V., Minucci, S., and d'Adda di Fagagna, F. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cell Biol., 2011, 13(3), 292-302. http://dx.doi.org/10.1038/ncb2170 [30] Kim, M.S., Kwon, H.J., Lee, Y.M., Baek, J.H., Jang, J.E., Lee, S.W., Moon, E.J., Kim, H.S., Lee, S.K., Chung, H.Y., Kim, C.W.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2001, 7(4), 437-43. http://dx.doi.org/10.1038/86507 [31] Savaskan, N.E., Heckel, A., Hahnen, E., Engelhorn, T., Doerfler, A., Ganslandt, O. Nimsky, C., Buchfelder, M., and Eyupoglu I.Y.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2008, 14(6), 629-32. http://dx.doi.org/10.1038/nm1772 [32] Eyupoglu, I.Y., Buchfelder, M., and Savaskan, N.E.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurol., 2013, 9(3), 141-51. http://dx.doi.org/10.1038/ nrneurol.2012.279 [33] Glas, M., Rath, B.H., Simon, M., Reinartz, R., Schramme, A., Trageser, D., Eisenreich, R., Leinhaas, A., Keller, M., Schildhaus H.U., Garbe, S., Steinfarz, B., Pietsch, T., Steindler, D.A.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurol., 2010, 68(2), 264-9. http://dx.doi.org/10.1002/ana.22036 [34] Eyupoglu, I.Y., Hore, N., Savaskan, N.E., Grummich, P., Roessler, K., Buchfelder, M., and Ganslandt, O.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"http://dx.doi.org/10.1371/ journal.pone.0044885 [35] Valdes, P.A., Kim, A., Brantsch, M., Niu, C., Moses, Z.B., Tosteson T.D., Wilson, B.C., Paulsen, K.D., Roberts, D.W., and Harris, B.T.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neuro Oncol., 2011, 13(8), 846-56. http://dx.doi.org/ 10.1093/neuonc/nor086 [36] Eyupoglu, I.Y., Hore, N., Fan, Z., Buslei, R., Merkel, A., Buchfelder, M. and Savaskan, N.E.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Rep., 2015, 5, 7958. http://dx.doi.org/10.1038/ srep07958 [37] Ungerstedt, J.S., Sowa, Y., Xu, W.S., Shao, Y., Dokmanovic, M. Perez, G., Ngo, L., Holmgren, A., Jiang, X., and Marks P.A.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Res., 2004, 64(2), 689-95. http://dx.doi.org/10.1158/0008-5472.CAN-03-2043 [39] Hahnen, E., Hahnen, E., Buslei, R., Siebzehnrubl.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Drugs, 2008, 17(2), 169-84. http://dx.doi.org/10.1517/ 13543784.17.2.169 [40] Eyüpoglu, I.Y., Hahnen, E., Buslei, R., Siebzehnrübl, F.A., Savaskan, N.E., Lüders, M., Tränkle, C., Wick, W., Weller, M., Fahlbusch, R., Blümcke, I. Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo a n d   in vivo.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurochem., 2005, 93(4), 992-9. http://dx.doi.org/10.1111/ j.1471-4159.2005.03098.x [41] Eyüpoglu, I.Y., Hahnen, E., Tränkle, C., Savaskan, N.E., Siebzehnrübl, F.A., Buslei, R., Lemke, D., Wick, W., Fahlbusch, R., Blümcke, I.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Ther., 2006, 5(5), 1248-55. http://dx.doi.org/10.1158/1535-7163.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurosurg., 2005, 102(4), 738-44. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Res., 2011, 71(20), 6514-23. http://dx.doi.org/10.1158/0008-5472.CAN-11-0782 [44] Engelhorn, T., Savaskan, N.E., Schwarz, M.A., Kreutzer, J., Meyer, E.P., Hahnen, E., Ganslandt, O., Dorfler, A., Nimsky, C., Buchfelder, M., and Eyupoglu, I.Y.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Sci., 2009, 100(10), 1856-62. http://dx.doi.org/10.1111/j.1349-7006.2009.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncol., 2011, 5, 265-314. http://dx.doi.org/10.4137/CMO.S7685 [46] Savaskan, N.E., et al., Dissection of mitogenic and neuro- degenerative actions of cystine and glutamate in malignant gliomas.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncogene, 2011, 30(1), 43-53. http://dx.doi.org/10.1038/ onc.2010.391 [47] Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., Sasaki, T., and Ozawa, S. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2002, 8(9), 971-8. http://dx.doi.org/ 10.1038/nm746 [48] Ullrich, O., Diestel, A., Eyupoglu, I.Y., and Nitsch, R. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cell Biol., 2001, 3(12), 1035-42. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurosci., 2005, 25(11), 2952-64. http://dx.doi.org/10.1523/JNEUROSCI.4456-04.2005 [50] Eyupoglu, I.Y., Bechmann, I. and Nitsch, R. Modification of microglia function protects from lesion-induced neuronal",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"FASEB J, 2003, 17(9), 1110-1. http://dx.doi.org/10.1096/fj.02-0825fje [51] Mittelbronn, M., Platten, M., Zeiner, P., Dombrowski, Y., Frank, B., Zachskorn, C., Harter, P.N., Weller, M., and Wischhusen, J. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Acta Neuropathol., 2011, 122(3), 353-65. http://dx.doi.org/10.1007/s00401-011-0858-3 [52] Wolf, I.M., Fan, Z., Rauh, M., Seufert, S., Hore, N., Buchfelder, M., Savaskan, N.E., and Eyupoglu, I.Y.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Rep., 2014, 4, 6226. http://dx.doi.org/10.1038/srep06226 [53] Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., Masuko, T., Shimizu, T., Ishikawa, T., Kai, K., Takahashi, E., Imamura, Y., Baba, Y., Ohmura, M., Suematsu, M., Baba, H .",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Cell., 2011, 19(3), 387-400. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncogene, 2013. http://dx.doi.org/10.1038/onc.2012.638 [55] Siebzehnrubl, F.A., Buslei, R. Eyupoglu, I.Y., Seufert, S., Hahnen, E., and Blumcke, I. Histone deacetylase inhibitors i n c r e a s e  neuronal differentiation in adult forebrain precursor cells.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Brain Res., 2007, 176(4), 672-8. http://dx.doi.org/10.1007/s00221-006-0831-x [56] Takahashi, K. and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cell, 2006, 126(4), 663-76. http://dx.doi.org/10.1016/j.cell.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Science, 2013, 341, 651-4. http://dx.doi.org/10.1126/ science.1239278 [58] Suva, M.L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J.C., Baumer, K., Le Bitoux, M.A., Marino, D., Cironi, L., Marquez, V.E., Clement, V., and Stamenkovic, I. EZH2 is essential for glioblastoma cancer stem cell maintenance.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cancer Res., 2009, 69(24), 9211-8. http://dx.doi.org/10.1158/0008-5472.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Genet., 1999, 21(1), 103-7. http://dx.doi.org/10.1038/5047 [60] Hegi, M.E., Diserens, C., Gorlia, T., Hamou, M.F., de Tribolet, N., Weller, M., Kros, J.M., Hainfellner, J.A., Mason, W., Mariani, L., Bromberg, J.E., Hau, P., Mirimanoff, R.O., Cairncross, J.G., Janzer, R.C., and Stupp, R. MGMT gene silencing and benefit from temozolomide in glioblastoma.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2005, 352(10), 997-1003. http://dx.doi.org/10.1056/NEJMoa043331 [61] Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., and Mirimanoff, R.O.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Med., 2005, 352(10), 987-96. http://dx.doi.org/10.1056/NEJMoa043330 [62] Quillien, V., Lavenu, A., Karayan-Tapon, A., Carpentier, L., Labussiere, C., Lesimple, M., Chinot, O., Wager, M., Honnorat, J., Saikali, S., Fina F., Sanson, M., and Figarella-Branger, D. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze  O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Lancet Oncol., 2012, 13(7), 707-15. http://dx.doi.org/10.1016/S1470-2045(12)70164-X [64] Takeuchi, S., Platten, M., Meisner, C., Felsberg, J., Tabatabai, G., Simon, M., Nikkhah, G., Papsdorf, K., Steinbach, J.P., Sabel, M., Combs, S.E., Vesper, J., Braun, C., Meixensberger, J., Ketter, R., Mayer-Steinacker, R., Reifenberger, G., and Weller, M. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas.",OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Neurosurgery, 2013, 72(1), 33-41, discussion 41. http://dx.doi.org/10.1227/NEU.0b013e318276b2de [65] Branham, M.T., Marzese, D.M., Laurito, F.E., Gago, S.R., Orozco, J.I., Tello, O.M., Vargas-Roig, L.M., and M. Roque, Methylation profile of triple-negative breast carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"http://dx.doi.org/10.1038/oncsis.2012.17 [66] Ciceroni, C., Bonelli, E., Mastrantoni, C., Niccolini, M., Laurenza, Larocca, L.M., Pallini, R., Traficante, A., Spinsanti, P., Ricci-Vitiani, L., Arcella, A., De Maria, R., Nicoletti, F., Battaglia, G., Melchiorri, D. Type-3 metabotropic glutamate receptors regulate chemo resistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Cell  Death Differ., 2013, 20(3), 396-407. http://dx.doi.org/10.1038/cdd.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/CN-14-48.PMC4787285.pdf
"Oncogene, 2001, 20, 3094-9. http://dx.doi.org/10.1038/sj.onc.1204334 [2] Dillon, N. Gene regulation and large-scale chromatin organization in the nucleus.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Chromosome Res., 2006, 14(1), 117-26. http://dx.doi.org/10.1007/s10577-006-1027-8 [3] Saha, A.; Wittmeyer, J.; Cairns, B.R.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Biol., 2006, 7, 437-47. http://dx.doi.org/10.1038/nrm1945 [4] Luger, K.; Mader, A.W.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Nature, 1997, 389, 251-60. http://dx.doi.org/ 10.1038/38444 [5] Kouzarides, T. Chromatin modifications and their function.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell, 2007, 128, 693-705. http://dx.doi.org/10.1016/j.cell.2007.02.005 [6] Althaus, F.R.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Nature, 1997, 389, 349-52. http://dx.doi.org/10.1038/ 38664 [8] Nowak, S.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Trends Genet., 2004, 20(4), 214-20. http://dx.doi.org/10.1016/j.tig.2004.02.007 [9] Weake, V.M.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell, 2008, 29, 653-63. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Gene Dev., 2001, 15, 2343-60. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Science, 2001, 293, 1074-80. http://dx.doi.org/10.1126/science.1063127",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"http://dx.doi.org/ 10.1038/47412 [13] Kuo, M.H.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"BioEssays, 1998, 20, 6 1 5-26. http://dx.doi.org/10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H [14] Butler, K.V.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Des., 2008, 14, 505-28. http://dx.doi.org/10.2174/138161208783885353 [15] Illi, B.; Russo, D.C.; Colussi, C.; Rosati, J.; Pallaoro, M.; Spallotta, F.; Rotili, D.; Valente, S.; Ragone, G.; Martelli, F.; Biglioli, P.; Steinkuhler, C.; Gallinari, P.; Mai, A.; Capogrossi, M.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2008, 102(1), 51-8. http://dx.doi.org/10.1161/CIRCRESAHA.107.157305 [16] de Ruijter, A.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"J., 2003, 370, 7 3 7-49. http://dx.doi.org/10.1042/bj20021321 [17] Munshi, A.; Kurland, J.F.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cancer Res., 2005, 11(13), 4912-22. http://dx.doi.org/10.1158/1078-0432.CCR-04-2088 [18] Ren, M.; Leng, Y.; Jeong, M.; Leeds, P.R.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurochem., 2004, 8 9(6), 1358-67. http://dx.doi.org/10.1111/j.1471-4159.2004.02406.x [19] Qi, X.; Hosoi, T.; Okuma, Y.; Kaneko, M.; Nomura, Y.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Pharmacol., 2004, 66(4), 899-908. http://dx.doi.org/10.1124/ mol.104.001339 [20] Wu, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Anesthesiology, 2015, 122(6), 1327-1337. http://dx.doi.org/ 10.1097/ALN.0000000000000618 [21] Zhao, T.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2007, 76(3), 473-481. http://dx.doi.org/10.1016/ j.cardiores.2007.08.010 [22] Granger, A.; Abdullah, I.; Huebner, F.; Stout, A.; Wang, T.; Huebner, T.; Epstein, J.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"FASEB J., 2008, 22, 3549-3560. http://dx.doi.org/10.1096/fj.08-108548 [23] Wang, D.; Fang, C.; Zong, N.C.; Liem, D.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Proteom., 2013, 12(12), 3793-802. http://dx.doi.org/10.1074/mcp.M113.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Circulation, 2014, 129, 1 1 3 9-1151. http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002416 [25] Ma, X.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2015, 125(2), 140-6. http://dx.doi.org/10.3109/00207454.2014.912217 [26] Palii, C.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Stem Cell, 2014, 14(5), 644-657. http://dx.doi.org/10.1016/j.stem.2014.03.003 [27] Sun, J.; Wu, Q.; Sun, H.; Qiao, Y. Inhibition of Histone Deacetylase by Butyrate Protects Rat L i v e r  f r o m  I s c h e m i c  Reperfusion Injury.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Sci., 2014, 15(11), 21069-21079. http://dx.doi.org/10.3390/ijms151121069 [28] Kim, H.J.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cardiol., 2014, 7 2, 138-45. http://dx.doi.org/10.1016/j.yjmcc.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2015, 1 9 7(1), 191-200. http://dx.doi.org/10.1016/j.jss.2015.03.010 [31] Faraco, G.; Pancani, T.; Formentini, L.; Mascagni, P.; Fossati, G.; Leoni, F.; Moroni, F.; Chiarugi, A. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Pharmacol., 2006, 70(6), 1876-84. http://dx.doi.org/10.1124/mol.106.027912 [32] Yildirim, F.; Gertz, K.; Kronenberg, G.; Harms, C.; Fink, K.B.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurol., 2008, 210, 531-42. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurochem., 2014, 129(3), 509-15. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Drug Saf., 2014, 23(7), 759-767. http://dx.doi.org/10.1002/pds.3651 [35] Nural-Guvener, H.; Zakharova, L.; Feehery, L.; Sljukic, S.; Gaballa, M. Anti-fibrotic effects of class I HDAC inhibitor, mocetinostat is associated with IL-6/stat3 signaling in ischemic heart failure.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Sci., 2015, 16(5), 11482-1499. http://dx.doi.org/10.3390/ijms160511482 [36] Formisano, L.; Guida, N.; Valsecchi, V.; Cantile, M.; Cuomo, O.; Vinciguerra, A.; Laudati, G.; Pignataro, G.; Sirabella, R.; Di Renzo, G.; Annunziato, L. Sp3/ REST/ HDAC1/ HDAC2 Complex Represses and Sp1/ HIF-1/ p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2015, 35(19), 7332-7348. http://dx.doi.org/10.1523/JNEUROSCI.2174-14.2015 [37] Hasan, M.R.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2013, 38(9), 1921-34. http://dx.doi.org/10.1007/s11064-013-1098-9 [38] Broide, R.S.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2007, 31, 47-58. http://dx.doi.org/10.1007/ BF02686117 [39] Guan, J.; Haggarty, S.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"HDAC2 negatively regulates memory formation and synaptic plasticity, Nature, 2009, 459(7243), 55-60. http://dx.doi.org/10.1038/ nature07925 [40] MacDonald, J.L.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Dynam., 2008, 237, 2256-67. http://dx.doi.org/10.1002/dvdy.21626 [41] Montgomery, R.L.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"U.S.A., 2009, 106(19), 7876-81. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Learn Mem., 2006, 13, 241-4. http://dx.doi.org/10.1101/lm.278206",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuron, 2004, 42, 9 6 1-72. http://dx.doi.org/ 10.1016/j.neuron.2004.06.002 [44] Stefanko, D.P.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Learn Memory, 2011, 18, 7 1-9. http://dx.doi.org/10.1101/lm.1986911 [46] Fass, D.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuropharmacology, 2013, 64, 8 1-96. http://dx.doi.org/10.1016/j.neuropharm.2012.06.043 [47] Lopez-Atalaya, J.P.; Ito, S.; Valor, L.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Nuclei Acids Res., 2 0 1 3, 41(17), 8072-8074. http://dx.doi.org/10.1093/nar/gkt590 [48] Dompierre, J.P.; Godin, J.D.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2007, 27, 3571-83. http://dx.doi.org/10.1523/JNEUROSCI.0037-07.2007 [49] Haggarty, S.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"U.S.A., 2003, 100, 4389-94. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2015, 35(38), 13124-13132. http://dx.doi.org/10.1523/JNEUROSCI.0914-15.2015 [52] Roozendaal, B.; Hernandez, A.; Cabrera, S.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2010, 30(14), 5037-46. http://dx.doi.org/10.1523/JNEUROSCI.5717-09.2010 [53] Covington, H.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2009, 29, 11451-60. http://dx.doi.org/10.1523/JNEUROSCI.1758-09.2009 [54] Sung, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurol., 2013, 239, 192-201. http://dx.doi.org/10.1016/j.expneurol.2012.10.005 [55] Kilgore, M.; Miller, C.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuropsychopharmacology, 2010, 35(4), 870-880. http://dx.doi.org/10.1038/npp.2009.197 [56] Dagnas, M.; Micheau, J.; Decorte, L.; Beracochea, D.; Mons, N. Post-training, intra- h i p p o c a m pal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Hippocampus, 2015, 25(7), 827-37. http://dx.doi.org/ 10.1002/hipo.22406 [57] Graff, J.; Joseph, N.F.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell, 2014, 156, 261-76. http://dx.doi.org/10.1016/j.cell.2013.12.020 [58] Toropova, K.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Eurosci., 2015, 35(33), 11729-42. http://dx.doi.org/10.1523/jneurosci.4339-14.2015 [60] Steckert, A.V.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Lett., 2015, 595, 1 3 4-8. http://dx.doi.org/10.1016/j.neulet.2015.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Res., 2015, 334 (1), 136-145. http://dx.doi.org/10.1016/j.yexcr.2015.04.004 [62] Wagner, F.F.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Sci., 2015, 6(1), 804-15. http://dx.doi.org/10.1039/C4SC02130D [63] Rumbaugh, G.; Sillivan, S.E.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuropsychopharmacology, 2015, 40(10), 2307-16. http://dx.doi.org/10.1038/npp.2015.93 [64] Bowers, M.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Mem., 2015, 22, 225-231. http://dx.doi.org/ 10.1101/lm.036699.114 [65] Barichello, T.; Generoso, J.S.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurobiol., 2015, 52(1), 734-40. http://dx.doi.org/10.1007/s12035-014-8914-3 [66] Yoo, D.Y.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2014, 37(1), 69-76. http://dx.doi.org/10.1179/1743132814Y.0000000416 [67] Castellano, J.F.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Ther., 2014, 6(1), 12. http://dx.doi.org/ 10.1186/alzrt241 [69] Morris, M.J.; Mahgoub, M.; Na, E.S.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2013, 3 3(15), 6401-6411. http://dx.doi.org/10.1523/JNEUROSCI.1001-12.2013 [70] Bouton, M.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2007, 121(5), 1140-3. http://dx.doi.org/10.1037/0735-7044.121.5.1140 [73] Wang, Y.; Lai, J.; Cui, H.; Zhu, Y.; Zhao, B.; Wang, W.; Wei, S. Inhibition of Histone Deacetylase in the Basolateral Amygdala Facilitates Morphine Context-Associated Memory Formation in Rats.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2014, 55(1), 269-78. http://dx.doi.org/ 10.1007/s12031-014-0317-4 [74] Blank, M.; Dornelles, A.S.; Werenicz, A.; Velho, L.A.; Pinto, D.F.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Mem., 2014, 111, 1-8. http://dx.doi.org/10.1016/j.nlm.2014.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Mem., 2013, 102, 34-42. http://dx.doi.org/10.1016/j.nlm.2013.03.007 [76] Zhong, T.; Qing, Q.J.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Anaesth., 2014, 113(4), 634-43. http://dx.doi.org/10.1093/bja/aeu184 [77] Malvaez, M.; McQuown, S.C.; Rogge, G.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuropharmacology, 2013, 64, 414-23. http://dx.doi.org/10.1016/ j.neuropharm.2012.06.001 [79] Fujita, Y.; Morinobu, S.; Takei, S.; Fuchikami, M.; Matsumoto, T.; Yamamoto, S.; Yamawaki, S. Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2012, 4 6(5), 635-43. http://dx.doi.org/10.1016/j.jpsychires.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Chem., 2013, 56(17), 6775-91. http://dx.doi.org/10.1021/jm400564j [81] Ferrante, R.J.; Kubilus, J.K.; Lee, J.; Ryu, H.; Beesen, A.; Zucker, B.; Smith, K.; Kowall, N.W.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Chem., 2005, 2 8 0(1), 556-63. http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2004, 20, 896-902. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Dis., 2006, 22(1), 40-9. http://dx.doi.org/10.1016/j.nbd.2005.09.013 [87] Ryu, H.; Lee, J.; Olofsson, B.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Pharmacol., 2015, 79(3), 465-76. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurology, 2007, 68(1), 51-5. http://dx.doi.org/10.1212/ 01.wnl.0000249142.82285.d6 [90] Hogarth, P.; Lovrecic, L.; Krainc, D. Sodium phenylbutyrate in Huntington’s disease: a dose-finding study.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Disord., 2007, 22(13), 1962-4. http://dx.doi.org/10.1002/mds.21632 [91] Cudkowicz, M.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Lateral Scler., 2009, 10(2), 99-106. http://dx.doi.org/10.1080/ 17482960802320487 [92] Steffan, J.S.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Nature, 2001, 413(6857), 739-43. http://dx.doi.org/10.1038/35099568 [93] Saft, C.; Lauter, T.; Kraus, P.H.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"BMC Neurol., 2006, 6, 11. http://dx.doi.org/10.1186/1471-2377-6-11 [94] Ferrante, R.J.; Kubilus, J.K.; Lee, J.; Ryu, H.; Beesen, A.; Zucker, B.; Smith, K.; Kowall, N.W.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"http://dx.doi.org/ 10.1371/journal.pbio.1001717 [96] Jia, H.; Morris, C.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Chem., 2005, 280(1), 556-63. http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Gen., 2014, 2 3(11), 2995-3007. http://dx.doi.org/10.1093/hmg/ddu010 [99] Sugai, F.; Yamamoto, Y.; Miyaguchi, K.; Zhou, Z.; Sumi, H.; Hamasaki, T.; Goto, M.; Sakoda, S. Benefit of valproic acid in suppressing disease progression of ALS model mice.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2004, 20(11), 3179-3183. http://dx.doi.org/10.1111/ j.1460-9568.2004.03765.x [100] Ryu, H.; Smith, K.; Camelo, S.I.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurochem., 2005, 93(5), 1087-1098. http://dx.doi.org/10.1111/j.1471-4159.2005.03077.x [101] Andreassi, C.; Angelozzi, C.; Tiziano, F.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genet., 2004, 12(1), 59-65. http://dx.doi.org/10.1038/sj.ejhg.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurol., 2003, 54(5), 647-54. http://dx.doi.org/10.1002/ana.10743 [103] Riessland, M.; Brichta, L.; Hahnen, E.; Wirth, B.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genet., 2006, 120(1), 101-10. http://dx.doi.org/10.1007/s00439-006-0186-1 [104] Chang, J.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurochem., 2006, 98(1), 193-202. http://dx.doi.org/10.1111/j.1471-4159.2006.03868.x [106] Brahe, C.; Vitali, T.; Tiziano, F.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genet., 2005, 13(2), 256-9. http://dx.doi.org/10.1038/sj.ejhg.5201320 [107] Brichta, L.; Holker, I.; Haug, K.; Klockgether, T.; Wirth, B.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurol., 2006, 59(6), 970-5. http://dx.doi.org/10.1002/ana.20836 [108] Avila, A.M.; Burnett, B.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Invest., 2007, 117(3), 659-671. http://dx.doi.org/ 10.1172/JCI29562 [109] Weihl, C.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurology, 2006, 67(3), 500-1. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Dis., 2009, 36(3), 477-87. http://dx.doi.org/10.1016/j.nbd.2009.08.014 [111] Kwon, D.Y.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genet., 2011, 20(18), 3667-3677. http://dx.doi.org/10.1093/ hmg/ddr288 [112] Riessland, M.; Ackermann, B.; Förster, A.; Jakubik, M.; Hauke, J.; Garbes, L.; Fritzsche, I.; Mende, Y.; Blumcke, I.; Hahnen, E.; Wirth, B. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genet., 2010, 19(8), 1492-506. http://dx.doi.org/10.1093/hmg/ddq023 [113] Wadman, R.I.; Bosboom, W.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Med., 2011, 17, 457-65. http://dx.doi.org/10.2119/molmed.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurochem., 2002, 81, 5 4 1-9. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2 0 0 9, 89(11), 2608-14. http://dx.doi.org/10.1002/ jnr.22072 [121] Shen, S.; Sandoval, J.; Swiss, V.A.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"http://dx.doi.org/10.1038/ nn.2172 [122] Gaub, P.; Tedeschi, A.; Puttagunta, R.; Nguyen, T.; Schmandke, A.; Di Giovanni, S. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Death Differ., 2 0 1 0, 17, 1392-1408. http://dx.doi.org/10.1038/cdd.2009.216 [123] Finelli, M.J.; Wong, J.K.; Zou, H. Epigenetic Regulation o f  Sensory Axon Regeneration after Spinal Cord Injury.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2013, 33(50), 19664-19676. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Genes Dev., 2013, 27(13),1473-83. http://dx.doi.org/10.1101/gad.209619.112 [125] Lv, L.; Han, X.; Sun, Y.; Wang, X.; Dong, Q. Valproic acid improves locomotion in vivo a f t e r  S C I  a n d  a x o n a l  g r o w t h  o f  neurons in vitro.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurol., 2012, 2 3 3(2), 783-90. http://dx.doi.org/10.1016/j.expneurol.2011.11.042 [126] Ng, F.; Tang, B.L.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Res., 2015, 10, 8 7 0-1. http://dx.doi.org/10.4103/ 1673-5374.158333 [127] Hashioka, S.; Klegeris, A.; McGeer, P.L.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neuroinflam., 2012, 9, 113. http://dx.doi.org/10.1186/1742-2094-9-113 [128] Fukui, T.; Asakura, K.; Hikichi, C.; Ishikawa, T.; Murai, R.; Hirota, S.; Murate, K.; Kizawa, M.; Ueda, A.; Ito, S.; Mutoh, T. Histone deacetylase inhibitor attenuates neurotoxicity of clioquinol",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"T o x i c o l o g y, 2015, 331, 112-8. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"FEBS J., 2013, 280(24), 6691-701. http://dx.doi.org/10.1111/febs.12572 [131] Formisano, L.; Guida, N.; Laudati, G.; Mascolo, L.; Di Renzo, G.; Canzoniero, L.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Ther., 2 0 1 5, 352(2), 236-43. http://dx.doi.org/10.1124/ jpet.114.219345 [132] Kim, J.Y.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2010, 13(2),180-9. http://dx.doi.org/10.1038/nn.2471 [133] Sun, Q.; Yao, Y.; Liu, C.; Li H, Yao H, Xue X, Liu J, Tu Z, Jiang S. Design, synthesis, and biological evaluation of novel histone deacetylase 1 inhibitors through click chemistry.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Lett., 2013, 23(11), 3 29 5-9. http://dx.doi.org/10.1016/j.bmcl.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Rev., 2 0 0 8, 3 7, 1402-13. http://dx.doi.org/10.1039/b703830p [135] Kalyaanamoorthy, S.; Chen, Y.P.P.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Dyn., 2015, 3 3(2), 374-87. http://dx.doi.org/10.1080/07391102.2013.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2006, 9(4), 519-525. http://dx.doi.org/10.1038/nn1659 [138] Fujiki, R.; Sato, A.; Fujitani, M.; Yamashita, T. A proapoptotic effect of VPA on progenitors of embryonic stem cell-derived glutamatergic neurons.",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"http://dx.doi.org/10.1038/cddis.2013.205 [139] Bardai, F.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Chem., 2012, 287(42), 35444-53. http://dx.doi.org/10.1074/jbc.M112.394544 [140] Bardai, F.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Neurosci., 2 0 1 1, 31(5), 1746-51. http://dx.doi.org/10.1523/JNEUROSCI.5704-10.2011 [141] Pfister, J,A.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"http://dx.doi.org/10.1371/journal.pone.0004090 [142] Shah, M.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cancer Res., 2006, 12(13), 3997-4003. http://dx.doi.org/10.1158/1078-0432.CCR-05-2689 [143] Molife, R.; Fong, P.; Scurr, M.; Judson, I.; Kaye, S.; de Bono, J. HDAC inhibitors and cardiac safety.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cancer Res., 2007, 13(3), 1068-9. http://dx.doi.org/10.1158/1078-0432.CCR-06-1715 [144] Bastian, L.; Hof, J.; Pfau, M.; Fichtner, I.; Eckert, C.; Henze, G.; Prada, J.; von Stackelberg, A.; Seeger, K.; Shalapour, S. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-kappaB.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cancer Res., 2013, 19, 1445-57. http://dx.doi.org/10.1158/1078-0432.CCR-12-1511 [145] Dowdy, S.C.; Jiang, S.; Zhou, X.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cancer Ther., 2006, 5, 2767-76. http://dx.doi.org/10.1158/1535-7163.MCT-06-0209 [146] Eriksson, I.; Joosten, M.; Roberg, K.; Ollinger, K. The histone deacetylase inhibitor Trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Cell Res., 2013, 319(1), 12-20. http://dx.doi.org/10.1016/j.yexcr.2012.10.004   Received: March 26, 2015 Revised: August 23, 2015 Accepted: October 08, 2015",OADS,/arxiv_data1/oa_pdf/5a/57/CN-14-55.PMC4787286.pdf
"Protoc., 2006, 1(4), 2128-2136. http://dx.doi.org/10.1038/ nprot.2006.316 [2] Tessier-Lavigne, M.; Goodman, C.S.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Science, 1996, 274(5290), 1123-1133. http://dx.doi.org/10.1126/science.274.5290.1123 [3] Nedelec, S. Concentration-dependent requirement for local protein synthesis in motor neuron subtype-specific response to axon guidance cues.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2012, 32(4), 1496-1506. http://dx.doi.org/10.1523/JNEUROSCI.4176-11.2012 [4] Nishikimi, M.; Oishi, K.; Nakajima, K. Axon guidance mechanisms for establishment of callosal connections.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Plast., 2013, 2013, 149060. http://dx.doi.org/10.1155/2013/149060 [5] Deck, M. Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2013, 77(3),472-484. http://dx.doi.org/10.1016/j.neuron.2012.11.031 [6] Paola V.; Plazas, X.N.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2013, 16(2), 166-173. http://dx.doi.org/10.1038/nn.3290 [8] Wright, K.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2012, 7 6 ( 5 ), 931-944. http://dx.doi.org/10.1016/j.neuron.2012.10.009 [9] Duman-Scheel, M. Deleted in Colorectal Cancer (DCC) pathfinding: axon guidance gene finally turned tumor suppressor.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Drug Targets, 2012, 13(11), 1445-53. http://dx.doi.org/10.2174/ 138945012803530215 [10] Huettl, R.E.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"http://dx.doi.org/10.1371/journal.pone.0041095 [11] McAllister, A.K.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2007, 30, 425-450. http://dx.doi.org/10.1146/ annurev.neuro.29.051605.112830 [12] Ko, J. LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2010, 3 0 ( 2 2 ), 7495-7506. http://dx.doi.org/10.1523/ JNEUROSCI.0470-10.2010 [14] Bennett, S.A.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Fro nt Physiol., 2013, 4, 168. http://dx.doi.org/10.3389/fphys.2013.00168 [15] Carasatorre, M.; Ramirez-Amaya, V.; Diaz, C.S.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2000, 23, 649-711.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Res., 2013, 91 (11),1402-7. http://dx.doi.org/10.1002/jnr.23269 [18] Udupa, K., Chen, R. Motor Cortical Plasticity in Parkinson's Disease.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurol., 2013, 4, 128. http://dx.doi.org/10.3389/ fneur.2013.00128 [19] Barth, A.L.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2013, 79(5), 8 2 9-831. http://dx.doi.org/10.1016/j.neuron.2013.08.021 [20] Boulland, J.L.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Physiol., 2013, 4, 69. http://dx.doi.org/10.3389/ fphys.2013.00069 [22] Lignani, G. Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2013, 6, 22. http://dx.doi.org/10.3389/fnmol.2013.00022 [23] Judas, M.; Sedmak, G.; Kostovic, I.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2013, 7, 423. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biol., 2012, 367(2), 140-53. http://dx.doi.org/10.1016/j.ydbio.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2013, 16 (10), 1383-91. http://dx.doi.org/10.1038/nn.3514 [27] Ouyang, Q. Christianson Syndrome Protein NHE6 Modulates TrkB Endosomal Signaling Required for Neuronal Circuit Development.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2013, 80 (1), 97-112. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neural Develop., 2013, 8, 17. http://dx.doi.org/10.1186/1749-8104-8-17 [30] Meziane, H. The homeodomain factor Gbx1 is required for locomotion and cell specification in the dorsal spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"http://dx.doi.org/10.7717/peerj.142 [31] Chang, P.K.Y.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2012, 35(12), 1908-1916. http://dx.doi.org/10.1111/j.1460-9568.2012.08165.x [32] Letso, R.R.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biol., 2013, 8(5), 914-922. http://dx.doi.org/10.1021/cb300374h [33] Sun, Y. Zebrafish chemical screening reveals the impairment o f  dopaminergic neuronal survival by cardiac glycosides.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"http://dx.doi.org/10.1371/journal.pone.0035645 [34] Joost, S., K.J.S.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2004, 4(2), 91-97. http://dx.doi.org/10.1039/b311214d [36] Banker, G.A.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurol., 1979, 187(3),  469-493. http://dx.doi.org/10.1002/cne.901870302 [37] Brewer, G. Optimized survival of hippocampal neurons in B27-­‐supplemented neurobasal™, a new serum-­‐free medium",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Res., 1993, 35(5), 567-576. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2008, 31, 151-173. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurol., 2010, 67(6), 715-725. http://dx.doi.org/10.1002/ana.21995 [41] Gross, P.G.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Sci., 2007, 252(2), 135-143. http://dx.doi.org/10.1016/j.jns.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2009, 9(5), 644-652. http://dx.doi.org/10.1039/B813495B [43] Taylor, A.; Jeon, N.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2013, 13(4), 509-521. http://dx.doi.org/10.1039/c2lc41081h [45] Park, J.W.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Protoc., 2006, 1(4), 2128-2136. http://dx.doi.org/10.1038/ nprot.2006.316 [46] Campenot, R.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurobiol., 2004, 58(2), 217-229. http://dx.doi.org/10.1002/neu.10322 [48] Campenot, R.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Cell Biol., 1996, 135, 701-9. http://dx.doi.org/10.1083/ jcb.135.3.701 [49] MacInnis, B.L.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Science, 2002, 295(5559), 1536-1539. http://dx.doi.org/10.1126/ science.1064913 [50] Eng, H.; Lund, K.; Campenot, R.B.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Dis., 2001, 8(1), 1 1-8. http://dx.doi.org/ 10.1006/nbdi.1998.0228 [52] Campenot, R.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Nature, 2005, 436(7053), 1020-1024. http://dx.doi.org/ 10.1038/nature03885 [56] Poon, M.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2006, 26(51), 13390-13399. http://dx.doi.org/10.1523/JNEUROSCI.3432-06.2006 [57] Willis, D.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"2011, Springer, 335-352. http://dx.doi.org/10.1007/978-1-61779-005-8_21 [58] Willis, D.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Cell Biol., 2007, 178(6), 965-980. http://dx.doi.org/10.1083/jcb.200703209 [59] Willis, D. Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs i n  a x o n s.  J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2005, 25(4), 778-791. http://dx.doi.org/10.1523/ JNEUROSCI.4235-04.2005 [60] Clark, P.; Britland, S.; Connolly, P. Growth cone guidance and neuron morphology on micropatterned laminin surfaces.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biomaterials, 2001, 22(10), 1049-1054. http://dx.doi.org/10.1016/S0142-9612(00)00352-5 [62] Von Philipsborn, A.C. Microcontact printing of axon guidance molecules for generation of graded patterns.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"protoc., 2006, 1(3), 1322-1328. http://dx.doi.org/10.1038/nprot.2006.251 [63] Shi, P.; Shen, K.; Kam, L.C.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurobiol., 2007, 67(13), 1765-1776. http://dx.doi.org/10.1002/dneu.20553 [64] Shi, P. Combined microfluidics/protein patterning platform for pharmacological interrogation of axon pathfinding.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2010, 10(8), 1005-1010. http://dx.doi.org/10.1039/b922143c [65] Fricke, R. Axon guidance of rat cortical neurons by microcontact printed gradients.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biomaterials, 2011, 32(8), 2070-2076. http://dx.doi.org/10.1016/j.biomaterials.2010.11.036 [66] Gomez, N. Immobilized nerve growth factor and microtopography have distinct effects on polarization versus axon elongation in hippocampal cells in culture.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biomaterials, 2007, 28(2), 271-284. http://dx.doi.org/10.1016/j.biomaterials.2006.07.043 [67] Mai, J. Axon initiation and growth cone turning on bound protein gradients.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2009, 29(23), 7450-7458. http://dx.doi.org/ 10.1523/JNEUROSCI.1121-09.2009 [68] Shelly, M. Semaphorin3A regulates neuronal polarization by suppressing axon formation and promoting dendrite growth.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2011, 71(3), 433-446. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2012, 12(12), 2265-2276. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biomaterials, 2002, 23(3), 893-900. http://dx.doi.org/10.1016/ S0142-9612(01)00199-5 [71] Vogt, A.K.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biotechnology progress, 2003, 19(5), 1562-1568. http://dx.doi.org/10.1021/bp034016f [72] Feinerman, O.; Rotem, A.; Moses, E. Reliable neuronal logic devices from patterned hippocampal cultures.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Phys., 2008, 4(12), 967-973. http://dx.doi.org/10.1038/nphys1099 [73] Frimat, J.P.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2010, 10(6), 701-709. http://dx.doi.org/10.1039/ b922193j [74] Hardelauf, H. High fidelity neuronal networks formed by plasma masking with a bilayer membrane: analysis of neurodegenerative and neuroprotective processes.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2011, 11(16), 2763-2771. http://dx.doi.org/10.1039/c1lc20257j [75] Ma, W. Central neuronal synapse formation on micropatterned surfaces.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Brain Res., 1998, 111(2), 231-243. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Commun., 2013, 4, 2252. http://dx.doi.org/10.1038/ncomms3252 [77] Whitesides, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Nature, 2006, 442(7101), 368-373. http://dx.doi.org/10.1038/ nature05058 [78] Taylor, A.M.; Jeon, N.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurobiol., 2010, 20(5), 640-647. http://dx.doi.org/10.1016/j.conb.2010.07.011 [79] Park, J.K.; Yeon, J.H.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biomicrofluidics, 2009, 3(3), 34106. http://dx.doi.org/10.1063/1.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2010, 10(14), 1758-73. http://dx.doi.org/10.1039/ b924109d [82] Atencia, J.; Beebe, D.J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Nature, 2005, 437(7059), 648-655. http://dx.doi.org/10.1038/nature04163 [83] Guo, M.T.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2012, 12(12), 2146-55. http://dx.doi.org/10.1039/c2lc21147e",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Eng., 2001, 3, 335-373. http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chem., 2006, 78, 3084-9. http://dx.doi.org/10.1021/ ac0519460 [86] Jang, K. Development of a Microfluidic Platform for Single-cell Secretion.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Sci., 2011, 2 7, 973-8. http://dx.doi.org/10.2116/ analsci.27.973 [87] van den Brink, F.T.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Electrophoresis, 2011, 32(22), 3094-100. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Soc., 2008, 130(43), 14324-14328. http://dx.doi.org/10.1021/ja805361j [89] Hansen, C.L.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"U. S. A., 2002, 99(26), 16531-16536. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biotechnol., 2011, 22(5), 681-689. http://dx.doi.org/10.1016/j.copbio.2011.05.512 [91] Webster, A.; Greenman, J.; Haswell, S.J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Trends neurosci., 2012, 35, 752-61. http://dx.doi.org/10.1016/j.tins.2012.09.001 [93] El-Ali, J.; Sorger, P.K.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Nanotechnol., 2009, 9(12), 7330-7335. http://dx.doi.org/10.1166/jnn.2009.1769 [95] Regehr, K.J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2009, 9(15), 2132-2139. http://dx.doi.org/10.1039/b903043c [96] Toepke, M.W.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2006, 6(12), 1484-1486. http://dx.doi.org/10.1039/b612140c [97] Heo, Y.S.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Science, 2000, 288(5463), 1 1 3-116. http://dx.doi.org/10.1126/science.288.5463.113 [99] McDonald, J.C.; Duffy, C.D.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Electrophoresis, 2000, 21, 27-40. http://dx.doi.org/10.1002/(SICI) 1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C [100] Taylor, A.M. Microfluidic multicompartment device for neuroscience research.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Langmuir, 2003, 19(5), 1551-1556. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2010, 10(12), 1525-1535. http://dx.doi.org/10.1039/c001552k [102] Taylor, A.M. Microfluidic local perfusion chambers for the visualization and manipulation of synapses.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2010, 66(1), 57-68. http://dx.doi.org/10.1016/j.neuron.2010.03.022 [103] Dworak, B.J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2009, 9(3), 404-410. http://dx.doi.org/10.1039/B806689B [104] Pan, L. Propagation of action potential activity in a predefined microtunnel neural network.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"J. Neural Eng., 2011, 8(4), 046031. http://dx.doi.org/10.1088/1741-2560/8/4/046031 [105] Park, J. Multi-compartment neuron–glia co-culture platform f o r  localized CNS axon–glia interaction study.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2012, 12(18), 3296-3304. http://dx.doi.org/10.1039/c2lc40303j [106] Hosmane, S. Circular compartmentalized microfluidic platform: study of axon–glia interactions.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2010, 10(6), 741-747. http://dx.doi.org/10.1039/b918640a [107] Park, J.W.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"J., 2009, 4(11), 1573-1577. http://dx.doi.org/10.1002/ biot.200900159 [108] Dinh, N.-D. Microfluidic construction of minimalistic neuronal co-cultures.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2013, 13 (7), 1 4 0 2-12. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2010, 10(12), 1509-1517. http://dx.doi.org/10.1039/b927258e [111] Zhan, M.; Chingozha, L.; Lu, H. Enabling Systems Biology Approaches Through Microfabricated Systems.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chem., 2013, 85(19), 8882-8894. http://dx.doi.org/10.1021/ac401472y [112] Dickson, B.J.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Science, 2002, 298(5600), 1959-1964. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurosci., 2005, 6(8), 615-625. http://dx.doi.org/10.1038/nrn1727 [114] Hur, E.M. Engineering n e u r o n a l  g r o w t h  c o n e s  t o  p r o m o t e  a x o n  regeneration over inhibitory molecules.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Science, 2002, 297(5580), 353-356. http://dx.doi.org/10.1126/science.1072994 [117] Ittner, L.M.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neuron, 2003, 39(6), 889-909. http://dx.doi.org/10.1016/ S0896-6273(03)00568-3 [119] Taylor, A.M. A microfluidic culture platform for CNS axonal injury, regeneration and transport.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Methods, 2005, 2(8), 599-605. http://dx.doi.org/10.1038/nmeth777 [120] Zhang, K. Single-molecule imaging of NGF axonal transport in microfluidic devices.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab chip, 2010, 10(19), 2566-2573. http://dx.doi.org/10.1039/c003385e [121] Cohen, M.S.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Sci., 2011, 108(27), 11246-11251. http://dx.doi.org/ 10.1073/pnas.1012401108 [122] Xie, W.; Zhang, K.;  Cui, B. Functional characterization and axonal transport of quantum dot labeled BDNF.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Biol., 2012, 4(8), 953-960. http://dx.doi.org/10.1039/c2ib20062g [123] Mudrakola, H.V.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Structure, 2009, 17(11), 1433-1441. http://dx.doi.org/10.1016/j.str.2009.09.008 [124] Kim, H.J.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Aging, 2011, 32(5), 821-833. http://dx.doi.org/10.1016/ j.neurobiolaging.2009.05.012 [126] Stoothoff, W. Differential effect of three-­‐repeat and four-­‐repeat tau on mitochondrial axonal transport.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurochem., 2009, 111(2), 417-427. http://dx.doi.org/10.1111/j.1471-4159.2009.06316.x [127] Mckeon, R.J.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Cell Biol., 1988, 107, 2281-91. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Neurol., 1999, 45, 778-86. http://dx.doi.org/10.1002/1531-8249(199906)45: 6<778::aid-ana12>3.0.co;2-b [130] Kilinc, D. Wallerian-like degeneration of central neurons after synchronized and geometrically registered mass axotomy in a three-compartmental microfluidic chip.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Res., 2011, 19(1), 149-161. http://dx.doi.org/10.1007/s12640-010-9152-8",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chem., 2012, 84(15), 6444-6453. http://dx.doi.org/10.1021/ac3013708 [132] Hosmane, S. Valve-based microfluidic compression platform: single axon injury and regrowth.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2011, 11(22), 3888-3895. http://dx.doi.org/10.1039/c1lc20549h [133] Kim, Y.T.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Chip, 2009, 9(17), 2576-2581. http://dx.doi.org/10.1039/b903720a [134] Vahidi, B. Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Methods, 2008, 170, 188-96. http://dx.doi.org/10.1016/j.jneumeth.",OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"Lab Chip, 2010, 10(9), 1120-1127. http://dx.doi.org/10.1039/b920585c   Received: December 24, 2014 Revised: April 09, 2015 Accepted: May 12, 2015",Non-OADS,/arxiv_data1/oa_pdf/c4/26/CN-14-72.PMC4787287.pdf
"J. Psychiatry, 2003, 160, 636-645. http://dx.doi.org/10.1176/appi.ajp.160.4.636 [5] Uhl, G. R. Molecular genetics of addiction vulnerability.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychol., 1968, 3 2, 420. http://dx.doi.org/10.1037/h0026047 [12] Cloninger, C. The tridimensional personality questionnaire, version IV.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Dis., 1994, 182, 284-289. http://dx.doi.org/10.1097/00005053-199405000-00006 [14] Wills, T.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychol., 1998, 74, 387. http://dx.doi.org/10.1037/0022-3514.74.2.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neurosci., 2005, 8, 1450-1457. http://dx.doi.org/10.1038/nn1583 [20] Flagel, S.B.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 1996, 77, 23-43. http://dx.doi.org/10.1016/0166-4328(95)00203-0 [24] Kandel, D.B.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Public Health, 1984, 7 4, 660-666. http://dx.doi.org/10.2105/AJPH.74.7.660 [25] Spear, L.P.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Rev., 2000, 2 4, 417-463. http://dx.doi.org/10.1016/S0149-7634(00)00014-2 [27] Steinberg, L. Risk taking in adolescence new perspectives from brain and behavioral science.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychol., 2007, 16, 55-59. http://dx.doi.org/10.1111/j.1467-8721.2007.00475.x [28] Crews, F.T.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 2009, 93, 212-221. http://dx.doi.org/10.1016/j.pbb.2009.01.021 [30] Rodríguez-Arias, M.; Aguilar, M.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Polydrug use in adolesc ence;  INTECH Open Access Publisher: 2012. http://dx.doi.org/10.5772/ 47961 [31] Martin, C.A.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychiatry., 2002, 4 1, 1495-1502. http://dx.doi.org/ 10.1097/00004583-200212000-00022 [32] Martin, C.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Rep., 2004, 94, 1075-1082. http://dx.doi.org/10.2466/pr0.94.3.1075-1082 [33] Sargent, J.D.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 2007, 32, 1177-1188. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Drug Alcohol Depend., 1998, 4 9, 115-121. http://dx.doi.org/10.1016/ S0376-8716(97)00154-3 [36] Kandel, D.B.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Alcohol, 1992, 5 3, 447. http://dx.doi.org/10.15288/jsa.1992.53.447 [37] Kuhn, C.; Johnson, M.; Thomae, A.; Luo, B.; Simon, S.A.; Zhou, G.; Walker, Q.D.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychiatry, 1998, 44, 1192-1195. http://dx.doi.org/10.1016/S0006-3223(98)00168-1 [42] Hutchison, K.E.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacol., 1999, 7, 493. http://dx.doi.org/10.1037/1064-1297.7.4.493 [43] Kelly, T.H.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2006, 189, 17-25. http://dx.doi.org/10.1007/ s00213-006-0487-z [44] Nees, F.; Tzschoppe, J.; Patrick, C.J.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Drug Educ., 2006, 3 6, 247-270. http://dx.doi.org/10.2190/Y223-2623-7716-2235 [47] Corr, P.J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"J. Psycho- pharmacol., 2000, 1 4, 371-377. http://dx.doi.org/10.1177/ 026988110001400406 [48] White, T.L.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuro- psychopharmacol., 2006, 31, 1064-1074. http://dx.doi.org/10.1038/ sj.npp.1300939 [49] Ersche, K.D.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Rev., 2007, 31, 673-704. http://dx.doi.org/10.1016/j.neubiorev.2007.01.005 [54] Marquez, C.; Nadal, R.; Armario, A. Responsiveness of the hypothalamic-pituitary adrenal axis to different novel environments is a consistent individual trait in adult male outbred rats.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psycho- neuroendocrinology., 2005, 30, 179-187. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology., 2007, 191, 311-322. http://dx.doi.org/10.1007/s00213-006-0646-2 [56] Piazza, P.V.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Science., 1989, 2 4 5, 1511-1513. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Pharmacol., 2001, 12, 267-275. http://dx.doi.org/10.1097/00008877-200107000-00005 [58] Philpot, R. M.; Wecker, L. Dependence of adolescent novelty-seeking behavior on response phenotype and effects of apparatus scaling.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 2005, 1 6 1, 69-74. http://dx.doi.org/10.1016/j.bbr.2005.01.004 [66] Pawlak, C.R.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2005, 178, 440-450. http://dx.doi.org/10.1007/s00213-004-2024-2 [68] Pawlak, C.R.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Be., 2002, 7 3, 679-687. http://dx.doi.org/10.1016/S0091-3057(02)00852-3 [69] Harro, J.; Oreland, L.; Vasar, E.; Bradwejn, J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuropsychopharm., 1995, 5, 447-455. http://dx.doi.org/10.1016/0924-977X(95)80003-K [70] Larson, E.B.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Be., 2005, 8 2, 590-600. http://dx.doi.org/10.1016/j.pbb.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 1968, 16, 92-96. http://dx.doi.org/10.1016/0003-3472(68)90116-4 [72] Parker, L.A. Place conditioning in a three-or four-choice apparatus: role of stimulus novelty in drug-induced place conditioning.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neurosci., 1992, 1 0 6, 294. http://dx.doi.org/10.1037/0735-7044.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacol., 2005, 13, 367. http://dx.doi.org/10.1037/1064-1297.13.4.367 [75] Vidal-Infer, A.; Arenas, M.C.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Biobehav R., 2002, 2 6, 91-104. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychol., 1959, 1 3, 151. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Rep., 1965, 16, 87-92. http://dx.doi.org/10.2466/pr0.1965.16.1.87 [79] Boissier, J.R.; Simon, P. The exploration reaction in the mouse.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 2006, 167, 175-182. http://dx.doi.org/10.1016/ j.bbr.2005.09.003 [82] Mateos-García, A.; Roger-Sánchez, C.; Rodriguez-Arias, M.; Miñarro, J.; Aguilar, M.; Manzanedo, C.; Arenas, M. Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Pharmacol., 1998, 3 5 0, 21-29. http://dx.doi.org/10.1016/S0014-2999(98)00223-4 [84] Saitoh, A.; Hirose, N.; Yamada, M.; Yamada, M.; Nozaki, C.; Oka, T.; Kamei, J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Genes Brain Behav., 2007, 6, 608-618. http://dx.doi.org/10.1111/j.1601-183X.2006.00289.x [87] Nicholls, B.; Springham, A.; Mellanby, J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Methods, 1992, 4 3, 171-180. http://dx.doi.org/10.1016/ 0165-0270(92)90026-A [88] Klebaur, J.; Bardo, M. Individual differences in novelty seeking on the playground maze predict amphetamine conditioned place preference.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Be., 1999, 6 3, 131-136. http://dx.doi.org/10.1016/S0091-3057(98)00258-5 [89] Frick, K.M.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neurosci., 2003, 117, 1283. http://dx.doi.org/10.1037/0735-7044.117.6.1283 [90] Ennaceur, A.; Aggleton, J.P.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 1997, 88, 181-193. http://dx.doi.org/10.1016/S0166-4328(97)02297-3 [91] Bevins, R.A.; Bardo, M.T.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 1999, 9 9, 53-60. http://dx.doi.org/10.1016/ S0166-4328(98)00069-2 [92] Douglas, L.A.; Varlinskaya, E.I.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"R., 2003, 27(1), 19-31. http://dx.doi.org/10.1016/S0149-7634(03)00006-X [95] Kellogg, C.K.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuroscience, 1998, 83, 681-689. http://dx.doi.org/10.1016/ S0306-4522(97)00408-9 [96] Adriani, W.; Macrì, S.; Pacifici, R.; Laviola, G. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuropsychopharmacology, 2002, 27:212-224. http://dx.doi.org/10.1016/S0893-133X(02)00295-6 [97] Macrì, S.; Adriani, W.; Chiarotti, F.; Laviola, G. Risk-taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Animal Behav., 2002, 64, 541-546. http://dx.doi.org/10.1006/anbe.2002.4004 [98] Calkins, S.D.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 2001, 68, 115-124. http://dx.doi.org/10.1016/S0091-3057(00) 00430-5 [101] Walker, Q.D.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Pharmacol., 2006, 550, 95-106. http://dx.doi.org/10.1016/j.ejphar.2006.08.034 [103] Frantz, K.J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuropsychopharmacology, 2007, 32, 625-637.http://dx.doi.org/ 10.1038/sj.npp.1301130",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"J. Psychiatry, 2003, 160(6), 1041-1052.http://dx.doi.org/10.1176/appi.ajp.160.6.1041 [106] Fareri, D.S.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Oxford University Press, New York, 2007, 9-30.http://dx.doi.org/10.1093/acprof:oso/ 9780195306255.003.0001 [109] Doremus, T.L.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Sci., 2004, 1021, 395-398.http://dx.doi.org/10.1196/annals.1308.051 [112] Wilmouth, C.E.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Teratol., 2007, 29, 37-46.http://dx.doi.org/10.1016/j.ntt.2006.09.002 [118] Balda, M.A.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuro- pharmacology., 2006, 51, 341-349.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 2000, 68, 487-493. http://dx.doi.org/10.1016/S0031-9384(99)00225-5 [120] Schramm-Sapyta, N.L.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2004, 173, 41-48.http://dx.doi.org/10.1007/ s00213-003-1696-3 [121] Doremus-Fitzwater, T.L.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Genet., 2007, 37, 101-118. http://dx.doi.org/10.1007/s10519-006-9097-0 [125] Kabbaj, M. Individual differences in vulnerability to drug  abuse: the high responders/low responders model.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Drug Targets, 2006, 5, 513-520. http://dx.doi.org/10.2174/ 187152706778559318 [126] Pierre, P.J.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 1997, 129, 277-284.http://dx.doi.org/10.1007/s002130050191 [127] Grimm, J.W.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 1997, 61, 755-761. http://dx.doi.org/10.1016/S0031-9384(96)00532-X [128] Marinelli, M.; White, F.J.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2001, 157, 31-39. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2001, 158, 382-387. http://dx.doi.org/10.1007/s002130100918 [134] De la Peña, I.; Gonzales, E.L.; de la Peña, J.B.; Kim, B.N.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neurosci., 2005, 119, 464-472.http://dx.doi.org/ 10.1037/0735-7044.119.2.464 [136] Bird, J.; Schenk, S. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, http://www.ncbi.nlm.nih.gov/pubmed/ 11255927 2000, 153, 31-43.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Biol., 2007, 12, 227-462. http://dx.doi.org/10.1111/j.1369-1600.2007.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neurobiol., 1998, 56, 613-672. http://dx.doi.org/10.1016/S0301-0082(98)00060-4 [142] Robbins, T.W.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 1994, 48, 581-586.http://dx.doi.org/10.1016/0091-3057(94)90317-4 [145] Pelloux, Y.; Costentin, J.; Duterte-Boucher, D. Differential effects of novelty exposure on place preference conditioning to amphetamine and its oral consumption.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 2004, 171, 277-285.http://dx.doi.org/10.1007/s00213-003-1584-x [146] Kosten, T.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 1998, 60, 785-791.http://dx.doi.org/10.1016/S0091-3057(97)00388-2 [147] Dietz, D.; Wang, H.; Kabbaj, M. Corticosterone fails to produce conditioned place preference or conditioned place aversion in rats.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 2007, 181, 287-291.http://dx.doi.org/10.1016/ j.bbr.2007.04.005 [148] Capriles, N.; Watson, S.Jr.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 1996, 707, 64-74.http://dx.doi.org/10.1016/0006-8993(95)01222-2 [150] Shimosato, K.; W a t a n a b e ,  S .",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Methods, 2003, 128, 103-110. http://dx.doi.org/10.1016/S0165-0270(03)00153-5 [151] Brabant, C.; Quertemont, E.; Tirelli, E. Evidence that the relations between novelty-induced activity, locomotor stimulation and place preference induced by cocaine qualitatively depend upon the dose: a multiple regression analysis in inbred C57BL/6J mice.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Brain Res., 2005, 158, 201-210.http://dx.doi.org/10.1016/j.bbr.",OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Pharmacol., 2006, 17, 119-131.http://dx.doi.org/ 10.1097/01.fbp.0000190685.84984.ec [153] Montagud-Romero, S.; Daza-Losada, M.; Vidal-Infer, A.; Maldonado, C.; Aguilar, M.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Neuro- psychopharmacology, 2005, 30, 1818-1831.http://dx.doi.org/10.1038/ sj.npp.1300724 [160] Misslin, R.; Ropartz, P.; Jung, L. Impairment of responses to novelty by apomorphine and its antagonism by neuroleptics in mice.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Psychopharmacology, 1984, 82, 113-117. http://dx.doi.org/ 10.1007/BF00426392 [161] Pierce, R.C.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Behav., 1990, 36, 321-325.http://dx.doi.org/10.1016/0091-3057(90)90411-A [162] Powell, S.B.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Genet., 1996, 12, 78-80.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
"Gen. Psychiatry, 1987b, 44, 573-588.http://dx.doi.org/10.1001/ archpsyc.1987.01800180093014 [167] Bevins, R.A.; Klebaur, J.E.",Non-OADS,/arxiv_data1/oa_pdf/9d/3d/CN-14-87.PMC4787288.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.101 6/j.jacbts.2016.01.008,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
Available at: http://www.nhlbi.nih.gov/research/ reports/2013-onsite-tools .,OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
Availableat:http://www.fda.gov/downloads/medicaldevices/ deviceregulationandguidance/guidancedocuments/ ucm416685.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
Available at:http://www.fda.gov/downloads/MedicalDevices/ ./UCM263366.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
Available at: http://www.healthit.gov/policy-researchers- implementers/hipaa-and-health-it .,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/main.PMC4787294.pdf
"Psychophysics Task Stimuli for the psychophysics experiment were generated  in  MATLAB  R2012a  (MathWorks, Inc.) and displayed using the Psychtoolbox package ( http://psychtoolbox.org).",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"All stimuli were generated in MATLAB R2012a (MathWorks, Inc.) and displayed using the Psychtoolbox package (http://psychtoolbox.org).",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
MRI Data Analysis FreeSurfer ( http://surfer.nmr.mgh.harvard.edu/ ) was used for surface reconstructions.,OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
Pre-processing of functional images  was  completed  in  SPM8  ( http://www.fil.ion.ucl.ac.uk/spm/).,OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
Software  built  in  house  was  used  in  order  to complete the pRF mapping analysis (http://dx.doi.org/10.6084/m9.figshare.1344765).,OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1113/jphysiol.1970.sp009022 ] [PMID: 5498493 ] [2] Wiesel TN, Hubel DH.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuron.2009.12.006 ] [PMID: 20152110 ] [4] Baseler HA, Gouws A, Haak KV, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1038/nn.2793 ] [PMID: 21441924 ] [5] Raemaekers M, Bergsma DP, van Wezel RJ, van der Wildt GJ, van den Berg AV.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1152/jn.00308.2010 ] [PMID: 21160012 ] [6] Neville HJ, Lawson D. Attention to central and peripheral visual space in a movement detection task.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/0006-8993(87)90297-6 ] [PMID: 3567606 ] [7] Bottari D, Caclin A, Giard MH, Pavani F. Changes in early cortical visual processing predict enhanced reactivity in deaf individuals.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1371/journal.pone.0025607 ] [PMID: 21980501 ] [8] Bottari D, Nava E, Ley P, Pavani F. Enhanced reactivity to visual stimuli in deaf individuals.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.3758/BF03333964 ] [10] Neville  HJ,  Lawson  D.  Attention  to  central  and  peripheral  visual  space  in  a  movement  detection  task:  an  event-related  potential  and behavioral study.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/0006-8993(87)90296-4 ] [PMID: 3567605 ] [11] Finney EM, Fine I, Dobkins KR.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
[http://dx.doi.org/10.1038/nn763 ] [PMID: 11704763 ] [12] Bross M. Response bias in deaf and hearing subjects as a function of motivational factors.,Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.2466/pms.1979.49.3.779 ] [PMID: 530780 ] [13] Mitchell TV, Armstrong BA, Hillyard SA, Neville HJ.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
[http://dx.doi.org/10.2466/pms.1980.51.3.839 ] [PMID: 7208225 ] [15] Mills CB.,Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.3758/BF03329860 ] [16] Tallal P, Poizner H. Temporal processing in deaf signers.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1038/nrn2758 ] [PMID: 19935836 ] [18] Bavelier D, Brozinsky C, Tomann A, Mitchell T, Neville H, Liu G. Impact of early deafness and early exposure to sign language on the cerebral organization for motion processing.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1162/089892905774597173 ] [PMID: 16269101 ] [20] Lomber SG, Meredith MA, Kral A. Adaptive crossmodal plasticity in deaf auditory cortex: areal and laminar contributions to supranormal vision in the deaf.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/B978-0-444-53752-2.00001-1 ] [PMID: 21741556 ] [21] Barone P, Lacassagne L, Kral A.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1371/journal.pone.0060093 ] [PMID: 23593166 ] [22] Kok MA, Chabot N, Lomber SG.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1002/cne.23439 ] [PMID: 23897533 ] [23] Cappe C, Morel A, Barone P, Rouiller EM.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhn228 ] [PMID: 19150924 ] [24] Falchier A, Clavagnier S, Barone P, Kennedy H. Anatomical evidence of multimodal integration in primate striate cortex.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
[http://dx.doi.org/10.1093/cercor/1.1.1 ] [PMID: 1822724 ] [26] Van Essen DC.,Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/S0079-6123(05)49013-5 ] [PMID: 16226584 ] [27] Huk AC, Dougherty RF, Heeger DJ.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1152/jn.00102.2009 ] [PMID: 19587323 ] [29] Sereno MI, Lutti A, Weiskopf N, Dick F. Mapping the human cortical surface by combining quantitative T(1) with retinotopy.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhs213 ] [PMID: 22826609 ] [30] Codina C, Pascalis O, Mody C, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1371/journal.pone.0020417 ] [PMID: 21673805 ] [31] Lyness RC, Alvarez I, Sereno MI, MacSweeney M. Microstructural differences in the thalamus and thalamic radiations in the congenitally deaf.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"Deafness Causes Plasticity in V1 The Open Neuroimaging Journal, 2016, Volume 10    17 [http://dx.doi.org/10.1016/j.neuroimage.2014.05.077 ] [PMID: 24907483 ] [32] Sereno MI, Dale AM, Reppas JB, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1126/science.7754376 ] [PMID: 7754376 ] [33] Dumoulin SO, Wandell BA.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2007.09.034 ] [PMID: 17977024 ] [34] Duncan RO, Boynton GM.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/S0896-6273(03)00265-4 ] [PMID: 12765616 ] [35] Harvey BM, Dumoulin SO.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2572-11.2011 ] [PMID: 21940451 ] [36] Song C, Schwarzkopf DS, Kanai R, Rees G. Neural population tuning links visual cortical anatomy to human visual perception.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuron.2014.12.041 ] [PMID: 25619658 ] [37] Jiang J, Zhu W, Shi F, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.5451-08.2009 ] [PMID: 19228973 ] [38] Park HJ, Lee JD, Kim EY, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2009.03.076 ] [PMID: 19361567 ] [39] Bridge H, von dem Hagen EA, Davies G, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.cortex.2012.08.010 ] [PMID: 23039995 ] [40] Lomber SG, Meredith MA, Kral A. Cross-modal plasticity in specific auditory cortices underlies visual compensations in the deaf.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1038/nn.2653 ] [PMID: 20935644 ] [41] Meredith MA, Kryklywy J, McMillan AJ, Malhotra S, Lum-Tai R, Lomber SG.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.bandl.2008.03.005 ] [PMID: 18471869 ] [43] Bosworth RG, Dobkins KR.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1006/brcg.2001.1497 ] [PMID: 12027400 ] [44] Tyler CW, Likova LT, Chen CC, Kontsevich LL, Schira MM, Wade AR.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.2174/157340505774574772 ] [45] Dale AM, Fischl B, Sereno MI.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1006/nimg.1998.0395 ] [PMID: 9931268 ] [46] Fischl B, Sereno MI, Dale AM.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1006/nimg.1998.0396 ] [PMID: 9931269 ] [47] Fischl B, Dale AM.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1109/42.906426 ] [PMID: 11293693 ] [49] Fischl B, Salat DH, Busa E, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/S0896-6273(02)00569-X ] [PMID: 11832223 ] [50] Fischl B, van der Kouwe A, Destrieux C, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhg087 ] [PMID: 14654453 ] [51] Ségonne F, Dale AM, Busa E, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2004.03.032 ] [PMID: 15219578 ] [52] Han X, Jovicich J, Salat D, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2006.02.051 ] [PMID: 16651008 ] [53] Jovicich J, Czanner S, Greve D, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2005.09.046 ] [PMID: 16300968 ] [54] Ségonne F, Pacheco J, Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1109/TMI.2006.887364 ] [PMID: 17427739 ] [55] Andersson JL, Hutton C, Ashburner J, Turner R, Friston K. Modeling geometric deformations in EPI time series.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1006/nimg.2001.0746 ] [PMID: 11304086 ] [56] Zuiderbaan W, Harvey BM, Dumoulin SO.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1167/12.3.10 ] [PMID: 22408041 ] [57] Cavanaugh JR, Bair W, Movshon JA.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1152/jn.00692.2001 ] [PMID: 12424292 ] [58] Lagarias JC, Reeds JA, Wright MH, Wright PE.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1137/S1052623496303470 ] [59] Schwarzkopf DS, Anderson EJ, de Haas B, White SJ, Rees G. Larger extrastriate population receptive fields in autism spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.4416-13.2014 ] [PMID: 24523560 ] [60] Johnson JA, Zatorre RJ.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhi039 ] [PMID: 15716469 ] [61] Laurienti PJ, Burdette JH, Wallace MT, Yen YF, Field AS, Stein BE.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1162/089892902317361930 ] [PMID: 11970801 ] [62] Eurich CW, Schwegler H. Coarse coding: calculation of the resolution achieved by a population of large receptive field neurons.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1007/s004220050349 ] [PMID: 9237361 ] [63] Moran J, Desimone R. Selective attention gates visual processing in the extrastriate cortex.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1126/science.4023713 ] [PMID: 4023713 ] [64] Anton-Erxleben K, Stephan VM, Treue S. Attention reshapes center-surround receptive field structure in macaque cortical area MT.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhp002 ] [PMID: 19211660 ] [65] Anton-Erxleben K, Carrasco M. Attentional enhancement of spatial resolution: linking behavioural and neurophysiological evidence.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1038/nrn3443 ] [PMID: 23422910 ] [66] de Haas B, Schwarzkopf DS, Anderson EJ, Rees G. Perceptual load affects spatial tuning of neuronal populations in human early visual cortex.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.cub.2013.11.061 ] [PMID: 24456976 ] [67] Klein BP, Harvey BM, Dumoulin SO.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuron.2014.08.047 ] [PMID: 25242220 ] [68] Saygin AP, Sereno MI.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1093/cercor/bhm242 ] [PMID: 18234687 ] [69] Buckley D, Codina C, Bhardwaj P, Pascalis O.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.visres.2009.11.018 ] [PMID: 19962395 ] [70] Bosworth RG, Wright CE, Bartlett MS, Corina DP, Dobkins KR.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1167/13.7.13 ] [PMID: 23788461 ] [72] Pénicaud S, Klein D, Zatorre RJ, et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2012.09.076 ] [PMID: 23063844 ] [73] Allen JS, Emmorey K, Bruss J, Damasio H. Neuroanatomical differences in visual, motor, and language cortices between congenitally deaf signers, hearing signers, and hearing non-signers.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1016/j.bandl.2011.05.007 ] [PMID: 21705060 ] Received: May 9, 2015 Revised: October 4, 2015 Accepted: October 10, 2015 © Smittenaar et al.",OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  (https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/TONIJ-10-1.PMC4787313.pdf
"[http://dx.doi.org/10.1097/NMC.0b013e3182836bb7] [PMID: 23579417] [2] Riggs JW, Blanco JD.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1016/S0146-0005(98)80013-X] [PMID: 9738989] [3] Lamont RF, Sobel JD, Akins RA, et al.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1111/j.1471-0528.2010.02840.x ] [PMID: 21251190 ] [4] Collins MD, Jovita MR, Hutson RA, Ohlén M, Falsen E. Aerococcus christensenii sp.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1099/00207713-49-3-1125 ] [PMID: 10425770 ] [5] De Martino SJ, Mahoudeau I, Brettes JP, Piemont Y, Monteil H, Jaulhac B. Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1128/JCM.42.12.5940-5943.2004 ] [PMID: 15583348 ] [6] Ulger-Toprak N, Summanen PH, Liu C, Rowlinson MC, Finegold SM.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1099/ijs.0.001966-0 ] [PMID: 19666813 ] [7] Jensen KH, Dargis R, Christensen JJ, Kemp M. Ribosomal PCR and DNA sequencing for detection and identification of bacteria: experience from 6 years of routine analyses of patient samples.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1111/apm.12139 ] [PMID: 23879657 ] [8] Morita M, Wang HL.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1034/j.1600-051x.2001.028009813.x ] [PMID: 11493349 ] [9] Cabrera IB, Quinones JN, Durie DE, et al.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1097/01.AOG.0000447324.05518.6e ] [10] Cahill AG, Duffy CR, Odibo AO, Roehl KA, Zhao Q, Macones GA.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
[http://dx.doi.org/10.1097/AOG.0b013e318256ce3f ] [PMID: 22617572 ] [11] DiGiulio DB.,Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1016/j.siny.2011.10.001 ] [PMID: 22137615 ] [12] Wang X, Buhimschi CS, Temoin S, Bhandari V, Han YW, Buhimschi IA.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1371/journal.pone.0056131 ] [PMID: 23437088 ] [13] Jose A, Cunha BA, Klein NC, Schoch PE.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1016/j.hrtlng.2013.11.005 ] [PMID: 24341951 ] [14] Boennelycke M, Christensen JJ, Arpi M, Krause S. Leptotrichia amnionii found in septic abortion in Denmark.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
[http://dx.doi.org/10.1080/00365540601053022 ] [PMID: 17454911 ] [15] Murdoch DA.,Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1093/clinids/22.3.471 ] [PMID: 8852965 ] [17] Faro S, Walker C, Pierson RL.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1097/00006250-198003001-00003 ] [PMID: 7360458 ] [18] Christensen JJ, Korner B, Casals JB, Pringler N. Aerococcus-like organisms: use of antibiograms for diagnostic and taxonomic purposes.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
[http://dx.doi.org/10.1093/jac/38.2.253 ] [PMID: 8877539 ] [19] Rasmussen M. Aerococci and aerococcal infections.,Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1016/j.jinf.2012.12.006 ] [PMID: 23277106 ] [20] Uemura H, Hayakawa K, Shimada K, et al.",OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/TOMICROJ-10-27.PMC4787314.pdf
"[http://dx.doi.org/10.1902/jop.1965.36.3.177 ] [PMID: 14296927 ] [2] Theilade E, Wright WH, Jensen SB, Löe H. Experimental gingivitis in man.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1111/j.1600-0765.1966.tb01842.x ] [PMID: 4224181 ] [3] Socransky SS.,OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1177/00220345700490020401 ] [PMID: 4313844 ] [4] Lindhe J, Hamp S, Löe H. Experimental periodontitis in the beagle dog.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-0765.1973.tb00735.x ] [PMID: 4272068 ] [5] Dzink JL, Socransky SS, Haffajee AD.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1988.tb01590.x ] [PMID: 3292595 ] [6] Socransky SS, Haffajee AD.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1111/j.1600-0757.2005.00107.x ] [PMID: 15853940 ] [7] Genco RJ.,OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1902/jop.1996.67.10.1041 ] [PMID: 8910821 ] [8] Pennel BM, Keagle JG.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1902/jop.1977.48.9.517 ] [PMID: 333086 ] [9] Heitz-Mayfield  LJ.,OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2005.00803.x ] [PMID: 16128838 ] [10] Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1982.tb02108.x ] [PMID: 6960023 ] [11] Socransky SS, Haffajee AD, Goodson JM, Lindhe J.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1984.tb01305.x ] [PMID: 6582072 ] [12] Kina JR, Kina J, Kina EF, Kina M, Soubhia AM.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1590/S1678-77572008000300008 ] [PMID: 19089219 ] [13] Kina JR, Suzuki TY, Kina J, Kina M, Kina EF.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1046/j.0906-6713.2002.003421.x ] [PMID: 14717852 ] [16] Smalley JW.,OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.1997.tb00192.x ] [PMID: 9567966 ] [18] Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1902/jop.2003.74.7.1007 ] [PMID: 12931763 ] [19] Takata T, Donath K. The mechanism of pocket formation.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1902/jop.1988.59.4.215 ] [PMID: 3164372 ] [20] Page RC, Sturdivant EC.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1034/j.1600-0757.2002.03003.x ] [PMID: 12236893 ] [21] Repeke CE, Cardoso CR, Claudino M, et al.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1590/S1678-77572012000100020 ] [PMID: 22437688 ] [22] Schmidt AM, Weidman E, Lalla E, et al.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"Non-Inflammatory Destructive Periodontal Disease The Open Dentistry Journal, 2016, Volume 10    57 [http://dx.doi.org/10.1111/j.1600-0765.1996.tb01417.x ] [PMID: 8915955 ] [23] Nyman S, Lindhe J, Ericsson I.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1978.tb02282.x ] [PMID: 279549 ] [24] Rosania AE, Low KG, McCormick CM, Rosania DA.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1902/jop.2009.080334 ] [PMID: 19186966 ] [25] Dawson PE.,Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
[http://dx.doi.org/10.1016/j.jsb.2012.10.008 ] [PMID: 23110851 ] [28] Pavone BW.,OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1016/0022-3913(85)90026-5 ] [PMID: 3858535 ] [29] Yustin D, Neff P, Rieger MR, Hurst T. Characterization of 86 bruxing patients with long-term study of their management with occlusal devices and other forms of therapy.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1902/jop.2009.090149 ] [PMID: 19961379 ] [32] Zubery Y, Machtei EE.",OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1984.tb00837.x ] [PMID: 6199377 ] Received: December 27, 2014 Revised: September 17, 2015 Accepted: October 27, 2015 © José Ricardo Kina et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/TODENTJ-10-50.PMC4787315.pdf
"[http://dx.doi.org/10.1183/09031936.00128008 ] [PMID: 19407051 ] [2] Decramer M, Rennard S, Troosters T, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1080/15412550802237531 ] [PMID: 18671149 ] [3] Eickhoff P, Valipour A, Kiss D, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1164/rccm.200709-1412OC ] [PMID: 18836149 ] [4] Brekke PH, Omland T, Holmedal SH, Smith P, Søyseth V. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00015807 ] [PMID: 18032444 ] [5] Man SF, Xing L, Connett JE, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00153207 ] [PMID: 18799503 ] [6] Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1513/pats.200708-142ET ] [PMID: 18453369 ] [7] Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00015608 ] [PMID: 18978137 ] [8] Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1378/chest.130.2.326 ] [PMID: 16899829 ] [9] Price LC, Wort SJ, Perros F, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1378/chest.11-0793 ] [PMID: 22215829 ] [10] Chaouat A, Savale L, Chouaid C, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1378/chest.08-2420 ] [PMID: 19349390 ] [11] Kwon YS, Chi SY, Shin HJ, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.3346/jkms.2010.25.10.1487 ] [PMID: 20890431 ] [12] Andersen CU, Mellemkjær S, Nielsen-Kudsk JE, Bendstrup E, Hilberg O, Simonsen U.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
[http://dx.doi.org/10.1016/j.ijcard.2013.06.033 ] [PMID: 23849967 ] [13] Burger CD.,OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1080/15412550902754252 ] [PMID: 19378227 ] [14] Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00015608 ] [PMID: 18978137 ] [15] Solidoro P, Boffini M, Lacedonia D, Scichilone N, Paciocco G, Di Marco F. Pulmonary hypertension in COPD and lung transplantation: timing and procedures.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1016/j.rmed.2010.05.009 ] [PMID: 20547449 ] [17] Hanaoka M, Ideura G, Ito M, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1111/j.1440-1843.2008.01318.x ] [PMID: 18657066 ] [18] Naeije R, Boerrigter BG.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00173512 ] [PMID: 23633606 ] [19] Lewis GD, Bossone E, Naeije R, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000667 ] [PMID: 24060943 ] [20] Pellegrino R, Viegi G, Brusasco V, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.05.00035205 ] [PMID: 16264058 ] [21] Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09041950.041s1693 ] [PMID: 24576916 ] [22] Sue DY, Wasserman K, Moricca RB, Casaburi R. Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
[http://dx.doi.org/10.1378/chest.94.5.931 ] [PMID: 3180897 ] [23] Campbell SC.,Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1249/00005768-198205000-00012 ] [PMID: 7154893 ] [25] Sahn DJ, DeMaria A, Kisslo J, Weyman A.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1161/01.CIR.58.6.1072 ] [PMID: 709763 ] [26] Hatle L, Angelsen B. Doppler ultrasound in cardiology: Physical principles and clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"Pulmonary Arterial Pressure and Exercise The Open Respiratory Medicine Journal, 2016, Volume 10    11 [http://dx.doi.org/10.1161/01.CIR.70.4.657 ] [PMID: 6478568 ] [28] Simonson JS, Schiller NB.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1016/0735-1097(88)91531-8 ] [PMID: 3343458 ] [29] Currie PJ, Seward JB, Chan KL, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1016/S0735-1097(85)80477-0 ] [PMID: 4031289 ] [30] Kimberly MM, Vesper HW, Caudill SP, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1373/49.4.611 ] [PMID: 12651814 ] [31] Pyxaras SA, Pinamonti B, Barbati G, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1093/ejechocard/jer127 ] [PMID: 21821609 ] [32] Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.00145608 ] [PMID: 19324955 ] [33] Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1046/j.1469-7580.2002.00096.x ] [PMID: 12430958 ] [34] Cao JJ, Arnold AM, Manolio TA, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.645606 ] [PMID: 17576871 ] [35] Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1056/NEJMoa0707402 ] [PMID: 18971492 ] [36] Robbins IM, Newman JH, Johnson RF, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1378/chest.08-2008 ] [PMID: 19188551 ] [37] Lam CS, Borlaug BA, Kane GC, Enders FT, Rodeheffer RJ, Redfield MM.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.108.838698 ] [PMID: 19433755 ] [38] Skjørten  I,  Hilde  JM,  Melsom  MN,  Hansteen  V,  Steine  K,  Humerfelt  S.  Pulmonary  artery  pressure  and  PaO2  in  chronic  obstructive pulmonary disease.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1016/j.rmed.2013.03.021 ] [PMID: 23768734 ] [39] Gläser S, Noga O, Koch B, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1016/j.rmed.2008.08.005 ] [PMID: 18804360 ] [40] Ammash NM, McGoon MD, Shub C, et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1186/1476-7120-6-51 ] [PMID: 18851729 ] [42] Janda S, Shahidi N, Gin K, Swiston J.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1136/hrt.2010.212084 ] [PMID: 21357375 ] [43] Peinado VI, Santos S, Ramírez J, Roca J, Rodriguez-Roisin R, Barberà JA.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"[http://dx.doi.org/10.1183/09031936.02.00282002 ] [PMID: 12212964 ] Received: June 25, 2015 Revised: October 20, 2015 Accepted: October 21, 2015 © Varga et al.",OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/e3/TORMJ-10-1.PMC4787317.pdf
